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ABSTRACT 
This thesIs attempts to determine the role of 5-hydroxytryptamine (5-HT) in 
rodent models of anxiety. Using the elevated X-maze it was possible to detect 
dose-dependent anxiolyttc effects of dIazepam and dose-dependent 
arudogenic effects of FG 7142 (a J3-carboline dertvative) and idazoxan. The 
fear-potentiated acoustic startle paradIgm also detected the effects of these 
compounds but the results were neither dose-dependent nor very 
reproducible. Using the X-maze the 5-HTIA receptor partIal agonIst 
ipsapirone had no effect after either acute or chroniC treatment. while both 
the 5-HT2 receptor antagonist. ritanserin. and the 5-HT3 receptor 
antagonist. ondansetron. had arudolytic activity after chrOniC treatment. 
Using in vivo mirodialysis it was demonstrated that extracellular levels of 
5-HT in the ventral hippocampus increase when the animal is on the X-
maze. and both diazepam and F 2692 (I-(3'-trtfluoro-methylphenyl) 1.4-
dihydro 3-amino 4-oxo 6-methyl pyrldazine) reduced the increased 5-HT 
levels and produced an arudolytic behavioural profile in the same animal. 
Thus. the inhibition of increased 5-HT release may be important for 
anxlolytic activity. However. ipsapirone also reduced the increased 5-HT but 
did not produce an anxlolytic profile. The lack of an anxlolytic effect may be 
the result of postsynaptic 5-HT1A receptor stimulation. 
Rats reared in isolation immedIately post-weaning (21 days of age) dIsplayed 
enhanced locomotor actMty and an anxiogenic profile on the X-maze. This 
anxiogenic profile was neither reversed by resocialisation of the isolation-
reared rats nor produced by Isolation of adult socially housed animals. 
indicating a permanent developmental change. Isolation-reared rats had 
reduced stimulated release of 5-HT measured in the frontal cortex. indicating 
reduced presynaptic function. and enhanced responsiveness to agonists 
acting at postsynaptic 5-HTl A and 5-HT2 receptors. suggesting 
supersensitivity at these sites. 
Overall. 5-HT appears to be involved in anxiety. with 'anxious' behaViour 
either on the X-maze or by isolation-reartng causing changes in 5-HT 
function. Thus one of the mechanisms of action of established and putative 
anxiolytic and anxiogenic compounds may be via modulation of the 
ascending dorsal raphe serotonergic neuronal pathways. 
All work in this thesis was undertaken under Home Office Personal LIcence 
PIL 70/02103 and Project Licences PPL 40/0380 (Nottingham University) 
and PPL 70/00349 (SmlthKline Beecham). 
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CHAPTER 1 
GENERAL INTRODUCTION 
Identlfication of 5 - H ~ t a m 1 n e e
The compound now known as 5-hydroxytryptamine (5-HT) was first isolated 
from bovine serum and given the name "serotonin" by Rapport (1949). The 
name was derived from its source (serum) and its activity (vasoconstriction). 
In 1951. the biogenic amine. serotonin. was definitely identified as 3-(2-
aminoethyl)-5-hydroxymdole or 5-HT (Hamlin and Fischer. 1951). About 
this time a substance called "enteramine". found in high concentrations in 
chromaffin cells of the intestinal mucosa. also seen to constrict smooth 
muscular elements. was shown to be identical to 5-HT (Erspamer and Asero. 
1952). In 1953. Twarog and Page identified 5-HT in the brain of rats and 
rabbits; and interest in 5-HT as a possible central nervous system (CNS) 
transmitter dates from the same year. when Fingl and Gaddum (1953) found 
that minute quantities of lysergic acid diethylamide (LSD) could antagonize 
the effect of 5-HT on the rat uterus. and suggested that its central effects (it 
was already known to be a potent psychotomimetic substance) might also be 
related to this action. Even though CNS 5-HT accounts for only about 1% of 
the total body content. it occupies a central position in the neurochemical 
hegemony (Jacobs and Gelpertn.1981: Osborne. 1982). 
Distribution of 5-HT 
Estimation of the amount of 5-HT in dissected brain areas by Amin et al. 
(1954) showed that the highest concentration was found in the 
hypothalamus. area postrema and midbrain. Using the technique of 
fluorescence histochemistry. developed by Falck et al. (1962), Dahlstrom and 
Fuxe (1964) showed that there were nine groups of cells (named BI-B9) 
containing 5-HT in the brainstem and midbrain. located mainly in the 
raphe nuclei. These cells send projections to the spinal cord. brain stem 
n u ~ l e i . . and the forebrain (Dahlstrom and Fuxe. 1964). A sagttal section 
showing these projections is shown in Figure 1. The dorsal (B7) and median 
(B8) raphe nuclei were shown to contain most of the 5-HT-producing 
neurones of the midbrain. From numerous studies it has emerged that there 
is good agreement in the overall distribution of the 5-HT-containing cell 
bodies in different mammalian species. Anden et al. (1966) demonstrated a 
loss of fluorescent 5-HT axons in forebrain following lesions of the anterior 
raphe nuclei or of the hypothalamus. These results. combined with the 
inability to find 5-HT-containing cell bodies in the forebrain. lead to the 
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Figure 1 
DIagrammatic representation of a sagittal section through a rat brain 
showing the serotonergic cell groups, B1 - B9 and theIr major neuronal 
pathways whIch provIde the serotonergic innervation of the brain. The 
drawing was taken from Consolazine and Cuello (1982). 
Key: OT = olfactoty tuberculum, sept = septum, C.Put = caudate putamen, 
G.Pal = globus pallidus, T = thalamus, H = habenula, S.Ntgra = substantia 
nigra. 

proposal that most of the ascending 5-HT projections arise from cell bodies 
situated in the raphe nuclei of the midbrain. Using anterograde transport of 
(3H)-proline it was shown that the projections from both the dorsal (B7) and 
median (B8) raphe nuclei ascended in 6 tracts and Innervated different areas 
of the brain (Azmitia and Segal. 1978). Using intracerebroventricular 
administration of (3H]-5-HT (Parent et aI.. 1981) two major ascending 
systems of fibres. the transtegmental and periventricular which met in the 
medial forebrain bundle in the hypothalamus. were found. Parent et al. 
( 1981) also described the distribution of varicosities and terminals in 
various areas of the brain. including a uniform innnervation of all cortical 
layers. obtaining clearer results than those seen with fluorescence (Fuxe. 
1965) or (3H]-proline (Azm1tia and Segal. 1978). Using an antibody to 5-HT 
to examine the distribution of 5-HT cell bodies and terminals Steinbush 
(1981) found that beSides labelling cell groups BI-B9. cell bodies were also 
seen in the area postrema. locus coeruleus and interpeduncular nucleus. 
Synthesis, Release and Metabolism of 5-HT 
5-HT is formed by a two-step process from the essential amino acid. L-
tryptophan. which enters the brain from the blood by both diffUSion and 
carrier-mediated transport (Young and Sourkes. 1977: Pratt. 1979). In the 
cytoplasm of serotonergic neurones. L-tryptophan is converted to 5-
hydroxytryptophan (5-HTP) by the enzyme tryptophan hydroxylase and 
then decarboxylated to 5-HT by aromatic L-amino acid decarboxylase 
(Boadle-Biber. 1982). Administration of tryptophan to rats causes an 
elevation in brain 5-HT levels (Fernstrom and Hirsh. 1974): however. the 
carrier-mediated transport depends both on the amount of tryptophan and 
the relative proportions of other amino acids in the diet (Partridge. 1979). 
Newly syntheSized 5-HT either remains in the cytoplasm or is taken up into 
synaptic veSicles. As most of the 5-HT in the brain is stored in vesicles it has 
been suggested that 5-HT is released by exocytosis. a process which is 
calcium-dependent (for review see Sanders-Bush and Martin. 1982). 
However. there is evidence which shows that 5-HT is not necessarily released 
by exocytosis and that it is newly synthesized 5-HT which is preferentially 
released (Kuhn et at. 1986). There appears to be two pools of 5-HT. one in the 
cytoplasm and one in the vesicles. the latter being a stable store which is 
2 
only released after prolonged stimulation (Grahame-Smith. 1971. 1974: Elks 
et al.. 1979). The release mechanism of 5-HT is unclear and all of the 
putative mechanisms put forward still require calcium for normal 
functioning (Unvas and Aborg. 1984: Kuhn et aI .. 1986). 
After release. 5-Hf is taken up into neurones by a carrier which is dependent 
upon Na+ /K+ ATPase (for review see Ross. 1982). After reuptake. 5-Hf either 
enters the vesicles or is rapidly metabolised to either melatonin by the 
enzymes N-acetyltransferase and hydroxindole-O-methyltransferase. or 5-
hydrOxyindole acetic acid (5-HIAA) by monoamine oxidase A and aldehyde 
dehydrogenase (Kuhn et aI .• 1986). There is evidence which suggests that 
excessive 5-Hf in the nerve termlnalis also metabolised to 5-HIAA and thus 
5-HIAA levels are not a good marker of 5-HT release (Grahame-Smith. 1971. 
1974: Kuhn et aI .• 1986). 
The actions of 5-Hf are profound and it is thought to playa modulatory role 
in many physiological functions. such as feeding (Blundell and Latham. 
1982: Samanin. 1983). locomotor activity (Jacobs et al.. 1984). and social 
and sexual behaviour (Ahlenius et al.. 1981: Hillegaart et al.. 1989). The 
diverse actions of 5-HT suggest that it is interacting with many different 
subtypes of the 5-Hf receptor. 
5-HT Receptor Clasalflcation 
In 1957 Gaddum and Picarelli presented evidence for the existence of two 
pharmacologically distinct types of receptor for 5-HT in guinea-pig Ueum. 
One type of receptor mediated the contraction of the smooth muscle and was 
antagonised by phenoxybenzamine (dibenzyl1ne). and was named the 'D' 
receptor subtype: the other type of receptor mediated depolartsaUon of the 
cholinergic nerves and was antagonised by morphine and named the 'M' 
receptor subtype (Gaddum and Picarelli. 1957). This hypothesis remained 
until the late 1970s when radioligand binding studies became available. 
Initially two binding sites were identified in the eNS using (3H)-5-HT and 
(3H)-spiperone (Peroutka and Snyder. 1979). Drugs such as 5-HT displayed 
different potenCies for displacing (3H)-5-HT and (3H]-spiperone binding and 
the Hill coefficient for [3H]-lysergic acid diethylamide (LSD) binding in the 
presence of 5-HT was less than one, indicating the existence of more than 
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one binding site. These two sites were called 5-HTl and 5-HT2 respectively 
(Peroutka and Snyder. 1979); the 5-HTl sites were labelled with nanomolar 
concentrations of 13H]-5-HT. and the 5-HT2 sites were labelled with 
micromolar concentrations of [3H)-5-HT and also showed high affinity for 
spiperone (Peroutka and Snyder. 1979). This discovery aroused interest and 
efforts were made to develop more selective compounds. Based on the 
atypical dIsplacement curves of spiperone on 13H]-5-HT the 5-HTl receptor 
was found to be dMded into at least two subtypes. one with high affinity and 
the other with low affinity (Pedigo et al.. 1981). The high affinity site was 
called the 5-HTIA site (Deshmukh et at. 1982) and characterised using the 
selective tetralin derivative. 8-hydroxy-2-(di-n-propylamino) tetralin (8-
OH-DPAT. Gozlan et aI.. 1983; MiddlemIss and Fozard. 1983). The low 
affinity site was named the 5-HTIB site and characterised with RU24969 
(Sills et aI.. 1984; Middlemiss. 1985) and cyanopindolol (Sills et aI .• 1984; 
Hoyer et aI.. 1985). The 5-HTIB receptor is present only in some rodent 
brains and has not been found in guinea-pig. cow. chicken. turtle. frog. or 
human brain membranes (Hoyer et aI .• 1986a; Heuring et at. 1986). A novel 
5-lIT binding site was found in porcine choroid plexus which was distinct 
from 5-lITIA. 5-HTIB and 5-HT2 binding sites (Pazos et aI .• 1984). This site 
has been named the 5-HTIC site because it has high affinity for 5-lIT and 
relatively low affinity for RU24969 and spiperone (Pazos et aI.. 1984). In 
bovine caudate a fourth type was found and caIled 5-HTID (Heuring and 
Peroutka. 1987). This receptor subtype was initially not thought to exist in 
the rodent brain but has subsequently been found there (Herrick-Davis and 
Titeler. 1988). Recent evidence suggests two subtypes of the 5-HTID binding 
site in guinea-pig. rabbit. dog and human cortex (Middlemiss et al.. 1990; 
Elliott et aI.. 1991). It is pOSSIble that the 5-HTID receptor in guinea-pig and 
non-rodent brains is equivalent to the 5-HTIB receptor in the rat and mouse 
(Hoyer and Middlemiss. 1989). Recently. other 5-HTl binding sites which 
have been deSCribed are the 5-HTIE receptor in human cortex (Leonhardt et 
al.. 1989). the 5-HTIP receptor in gUinea-pig enteric neurones (Mawe et aI .. 
1986). and the 5-HTIR receptor in rabbit caudate (Xiong and Nelson. 1989). 
Given the known species variations in 5-HTID/5-HTIB sites (Hoyer and 
Middlemiss. 1989). it is possible that the 5-HTIR binding site may represent 
the rabbit version of the 5-HTl D receptor binding site. To date. little 
evidence exists to demonstrate that these binding sites are functional 
receptors. Bradley et aI. (l986a) proposed that the subtypes of the 5-HTl 
receptor be referred to as '5-HTl-like' receptors until functional correlates 
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have been found for each subtype. The D receptor in the periphery has been 
shown to be the functional correlate of the central 5-HT2 receptor (Engel et 
aI.. 1985; Maayani et aI.. 1984; Bradley et al .. 1986a). It has been suggested 
that the 5-HT2 receptor has subtypes (McKenna and Peroutka. 1989) but there 
is much controversy surrounding this theory (Strange. 1990) with recent 
findings suggesting that apparent heterogeneity in functional 5-HT2 
receptors is species-dependent (Mylecharane and Martin. 1991). The M 
receptor was designated the 5-HT3 receptor (Richardson and Engel. 1986; 
Bradley et al.. 1986a) and was thought only to exist in the periphery (Bradley 
et al .• 1986a) but has subsequently been found in the eNS (Kilpatrick et aI.. 
1987). Work suggested that this receptor may have at least 3 distinct subtypes 
(Richardson et al .. 1985; Richardson and Engel. 1986; Bradley et aI.. 1986a) 
and although this was thought not to be the case (Mylecharane. 1989) recent 
evidence suggests heterogeneity at this site (Butler et al.. 1990; Eglen et al.. 
1991). and that the 5-HT3 receptors of the rat. mouse and gUinea-pig cervical 
ganglion may be different (Newberry et al .. 1991). Recently. a fourth 5-HT 
receptor subtype has been found in mouse embryo collicul1 neurons in 
primary culture (Dumuis et aI.. 1988). This has been named the 5-HT4 
receptor. and more recently has been found in rodent brain (Dumuis et al .. 
1989). guinea-pig ileum (Eglen et aI.. 1990), piglet left atrium (Kaumann et al .. 
1991) and gUinea-pig ascending colon (Bunce et aI.. 1991; Elswood et aI.. 
1991). 
5-HT Receptor Subtypes 
5-HTlA Receptors 
5-HTIA receptors are distributed in a number of brain regions with the 
highest densities in the cortex. hippocampus. and raphe nuclei. especially 
the dorsal raphe nucleus (DRN) (Pazos and Palacios. 1985; Hoyer et aI.. 1985; 
Verge et aI.. 1986). The receptors are located both pre- and post-synaptically. 
The pre-synaptic sites are found in the DRN on the cell bodies and dendrites 
(Pazos and Palacios. 1985; Hoyer et al .• 1985: Sotelo et aI.. 1991: Verge et al .. 
1986; Waeber et al .. 1989) and the receptors in the hippocampus and frontal 
cortex appear to be located post-synaptically (Pazos and PalaCiOS. 1985: 
Hoyer et al .• 1985: Verge et aI .• 1986; Waeber et al .• 1989). 
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Recently. a genomic clone (G-21). when expressed in monkey kidney cells. 
has the appearance of a 5-lITIA receptor (Fargm et aI .• 1988). The binding 
sites expressed by the cells have high affinity for ,3H)-8-0H-DPAT and 
appeared to have two affinity states. High affinity binding was converted to 
low affinity binding by the addition of guanyl nucleotides. The G-21 clone 
has 7 transmembrane domains (a sign of a G-protein coupled receptor) and a 
'45%, homology With adrenergic receptors (Fargm et al.. 1988). 
5-lITIA receptors are coupled to adenylate cyclase as their second messenger 
transduction system. Stimulation of adenylate cyclase by 5-IITIA receptor 
activation has been demonstrated in guinea-pig hippocampus (Shenker et 
al.. 1987) and rat cortex and hippocampus (Marksteln et al.. 1986; Mork and 
Geisler. 1990). 5-IITIA receptor activation also inhibits forskolin- or Ca2+-
stimulated adenylate cyclase activity in guinea-pig and rat hippocampus (de 
Vivo and Maayant. 1986; Bockaert et aI .. 1987). The exact roles of the two 
different couplings stm remains unclear. 
Electrophysiological data have demonstrated that 5-HTIA agontsts inhibit 
both the spontaneous firing rate of 5-lIT neurones in the DRN (Fallon et aI .• 
1983; VanderMaelen and' Wilderman. 1984; Sprouse and Aghajanian. 1986) 
and the population spike generated by hippocampal CAl cells (Beck and 
Goldfarb. 1985). 
Measurement of 5-HT in vivo using either microdialysis or differential 
pulse voltammetry. has found that 5-HTIA agontsts decrease 5-1IT release in 
terminaI regions such as the frontal cortex and hippocampus (Crespi et al.. 
1990; Hjorth and Magnusson; 1988; Hutson et aI .. 1989; Sharp et al .. 1989a). 
This effect is thought to be predominantly as a result of action at the 
somatodendritic autoreceptor in the dorsal raphe nucleus (Hjorth and 
Magnusson. 1988; Hutson et aI .. 1989; Sharp et aI .. 1989c). 
Administration of 5-HT precursors such as L-tryptophan or 5-
hydroxytryptophan (5-IITP) in the presence of a peripheral decarboxylase 
inhibitor results in a series of behaviours known as the '5-HT behavioural 
syndrome' (Grabame-Smith, 1971; Green et aI .• 1983b). The syndrome is also 
observed after 8-0H-DPAT (Hjorth et al.. 1982; Tricklebank et al.. 1985a; 
Goodwin and Green. 1985) and consists of hyperlocomotion. hindlimb 
abduction. head weaving, flat body posture and reciprocal forepaw treading 
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following prazosin or haloperidol pretreatment. hyperlocomoUon and head 
weaving are lost. suggesting a catecholaminergic component (Tricklebank et 
al.. 1985a). It Is thought that the flat body posture and reciprocal forepaw 
treading are mediated by post-synaptic 5-HTIA receptors. and this theory is 
supported by the fact that these behaviOUrs can be blocked by spiperone. 
plndolol. methlothepin. BMY 7378 and NAN-190 (HJorth et al.. 1982: 
Tricklebank et al .. 1985a: HJorth and Sharp. 1990: Sharp et al .. 1990). 
Administration of the selective 5-HTIA agonist 8-0H-DPAT (Arvidsson et 
al.. 1981: Middlemiss and Fozard. 1983) results in a decrease in rectal 
temperature in rats and mice maintained at normal ambient temperature 
(Goodwin et al.. 1985: Hutson et al.. 1987). 8-0H-DPAT also affects food 
--- ---- - .... 
Intake. inducing hyperphagia in freely feeding (satiated) rats (Dourish et aI .. 
J ~ ~ ~ ) . . and hypophagia in food deprived or restricted feeding rats or rats on a 
reversed light-dark cycle (Dourish et aI .. 1985; Marsden et aI .• 1989). 5-HTIA 
receptors may be involved in contractile vascular responses to 5-HT and in 
blood pressure control. The 5-HTIA receptor has been found to mediate 
contraction in the canine basilar artery and saphenous vein (Fenuik et al .. 
1985: Peroutka et al.. 1986: Frenken. 1989) and the rabbit basilar artery 
(Bradley et aI .. 1986b). 
5-HTlB Receptms 
These receptors are found in many areas of rodent brain but appear to be 
absent In brains of higher mammals (Heuring et al.. 1986). The greatest 
denSities of 5-HTIB sites are in the dorsal subiculum. caudate putamen. 
globus pallidus and substantia nigra (Pazos and Palacios. 1985; Verge et al.. 
1986). 
Synaptosomal release of 5-HT can be reduced by stimulation of the 5-HflB 
receptor in rat brain (Ratteri et al.. 1986). Other studies have shown that in 
the rat brain the terminal 5-J-IT autoreceptor in the frontal cortex is of the 5-
HTIB subtype (Brazell et al.. 1985; Hoyer et al .. 1985: Middlemiss. 1985. 1986: 
Engel et aI .. 1986). 
At present there are no behavioural tests of 5-HTIB receptor function but 
recent evidence suggests that RU24969-induced hyperlocomotion in mice is 
the result of 5-HT} B receptor activation and involves catecholamine 
neurones in its expression (Cheetham et al .• 1991). 
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5-HTIC Recepton 
5-HTIC receptor sites were initially only thought to exist in the choroid 
plexus. where they appear to account for all the 5-HTl sites (Waeber et al .. 
1989b). but using in situ hybridization histochemistry these sites have been 
found in lower concentrations in other brain regions such as the cortex. 
amygdala. hippocampus. thalamus. substantia nigra and brain stem (Hoyer 
et al .. 1986b. c: Hoffman and Mezey. 1989: Molineaux et al .. 1989). 
The 5-HTlC receptor has been cloned and sequenced (Julius et a1.. 1988) and 
consists of a 460 amino acid sequence which contains 7 transmembrane 
domains (a sign of a G-protein coupled receptor) (Julius et al .. 1988). The 5-
HTIC and 5-HT2 receptors show remarkable similarity in their amino acid 
sequence (Lubbert et a1.. 1987: Julius et a1.. 1988). and physiologically. 
activation of the 5-HTIC. or 5-HT2. site stimulates phospholnositol (PI) 
hydrolysis (Conn et a1.. 1986). Physiologically. the 5-HTIC site appears to 
modulate a CI- conductance channel via a pertUSSiS toxin sens1t1ve G-
protein. However. selective antagonists are required for full 
characterization of the 5-HTIC receptor (Bradley et a1.. 1986a). 
5-HTID Receptors 
5-HTID receptors are found in the gUinea-pig and man and are located in 
similar areas to 5-HTIB receptors in specles such as the rat (Herrick-Davis 
and Titeler. 1988: Waeber et a1.. 1989). being located throughout the brain 
with high concentrations in the basal ganglia (Pazos and Palacios. 1985: 
Waeber et al .. 1988a). 
5-HTID sites. like the 5-HTIB sites. are negatively coupled to adenylate 
cyclase in bovine substantia nigra (Hoyer and Shoeffer. 1988) and unilateral 
activation of the 5-HTID receptors In the substantia nigra of the gUinea-pig 
elicits contralateral rotation (HigginS et a1.. 1991). It Is also thought to be 
involved with kidney perfusion and contraction of the rat stomach fundus 
(Heuring and Peroutka. 1987). 
5-HT2 Receptors 
5-HT2 receptors are located post-synaptically in the cortex. claustrum and 
brain stem with lower levels in the caudate putamen and substantia nigra 
(Blackshear et a1.. 1981: Leysen et a1.. 1982: Pazos et a1.. 1985: Hoyer et a1.. 
1986b: McKerma et al .• 1989). 
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The 5-HT2 receptor has been cloned (Pritchett et al .• 1988) and found to have 
7 transmembrane domains. indicating possible coupling to G-proteins. and 
51% sequence homology with the cloned 5-HTIC receptor (Pritchett et al.. 
1988). Xenopus oocytes injected with the RNA encoding for the nucleotide 
sequences produced 5-HT2 receptors which controlled Ca2+-sensiUve 
chloride channels (Pritchett et a!.. 1988). Another group has cloned the 5-
HT2 receptor and found it coupled with PI hydrolysis (Julius et al .• 1990). The 
same group found the 5-HT2 and 5-HTIC receptor cDNAs distributed in 
different regions of the CNS and concluded they were not coding for the same 
receptor (Julius et al .• 1990). 
5-HT2 receptors are coupled to PI metabolism as their second messenger 
transduction system. Stimulation of PI by 5-HT2 receptor activation has 
been demonstrated in platelets (de Chaffoy de Courcelles et al .• 1985). smooth 
muscle cells (Doyle et al.. 1986) and rat cerebral cortex: (Conn and Sanders-
Bush. 1984. 1986: Kendall and Nahorski. 1985). 5-HT2 receptor stimulated PI 
hydrolysis Is not a large response. usually less than a 2-fold Increase (Conn 
and Sanders-Bush. 1984. 1986; Kendall and Nahorski. 1985) which Is 
blphaslc. with selective 5-HT2 receptor antagonists only capable of 
Inhibiting the high affinity component (Kendall and Nahorski. 1985). 
The main behavioural response seen after 5-HT2 receptor agonists Is the 
head-twitch response in mtce (Corne et al .• 1963; Corne and Pickering. 1967: 
Goodwin and Green. 1985: Heaton et al .• 1988) and the 'wet-dog shake' (WDS) 
response in rats (Bedard and Pycock. 1977; Mathews and Smith, 1980: 
Goodwin and Green. 1985). Intrathecal administration of the selective 5-HT2 
agonists 2.5-dimethoXY-Cl,4-dimethyl-2-amlnopropane (DOM) and 1-(2.5-
dimethoxy-4-iodomethyl)-2-aminopropane (001) produces WDS and also 
back muscle contractions; both behaviours can be antagonised by 
ketanserin. a 5-HT2 antagonist (Fone et aI., 1989. 1991). Both Cll-
adrenoceptor antagonists and cx2-adrenoceptor agonlsts Inhibit the WDS 
response generated by 5-HT2 agonlsts In rats and mice (Green and Heal, 1985: 
Handley and Brown. 1982), whereas .B-adrenoceptor agonlsts and CX2-
adrenoceptor antagonists potentiate the WDS response generated by 5-HT2 
agonists (Handley and Brown. 1982: Handley and Singh. 1986), indicating a 
catecholamtne component. In addition, benzodiazepines also potentiate the 
WDS response (Handley and Singh. 1986). Finally, other compounds apart 
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from 5-HT2 receptor agonlsts have been seen to produce the WDS response. 
such as TRH and its analogues (Drust and Connor. 1983: Fone et aI.. 1989) 
and eokephalins (Drust and Connor. 1983). suggesting that this Is a complex 
response involving several neurochemical systems. 
5-HTs receptors 
5-HT3 receptors are found in the cortex. amygdala. hippocampus. area 
postrema and the highest density is found in the area subpostrema 
(Kilpatrick et al .• 1987: Pratt et aI.. 1990). 5-HT3 sites have also been 
identified in the human brain (Barnes et aI.. 1988. 1989a) being 
predominantly located in the amygdala and hippocampus (Barnes et al .• 
1989a). 
The second messenger transduction system of centrally located 5-HT3 
receptors has as yet not been elucidated and it is now thought that the 
receptor may be directly coupled to the ion channel (Clarke et aI.. 1989). 
However. a recent study has shown 5-HT3 receptor agonists to stimulate PI 
hydrolysis in the fronto-clngulate and entorhinal cortices (Edwards et al.. 
1991). Using in uivo microdialysis it has been demonstrated that 5-HT3 
receptor stimulation in the ventral hippocampus increases 5-HT release in 
this region. suggesting presynaptic facllttatory 5-HT3 receptors are involved 
in the control of 5-HT release (Martin et aI.. 1991). 
Behavioural studies have shown that ondansetron (GR38032F), a selective 5-
HT3 antagonist. reduces dopamine mediated behaviour (produced by either 
amphetamine administration or chroniC intracerebral dopamine infusion) 
back to basal levels and does not produce the catalepsy observed with 
dopamine antagonists (Hagan et aI.. 1987: Costall et aI.. 1987a). suggesting 
possible use in the treatment of schizophrenia. 5-HT3 antagonists have also 
been found to increase acetylcholine release in cortical tissue but only in the 
presence of rItanserIn (Barnes et al.. 1989b) and to enhance cognitive 
performance in the marmoset (Domeney et aI.. 1991). 5-HT3 antagonlsts 
produce no direct observable behavioural effects but are active in several 
models ofanx1ety (Jones et al .• 1987. 1988: Costall et al.. 1988. 1989a). There 
Is evidence to suggest that 5-HT3 antagonists reduce the withdrawal effects 
observed with drugs of abuse (ethanol. nicotine and cocaine) (Costall et al .• 
1990a. b). Finally. 5-HT3 antagonists are very good anti-emetics especially 
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for cancer chemotherapy and radiation induced vomiting both in anImal 
studies (Costall et al., 1987b) and the cl1n1c (Carm1cheal et al., 1988). 
5-HT4 Receptors 
The 5-HT4 receptor Is the most recently described subtype and was first found 
in mouse embryo coll1cul1 neurones in prtmary culture where it Is positively 
coupled to adenylate cyclase (DumuIs et al., 1988). Since then these receptors 
have been found peripherally in guinea-pig ileum (Craig and Clarke, 1989; 
Eglen et al., 1990) where stimulation evokes peristalsis (Craig and Clarke, 
1991) and centrally in guinea-pig hippocampus (Shenker et aI., 1987). The 
hippocampal 5-HT4 receptor Is also positively coupled to adenylate cyclase 
(Shenker et al., 1987). 
ANXIETY 
Anxiety exists as a normal state in all of us, however it is possible for it to 
develop into a full-blown pathological condition. The distinction between a 
pathological, as opposed to a normal. state of anxiety, Is hard to draw. but In 
spite of (or perhaps because 00 this diagnostic vagueness. anxiolytic drugs 
are among the most frequently prescribed substances. A recent study in 
Western European countries showed that the proportion of the total 
population using anxiolytlc drugs regularly was 17% in Belgium and France, 
14% In the U.K. and 10% in Spain. 
A person suffering from anxiety experiences an unpleasant emotional state 
characterized by tension. neIVousness, heart palpitations, tremor. nausea, 
dizziness, inability to think clearly and sometimes an inability to speak: 
other symptoms may include backache. headache and diarrhoea. 
The Diagnostic and Statistical Manual of the American Psychiatric 
Association (American Psychiatric Association, 1987) has classified anxiety 
disorders as shown In Table 1. 
These are essentially human manifestations, and except for certain 
components of the somatic and autonomic changes. have no obviOUS 
measurable counterpart in experimental animals. To develop new 
anxiolytlc drugs It is essential to have animal tests that give a good guide to 
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Table 1 
DSM-III-R Classification of Anxiety Disorders. Taken from the Diagnostic 
and Statistical Manual of Mental Disorders (I987), 3rd Ed. revised, p. 7. 
American PsychiatriC Association: Washington D.C .. 
DSM-III-R. Classification of Anxiety Disorders 
Anxiety disorders (or anxiety and phobic neuroses) 
Panic disorder 
300.21 
300.01 
300.22 
300.23 
300.29 
300.30 
309.89 
300.02 
300.00 
with agrophobia 
Specify current severity of agrophobic avoidance 
Specify current severity of panic attacks 
without agrophobia 
Specify current severity of panic attacks 
Agrophobia without history of panic attacks 
Specify with or without limited symptom attacks 
Social phobia 
Specify if generalized type 
Simple phobia 
Obsessive compulsive disorder (or obsessive compulsive 
neurosis) 
Post-traumatic stress disorder 
Specify if delayed onset 
Generalized anxiety disorder 
Anxiety disorder NOS 
activity in man. and considerable effort has gone into developing and 
validating such tests. 
BEHAVIOURAL MODELS OF ANXIETY 
Animal models of anxiety are needed both for use in research into the neural 
basis of anxiety and in screening new drugs for possible arudolytic activity. 
For certain clinical conditions. such as depression or schizophrenia. it is 
unlikely that animal models will ever reflect the essential features of the 
condition. However. there is no obvious reason why animals should not 
experience anxiety. 
The conditions most likely to elicit anxiety - unpredictability/uncertainty 
(e.g. triggered by a novel situation). or antiCipation of aversive events are 
also able to produce profound behavioural and physiological responses in 
animals. It is then up to the phannacologist to determine whether or not it is 
justifiable to infer from these changes that an animal is feeling anxious. 
Animal models of anxiety can be broadly divided into three main groups: 
1. those based on conflict or conditioned fear: 
2. those exploiting the uncertainty and anxiety generated by novel 
situations: 
3. those in which anxiety or aversion is chemically induced. 
The following section will briefly review the various animal models. giving 
an indication of the rel1abllity and extent of validation. The most 
extensively used method of validation is by studying the effects of known 
anxiolyUc and anxiogenic compounds. This has meant relying heavily on 
the benzodlazeplnes (BDZ). Hence most of the tests have proved reliable in 
detecting behavioural changes after BDZ treatment but do not appear to be as 
sensitive to many of the newer arudolyUcs such as buspirone. Thus. it is apt 
to ask whether the models are actually models of anxiety or models which 
detect compounds with BDZ-like activity. It Is important to note that the 
BDZ also cause sedation. ataxia. are muscle relaxants and anticonvulsants. 
and these effects may overlap with the arudolytic effects we are trying to 
study. 
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CONFLICT TESTS 
a) The GeUer-8elfter test 
This is a widely used model of anxiety (Geller and Seifer, 1962, Geller et al., 
1962). In this test the SUbject, usually a rat, is trained to lever-press on a 
schedule of food reward that has two components. In one component 
responses are reinforced with food, typically after a variable intelVal (VI) of 
time (1.e. the 'non-conflict' period). In the second component, which is 
signalled, responses are both reinforced with food and punished with electric 
shock (i.e. the 'conflict' period). Following fairly extensive training, rats 
reliably confine most of their responding to the VI, or 'non-conflict', 
component of the schedule. responding less during the 'conflict' periods. 
BDZs increase the responding during the 'conflict' component (punished 
responding) with a less marked effect on the 'non-conflict' component 
(unpunished responding). An assumption In the test that an increase in 
punished responding reflects a reduction in anxtety. 
A second test based on the conflict between reward and punishment 
introduced by Vogel et al. (1971). In this test, a water-deprived rat is punished 
with an electric shock when it drinks from a water spout (the shock being 
adm1n1stered either through the spout or the feet). Again. it is important to 
include a measure of unpunished responding, in order that compounds 
which are dlpsogenic are not detected as possible anxtolytlc agents. This test 
has proved good at detecting anxi01ytic drugs. but has a low reliabtltty in 
that it has a high rate of false positives. It is possible to lower the shock 
intenSity so that the control animals make a higher number of licks, 
allowing anxtogenic or pro-conflict drugs to be detected (Corda et al., 1983). 
The first problem with the conflict tests is individual variability. Although 
it is an advantage that each animal acts as its own control, individual 
animals' baseline response rates during conflict periods may be quite 
variable and require careful Utrations of shock intensities to maintain 
levels of response suppression that are sensitive to the 'distnhibitory' effects 
of anxiolytic agents (Howard and Pollard. 1977). A second problem occurs in 
that the two schedules are unlikely to be equally sensitive to drug effects and 
it is therefore possible that the punished schedule is more sensitive to rate-
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enhancing effects. Hence false positives could be observed with drugs such as 
amphetamine (Lehmann and Ban. 1971: McKearney and Barrett. 1975: 
Miczek. 1973). A further problem with these conflict tests. is that by 
definition. they involve "crossed" motivations (e.g. the attainment of food 
and the avoidance of shock). It has been shown that many anxlolytics. 
including the BDZs. have powerful stimulatory effects on appetitive and 
consummatory behaviOUrs (Wise and Dawson. 1974) and this effect could be 
misinterpreted as possible anxlolytic activity. The period of unpunished 
responding is meant to control for this but often the rate of responding is 
a1most maxtmal during this period and thus increases due to hyperphagic or 
dipsogenic effects of the compound can easily be missed. The waiting 
capacity of a rat has been shown to be reduced by BDZs (Thiebot. 1986). thus 
it is possible that increased responding during the punished responding 
period is as a result of reduced waiting capacity and not anxiolyUc activity. 
TESTS BASED ON CLASSICAL CONDmONlNG 
Conditioned emotional respoDdiDg 
Conditioned emotional responding (CER) can be produced by presenting the 
subject with an unavoidable electriC shock that is reliably preceded by a 
signal, 1.e. a 'conditioned stimulus' (CS). The CS can be superimposed upon 
an ongoing behaviour that is being positively reinforced (i.e. an operant), 
either in the same situation as CS-shock pairings ('on baseline'), or in a 
different situation ('off-baseline'). The suppression of operant responding 
that occurs in the presence of the CS is called a conditioned emotional 
response (Brady and Hunt, 1955). or alternatively. conditioned suppression 
(Estes and Skinner, 1941). 
The results of studies of arudolyUc agents on CER have not been partIcularly 
consistent. For example, arudolytic agents have been reported to attenuate 
(Edwards and Eckennann, 1979: Methot and Deutsch, 1984) , facilitate (Stein 
and Berger, 1969), or have no effect on CER (Ray, 1964: ScobIe and Garske, 
1970). Non-arudolyUc agents have also been found to produce inconsistent 
results, with compounds such as amphetamine either attenuating CER 
(Capell et a1., 1972) or having no effect rrenen, 1967). 
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In spite of these problems. one variation of CER called the 'potentiated 
startle' paradigm may warrant further investigation (Davis, 1979a). In this 
procedure rats are first trained to associate a stimulus (e.g. light) with the 
onset of aversive footshock. When this conditioned 'fear' stimulus is 
presented in the context of a sudden. loud noise. the 'startle' reflex that occurs 
in response to the loud noise is 'potentiated'. Anxiolytics selectively block 
the 'potentiated' startle reflex without affecting the 'unconditioned' startle 
reflex that occurs when the loud nOise is presented alone (Davis. 1979a). This 
paradigm is one which is studied in this thesis and a more detailed 
description of the model and its validation to date will be deSCribed later. 
TESTS BASED ON UNCERTAINTY/NOVELTY 
TESTS OF EXPLORATION 
In low doses. BDZs can enhance exploratory behaviour of rodents in a novel 
environment. File (1985) reviewed the effects of BDZs on exploratory 
behaviour and concluded that. whilst undoubtedly anxiety is a factor 
influencing exploration. there are always several others also operating in 
any given test Situation and it is important that these be remembered in the 
analysis of the results. The effect of BDZs appears to be biphasic. with a 
facUltatory effect occurring at low doses and an inhibitory effect occurring 
at high doses due to the emergence of concurrent sedative effects (File. 1985). 
The effect is time dependent: facilitation of exploratory behaviour typically 
occurs during the initial phase of the test session. and may reverse during 
later phases (Iwahara and Sakama. 1972). 
a) ''Four-plate'' test 
In this test. usually with mice. locomotor activity around a small arena, 
consisting of four metal plates. is punished by administering electriC shock 
through the metal plates every time the animal crosses from one plate to 
another (Boisser et aI .• 1968). Boisser et al. (1968) found that the reduction in 
crossings could be reversed by a number of known anxlolytlcs. whereas 
neuroleptlcs. antidepressants and analgesics were Ineffective. However. 
some stimulants (e.g. amphetamine) did Increase the number of crossings 
(Boisser et al., 1968). This test needs considerably more validation before its 
usefulness can be properly assessed. 
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b) Two-Compartment Chamber (Black and WhIte Box) 
This test, Introduced by Crawley and her associates (Crawley and Goodwin, 
1980: Blumstein and Crawley, 1983), utilizeS the natural tendency of rodents 
to avoid brightly lit areas (File, 1980). Mice are placed on the brightly 
illuminated side of a two-compartment chamber, and time In each 
compartment, the number of transitions between the light and dark sides are 
recorded, along with total activity. The total amount of time spent In each of 
the two compartments is not reliably affected by arudolytic compounds. 
Indicating that the preference for the dark remained. but the balance 
between exploration of the novel two-compartment chamber and dark 
preference was shifted by anxiolytics (Crawley and Goodwin, 1980: 
Blumstein and Crawley, 1983). Further validation of this model using BDZ 
and non-BDZ compounds such as buspirone and 5-HT3 antagonists has 
found all to Increase the number of rears. line crossings. the time spent In 
the brightly llluminated side, the number of transitions from one side of the 
chamber to the other, and the latency of the first transit from the brightly 
illuminated side to the dark side (Costall et aI., 1989a). 
c) Elevated plus-maze test 
The test is based on a procedure used by Montgomery (1955) who showed that 
exposure to an elevated (open) maze alley evoked an approach-avoidance 
conflict that was conSiderably stronger than that evoked by exposure to an 
enclosed maze alley. Montgomery (1955) then showed, using a Y-maze with a 
varying ratio of open:enclosed arms, that animals clearly preferred (i.e. 
spent more time on) the enclosed arms. Handley and Mithani (1984) 
deSCribed a procedure based on that of Montgomery (1955), which consisted 
of a plus-maze with two open and two enclosed arms, elevated to a heIght of 
5Ocm. Pellow et al. (1985) described the validation of such a test by confining 
rats to either the two open arms or the two closed arms of the maze, and 
taking a series of measurements. There was a Significant decrease In the 
number of entries, and a Significant increase In the time spent motionless or 
freezing and in the number of defaecaUons in the rats confined to the open 
arms. Also. although rats confined to the open and enclosed arms had 
significantly elevated plasma corticosterone levels compared to home cage 
controls the elevation In corticosterone was Significantly greater In the rats 
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confined to the open anns (Pellow et at, 1985). It was suggested that a drug 
which reduced anxiety should increase the overall proportion of entries into 
the open anns, i.e. increase the open-ann entries as a percentage of the total 
entries. Also, the percentage of the total time spent on the open anns could 
also provide a valid measure of arudety. The total number of ann entries 
would provide a measure of general activity. 
Drugs that are active in the clinic as anxiolytic s, diazepam and 
chlordiazepoxide, were found to increase those measures on the plus-maze 
which are thought to reflect 'anxiety' (i.e. time on open anns, and percentage 
open:total entries and time) (Pellow et at, 1985). Other studies have shown 
that most compounds that are agonists at the benzodiazepine-GABAA 
receptor complex are active in the plus-maze. e.g. alprazolam. adinazolam, 
U-43,465 (File and Pellow, 1985). CGS 9896 (File and Pellow. 1986) and CL 
218.872 (Pellow and File, 1986). Work using either inverse agonlsts at the 
benzodiazepine-GABAA receptor complex. such as the ~ - c a r b o l l n e e derivative 
FG 7142 (Pellow and File. 1986). or a2-adrenoceptor antagonists such as 
yohimbine (Handley and Mithanl. 1984: Pellow et at. 1985). both of which 
are anx10genlc in the clinic (Dorow et al .. 1983: Charneyet a1.. 1984). found 
that these compounds Significantly reduced the measures thought to reflect 
'anxiety', indicating that the X-maze can also detect compounds with 
anxlogenic activity. Caffeine. an arudogenlc compound in man (Uhde et al., 
1984). also had Significant anx10genic effects in the plus-maze (Pellow et a!.. 
1985). The effects ofvanous 5-HT compounds in this model is addressed in 
this thesis and infonnation available in the literature on this subject is 
discussed later in the thesis. 
It is important that this test is not confounded by sedation or arousal. since 
these could produce false positives or negatives. as is the case with the 
majority of animal tests of anxiety. 
d) SoclallnteractioD 
Another test of arudolytic agents which exploits the rodents natural 
proclivity to avoid brightly Ulumlnated and unfamiliar surroundings is the 
'social interaction' test. In this test the dependent variable is the time that 
pairs of male rats spend in active social interaction. The conditions of the 
test arena are manipulated so that it is either familiar or unfamiliar to the 
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rats and is Uluminated by high or low light. A familiar arena with low 
1llumination w1ll cause the highest level of active social interaction in 
undrugged rats and this declines if the area is either brightly illuminated or 
unfamiliar or both; this decline is prevented by anxiolytic drugs (File and 
Hyde. 1978: File. 1980). By testing the animals in several test conditions and 
by simultaneously measuring locomotor activity. non-specific drug effects 
can also be detected. Extensive pharmacological validation of this model 
has taken place using BDZs (File and Hyde. 1978) and lesions of the 
serotonergic system (File et al .• 1979; File and Deakin. 1980; File et aI .. 1981). 
More recent work has found ondansetron. a 5-HT3 receptor antagonist. 
active in this test of anxiety. suggesting that it can detect arudolytlc activity 
of non-BDZ compounds (Jones et a1.. 1987). 
However. changing variables such as the weight of the animal or the time of 
day can cause substantial shifts in 'baseline' social activity (File and Hyde. 
1978). It is important to remember that social interaction is a composite 
measure of many behaviours. some of which. for example aggression. are not 
related in a simple way to the construct of 'anxiety'. 
e) Others 
The;e are many other uncertainty/novelty models which have yet to be fully 
validated as models of anxiety. such as the stretched attend posture (SAP) 
(Kaesermann and Dixon. 1986), the 'staircase test' in mice (Simiand et a1. 
1984; Emmanouil and Quock. 1990). shock-probe defensive burying in rats 
(Meert and Colpaert. 1986; Korte and Bohus. 1990) and marble-burying 
behaviour in rats (NJung'e and Handley, 1991). 
TESTS IN WHICH ANXIETY/AVERSION IS CHEMICALLY INDUCED 
Drug cllscrlmlnatlon 
Lal and Shearman (1982) described a drug discrimination procedure which 
they use as a model of chemically induced anxiety. In this model rats are 
trained to respond on one lever when injected with saline and on another 
when injected with pentylenetetrazole (PTZ - a drug which causes anxiety in 
humans); the discrimination is reinforced with a food pellet reward for 
pressing the correct lever. Test trials are then introduced and it has been 
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found that if rats are injected with an arudo)ytic as we)) as PTZ there is a 
dose-dependent suppression of PTZ dlscr1m1nation, i.e. they select the saline 
lever (Sheannan and Lal, 1979, 1980: Lal et al., 1982). Also, if solely Injected 
with an arudogenlc compound they selected the PTZ lever (Shearman and 
Lal, 1979, 1980: Lal et al., 1982). It is important to remember that the 
interoceptive cue provided by a drug will be as a result of all of its effects and 
will not just reflect one ofthem, i.e. the anxlolytlc one. 
This technique provides one of the best ways of comparing the subjective 
experience of drug effects in animals, but it 18 important to remember that it 
does not reflect the properties of a drug solely as they affect anxiety. By 
training animals to discriminate between saline and a BDZ the effects of 
other putative anxlolytics can be compared. Hence It is possible to determine 
if the subjective effects of a novel anxlolytlc are Similar to those of a BDZ. 
Convulsant agents, such as picrotoxin and strychnine, can substitute for 
PTZ in this test. suggesting that the effective discriminative stimulus in the 
PTZ test might be some form of sub-clinical seizure activity (c.f. Lal and 
Shearman, 1980). Thus, it is important to remember that this anti-PTZ-
discrimination effect of anxlolytics may be a result of their ability to 
suppress PTZ-induced seizures. 
ANXIETY TESTING ON HUMANS 
Various 'anxiety scale' tests have been devised (e.g. Hamilton Scale), In which 
a patient's responses to a standard list of questions are scored, and these are 
widely used to assay the clinical effectiveness of arudolytlc drugs. In these 
tests the effects of arudolytics have been clearly demonstrated but what has 
also been found is that placebo produces significant responses, sometimes 
comparable to that produced by active drugs. 
There are other tests which rely on measurement of the somatic and 
autonomic effects associated with anxiety. One of these is the galvanic skin 
response (GSR) in which the electrical conductivity of the skin Is used as a 
measure of sweat production. Any novel stimulus, whether pleasant or 
unpleasant. causes a brief reduction in resistance. If an innocuous stimulus 
is repeated at intervals, habituation of the response occurs. The rate of 
19 
habituation is less in anxious patients than in normal subjects. and is 
Increased by anxiolytIc drugs (Lader and Wing. 1966). GSR habituation 
seems to be a partIcularly sensItive measure. as many tests of autonomic 
function In anxious patients (e.g. heart rate changes) show no clear cut 
change In response to arudolytic drugs. 
INVOLVEMENT OF IS-BT IN ANXIETY 
Early behavioural studies suggested that 5-HT was involved as a central 
neurotransmitter in the modulation of anxiety as a mediator In a central 
punishment system (Stein et at. 1975. 1977; Crow and Deakin. 1981). and 
that the anxIolytic effects of drugs such as BDZs resulted from a reduction in 
the activity of these serotonin systems (Wise et al.. 1972). The involvement 
of 5-HT was supported by some observed activity of non-selective 5-HT 
antagonists in conflict models of anxiety (Cook and Sepinwall. 1975). 
However. more recent pharmacological studIes have produced results which 
are not consistent with these hypotheses (Shephard et al, 1982) indicating 
the need for a reappraisal of the role of 5-HT in behavioural models of 
anxiety and the mechanism of action of anxlolytic agents. 
Effect of LealODS of IS-BT Pathways on Animal Models of Anzlety 
Using the 'conflict' model of anxiety developed by Geller and Selfter (1960) It 
was found that depletion of 5-HT with parachlorophenylalanlne (PCPA). the 
tryptophan hydroxylase inhibitor. increases food motivated punished 
behaviour (Geller and Blum. 1970: Tye et al.. 1979; Shephard et al.. 1982). 
The ability of the 5-HT precursor. 5-hydroxytryptophan (5-HTP). to reverse 
the PCPA-induced Increase in punished behaviour suggests that it is having 
its effect via depletion of 5-HT (Geller and Blum. 1970. Tye et al.. 1979). 
Lesioning with the 5-HT neurotoxins 5.6-dihydroxytryptamlne (5.6-DHT) 
and 5.7-dibydroxytryptamme (5.7-DHT) has been shown to release punished 
responding in this animal model after either intraventricular injection 
(Stein et al.. 1975: Tye et al.. 1977) or injection into the ascending 5-HT 
pathways at the medial forebrain bundle level ('rye et al.. 1977). However. in 
another 'conflict' model. the Vogel punished drinking test (Vogel et al.. 1971). 
lesions of central 5-HT pathways have produced inconsistent results 
(Petersen and Lassen. 1981; Commissaris et al .. 1981). The situation is made 
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more uncertain by 8-0H-DPAT reversing the increase in punished 
responding obtained with PCPA in the Vogel punished drinking test but 8-
OH-DPAT on its own resulting in increased punished responding. thus acting 
this time as an agonist (Engel et al .. 1984). 
As stated earlier. it is important to have a period of unpunished responding 
when studying these models. as depletion of central 5-HT has been shown to 
cause hyperphagia (Blundell. 1977) and polydipsia (Barofsky et aI.. 1980). 
During the period of unpunished responding It is hoped that any hyperphagic 
or polydipsic effects of treatment will be detected as an increase in the rate of 
feeding or drinking respectively. 
Using the social Interaction model (File and Hyde. 1978). File and Hyde 
(1977) showed that PCPA pre-treatment produced a behavioural profile 
Similar to that seen in rats treated chronIcally with chlordiazepoxide. This 
was also obselVed with 5.7-DHT lesIons ofthe dorsal raphe (File et al .• 1979) 
and the lateral septum (Clarke and File. 1981). In contrast, 6-hydroxy-
dopamine lesions In the lateral septum did not have the same effect. 
However. not all 5-HT pathway lesions have this effect on social behaviour. 
5.7-DHT injections Into the medial raphe or both the dorsal and medial 
raphe nuclei or Into the amygdala decreased social Interaction (File and 
Deakin. 1980; File et al .. 1981). More recently. using the elevated plus-maze. 
5.7-DHT lesIons of the hippocampus produced an anxiolyUc-l1ke profile 
similar to that of the BDZs (Briley et at.. 1990). 
Effect of Reduclng 5-HT FuIlctloD 
The 5-HT synthesis inhIbitor PCPA has been seen to produce a release of 
response suppression in several behavioural models. Thus. it would be 
expected that lowering serotonergic transmission with 5-HT antagonists 
would also release response suppression; however. again the results are 
conflicting. An anxlolyUc action for the non-selective 5-HT antagonists 
methyserglde and clnanserln has been demonstrated in rat conflict 
procedures (Stein et aI.. 1973; Cook and SepInwall. 1975). and methyserglde 
and D-2-bromolysergic acid diethylamide have been reported to Increase 
punished response rates In the pigeon (Graeff and Schoenfeld. 1970). 
However. others have failed to find any anti-conflict effects with these 
antagonists (Commlssarts and Rech. 1982; Petersen and Lassen. 1981). 
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Microiontophoretic injections of 5-HT into the dorsal raphe were found to 
release punished responding (Thlebot et al.. 1982). 5-HT is thought to be 
acting via inhibition of the somatodendritic autoreceptors. thus depreSSing 
the neuronal ftrtng rate and supporting the hypothesis that decreased 5-HT 
actMty results in attenuation of behavioural suppression. 
Effect of EBhaDctn , 5-BT Function 
The effects of intracerebroventrlcular (I.c.v.) Injection of 5-HT. whilst 
complex. were in general in the direction of a proconflict effect in the rat 
(Stein et al.. 1973). The 5-HT agonists a-methyltryptamine and m-
chlorophenylpiperazine (mCPP) suppress both the punished and unpunished 
responding in the rat (Stein et aI.. 1973: Graeff and Schoenfeld. 1970: Kilts et 
al.. 1982). The fact that the results obtained with intraventricular 
administration of 5-HT are somewhat confusing is not that surprising since 
it is clear that 5-HT pathways in the brain and spInal cord are able to 
increase and decrease motor function independently (Gerson and 
Baldessarini. 1980) from their action on brain systems more specifically 
Involved In the expression of behavioural InhibItion induced by conflIct. 
Wise et al. (1972) demonstrated that i.c.v. injection of 5-HT antagonized the 
punishment releasing effect of oxazepam. These authors also carried out 
biochemIcal studies whIch showed acute administration of oxazepam 
decreased turnover of both NA and 5-HT. but chrOniC treatment with the BDZ 
only decreased 5-HT turnover. In the CER paradigm. 5-HT appUed directly in 
the vicinity of the dorsal raphe in the rat caused a marked release of 
suppressed responding (Thiebot et al.. 1984). It Is also known that 5-HT 
applied iontophoretically at this site and in amygdala will inhibit neuronal 
firing (Wang and Aghajanian. 1977). thus giving support to the theory that 
decreased 5-HT activity results In an attenuation of behavioural 
suppression. 
Fenfluramine. which releases 5-HT. had no effect on punished responding. 
whereas 5-hydroxtryptophan. the 5-HT percursor. had a proconflict effect 
(Kilts et al.. 1982). Amitriptyline. a 5-HT uptake inhibitor. depressed both 
punished and unpunished responding in a conflict task (Kilts et al.. 1982). 
This non-specifiC depressant effect of amitriptyline. and of other 5-HT 
uptake inhibitors. has also been observed in the social interaction test (File. 
1985). In a conditioned suppression of drinking conflict paradigm acute 
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amitriptyline or desipramine had no effect but chroniC treatment was seen 
to increased punished responding (Fontana et al .. 1989). 
Up until recently. the range of agonists and antagonists of 5-HT available for 
such studies had not been great. with doubts about their specifiCity for 5-HT. 
since many of them influence other neurotransmitter systems. Also. as yet 
the contribution of their peripheral effects to the behavioural changes has 
not been fully evaluated. It is for these reasons that it is not surprising that 
there are almost as many negative findings regarding manipulations of 5-HT 
and punishment as there are positive ones. However. the recent development 
of selective agonists and antagonists has allowed further investigation of the 
involvement of 5-HT in anxiety. and this is discussed below. 
5-HTlA Agonlsts 
With the development of the non-BDZ anxiolytic buspirone. which has been 
found to have activity in the clinic (Goldberg and Finnerty. 1979). and the 
close analogues of buspirone. namely gepirone and ipsapirone. it is possible 
to further elucidate the involvement of the 5-HTIA receptor in anxiety. 
However. it is important to conSider other actions (especially activity at 
other receptors) of these drugs when attempting to determine their effects 
and tie them in with the actions of 5-HTIA receptors. Buspirone. although it 
has high affinity for 5-HTIA receptors. also affects dopaminergic and 
noradrenergic systems (Taylor et al.. 1982). Gepirone. previously known as 
BMY 13805. is more selective for 5-HTIA sites having only weak effects on 
dopamine systems (Yevich et al .. 1983). and ipsapirone, previously known as 
1VXQ 7821. appears to be selective for the 5-HTIA site (Dompert et al., 1985; 
Glaser and Traber. 1985; Glaser et al., 1985). It is important to remember 
that with the 5-HTIA partial agonists the overall behavioural effect observed 
is a result of a balance between pre- and postsynaptic receptor stimulation 
(at the somatodentritic autoreceptor and receptors in the tenninal regions 
respectively) . 
Busplrone, gepirone and ipsapirone all inhibit dorsal raphe neurone firing, 
mimicking the effect of 5-HT (Dourtsh et al., 1986; Rowan and Anwyl, 1987: 
Van der Maelen et al., 1986: Wilkinson et al., 1987). In the hippocampus all 
three compounds produced only the inhibitory component of the action of 5-
HT (Rowan and Anwyl, 1987; Van der Maelen et al., 1986; Martin and Mason, 
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1987). The lack of specific antagonJsts prevents the dtrect confiImation that 
this inhibitory component is the result of 5-HTIA receptor stimulation; 
however, when the response to 5-HT was not present in the preparation, the 
response to busptrone was also absent (Van der Maelen et al., 1986). The 
ab1l1ty of these compounds to activate the 5-HTIA site Is further 
demonstrated in the drug d1scrtmtnation test where busptrone, geptrone and 
ipsapirone will all substitute for the selective 5-HTIA ligand 8-0H-DPAT, 
and gepirone will substitute for busptrone (Mansbach and Barrett, 1987; 
Cunningham et al., 1985; SchuUIman et al., 1986). 
In animal models of arudety (which have been mainly developed studying 
the effects of BDZ receptor ligands) the non-BDZ arudolytics are not 
conSistently active. Buspirone has shown activity in licking conflict 
paradigms (Eison et aI., 1986; Merlo Pich and Samanin, 1986) and food-
motivated operant conflict procedures (Geller and Hartmann, 1982; 
Weissmann et aI., 1984) in rat and monkey but this has not always been able 
to be reproduced in other similar procedures (Goldberg et at, 1983; Gardner, 
1986; Gleeson and Barrett, 1990). Both geptrone and ipsaplrone showed 
activity in a licking conflict paradigm (Eison et a1., 1986; Traber et aI., 1984) 
and ipsaptrone also showed activity in a conditioned avoidance paradigm 
(Traber et aI., 1984: Schuurman et aI., 1986). However in the social 
interaction model of arudety using the protocol of File (File, 1985) busptrone 
had very little effect but using a modified method (Guy and Gardner, 1985) it 
showed an arudolytic-like increase in social interaction of rats. Higgins et 
a1. (1987) demonstrated an anxiolytic profile in social Interaction with 8-
OH-DPAT, busptrone and Ipsapirone when administered locally into the 
dorsal raphe nucleus. Ipsaptrone showed activity in the social interaction 
model (Boaventura et at, 1986) although an increase in social behaviour in a 
relatively non-arudous condition (Schuurman et a1., 1986) suggests that this 
might not be a specific arudolytic effect. No anxiolytic-like activity was seen 
with either busptrone or ipsapirone in both the shock probe conflict model 
(Meert and Colpaert, 1986) and the elevated plus maze (Pellow, 1986: File et 
al., 1987). Both acute and chronic buspirone treatment was found to have no 
effect in the elevated X-maze (Moser, 1989b). However, buspirone, geplrone 
and ipsaptrone have been reported to be active in the elevated plus-maze but 
only over a narrow dose range (Soderpalm et aI., 1989), and 
intrahippocampal busplrone has also produced an arudolytlc profUe in this 
model (Kostowski et aI., 1989). There are also reports in the literature of 
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these compounds having an anxiogenic profile in this model (Pellow et al.. 
1987: Redfern and Williams. 1989). In a recently developed model of anxiety 
both buspirone and ipsapirone inhibited stress-induced ultrasounds in rat 
pups Oike BDZ anxiolytics). but this effect was associated with the induction 
of tremor and such disruption of behaviour can lead to the inhibition of 
ultrasounds so this may not be a specific anxiolyUc effect (Gardner. 1985). It 
is now thought that the ultrasounds emitted by rat pups are not a result of 
separation from the mother but a result of hypothermia (File. personal 
communication). this further questions the validity of this model. In the 
fear-potentiated acoustic startle paradigm busp1rone and ipsapirone have 
been shown to have an arudolytic profile (Davis et al .. 1988) but the doses 
found to be active were about loo-fold greater than those used by Soderpalm 
and co-workers (1989) on the X-maze. A further complication with 
buspirone. gepirone and ipsa pirone is that their main metabolite. 1-
pyrimidinylpiperazine (l-PP). is a potent cx2 -adrenoceptor antagonist 
(Bianchi et aI.. 1988) which. from the results of Handley and Mithani (1984) 
where another cx2-adrenoceptor antagonist. yohimbine. produced an 
anxlogenlc profile. would suggest that I-PP would produce an anxiogenic 
profile. offsetting any anxiolyUc effects of the parent compounds. However. 
it has been reported that I-PP does not produce an anxiogenic profile on the 
X-maze (Moser. 1989b). 
Thus. from the behavioural data available it is still unclear what the exact 
involvement of 5-HTIA sites in anxiety. as the results are not clear cut. with 
5-HTIA agontsts being active in certain behavioural models but not others. 
Both direct injections into the dorsal raphe nucleus and systemic 
administration of low doses of the 5-HTIA partial agonists. thought to 
predominantly act at the 5-HTIA somatodendritic autoreceptor. are 
generally active in some models of anxiety. Thus. by increasing the systemic 
dose this may offset any presynaptic arudolytic activity by postsynaptic 5-
HTIA receptor stimulation. It is now known that buspirone is active in the 
clinic (Goldberg and Finnerty. 1979: Kudoh. 1986; Saxenda et aI.. 1986) with 
a potency comparable to diazepam but with less sedation. so this leads us to 
question the ability of the behavioural models of arudety to detect novel. 
non-BDZ arudolytics. However. the clinical activity of buspirone indicates 
that there is an involvement of 5-lIT. and 5-HTIA sites. in anxiety. Certain 
clinical features of buspirone may help to explain some of the diverse reports 
about its clinical efficacy (and may help to explain some of the behavioural 
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data). First. compared to BDZs. buspirone has a delayed onset of action of 
two or more weeks and is more effective in patients who have not previously 
been treated with BDZs (Goa and Ward. 1986; Lader and Olajide. 1987). 
Second. tolerance has not yet been seen to develop to buspirone and it also 
does not interact with ethanol (Traber and Glaser. 1987). Gepirone and 
ipsapirone have been seen to produce similar results with the added 
observation that the efficacy of ipsa pirone as a clinical arudolytic is not 
dependent on the patient's prior history of BDZ treatment (Traber and 
Glaser. 1987). Thus. clinical data indicate that 5-HTIA agonists have 
anxtolytic activity in man. 
lS-HT2 Receptor Antagonists 
Many 5-HT2 antagonists are selective for these sites over other 5-HT receptor 
subtypes but may also affect noradrenaline and dopamine receptors (e.g. 
ketanserin has affinity for a 1 -adrenoceptors). Rltanserin is reasonably 
selective for 5-HT receptors (Van Neuten et al .• 1986). and thus a large amount 
of the recent behavioural work has been carried out on this compound. As 
well as high affinity for the 5-HT2 receptor ritanserin also binds to the 5-
HTIC receptor (Leysen et a1.. 1985). Rltanserin acts as a pure antagonist in an 
LSD-saline drug discrimination test in the rat. blocking the effects of LSD. 
resulting in the rats generalizing to the saline lever (Colpaert et a1.. 1985). 
Also. ritanserin has been found to be more active than the BDZ 
chlordiazepoxide in a neophobia-based open field exploration model 
(Colpaert et a1.. 1985). However. ritanserin has shown little arudolytic-like 
activity in the claSSical conflict models (licking conflict. food-motivated 
operant conflict or shock probe conflict) (Deacon and Gardner. 1986; 
Gardner. 1986; Meert and Colpaert. 1986; Ketelaars and Bruinvels. 1989) but 
these results need to be interpreted with caution as brain 5-HT neurons are 
also involved in the control of food and liquid intake. and rttanserln 
Increases food intake in satiated rats (Fletcher. 1988). In the elevated plus-
maze both anxtolytic- (Critchley and Handley. 1986) and arudogenic-like 
effects (Pellow. 1986; File et al .. 1987) have been reported. No specific effect 
was observed on streSS-induced ultrasounds (Gardner. 1985). 
A property which all 5-HT2 antagonists possess is their ability to produce 
down-regulation of 5-HT2 sites in the rat after chronic treatment rather than 
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the conventional supersensitivity seen with chronic antagonism of 
dopamine receptors (Blackshear et a1.. 1983: Leysen et a1.. 1986). It w1l1 be 
interesting to see if this property can be used to protect against tolerance and 
withdrawal effects associated with long-term clinical treatment. Clinical 
studies with rttansertn suggest that it is effective in generalized anxiety 
disorder (Ceulemans et al .• 1985: Arriaga et al .. 1986). which may be related 
to its ability to increase slow wave sleep (Arriaga et aI .• 1986). Initial studies 
have also shown ritanserin has therapeutic potential in patients with 
phobic anxiety (Humble et al .• 1986). 
5-BT3 Receptor Antagonlats 
Recent behavioural studies have shown that ondansetron (originally known 
as GR38032F). a potent 5-HT3 receptor antagonist. 18 active in both the social 
interaction test (Jones et a1.. 1987. 1988) and exploration of a light-dark two-
chambered open field (Costall et a1.. 1987a. 1989). Ondansetron also 
decreases aggressive behaviour of marmosets and cynomolgus monkeys 
(Costall et aI .. 1987a: Jones et a1.. 1987). However. File and Johnston (1989) 
found that acute administration of ondansetron and two other 5-HT3 
antagonists (BRL 43694 and zacopride) had no significant effect on social 
interaction. In the elevated X-maze. ondansetron and another 5-HT3 
antagonist. BRL 46470A. have been shown to produce an anxlolyUc profile 
(Costall et a1.. 1990a: Upton and Blackburn. 1991). There is evidence to 
suggest that ondansetron reduces the arudogenic withdrawal effects obseIVed 
with chronic BDZ treatment and drugs of abuse (Costall et a1.. 1990a). 
However. it has very little or no effect on other symptoms of withdrawal such 
as weight loss and reduced food intake (Leathleyet a1.. 1990). 
Ondansetron has also been found to reduce dopamine mediated behaviour 
(produced by either amphetamine administration or chronic intracerebral 
dopamine infusion) (Hagan et a1.. 1987: Costall at a1.. 1987a) and this 
reduction is only seen when the behaviour is enhanced. suggesting that 5-
HT3 antagonists have potential anti-psychotic as well as anti-anxiety 
actMty. Finally. ondansetron has also been found to increase acetylcholine 
release in cortical tissue but only in the presence of rttansertn (Barnes et a1.. 
1989b) and to enhance cognitive performance in the marmoset (Domeney et 
a1.. 1991). indicating involvement in memory and cognition. 
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In summary. the existing data indicate that reduced activity of 5-HT 
neuronal systems projecting to the cortical and limbic brain regions may be 
important in anxtolytic activity. 
Involvement of5-HT Systems in the AnDoIytlc Action ofBenzod1a:repines 
Since manipulation of 5-HT can to an extent mimic. the effect of BDZs in 
various behavioural models of anxiety. it has been suggested that the 
anxiolytic action of these drugs is mediated through their action on 
serotonergic pathways (Kahn et a!.. 1988; Iversen. 1984; Soubrie. 1986; Stein 
et aI.. 1975; Thiebot. 1986). Thus. the most important question is whether 
changes in serotonergic function can be related to the anxtolytic action of 
the BDZs. Wise et al. (1972) reported a reduction in 5-HT turnover after both 
acute and chronic oxazepam treatment. but a reduction in NA turnover only 
after acute treatment. This supported other work which showed that BDZs 
increased brain 5-HT concentrations (by decreasing 5-HT turnover) (Chase et 
al .. 1970; Lidbrink et aI.. 1973). Wise et al (1972) also found an antagonism of 
the anxtolytic effect of oxazepam by the intraventricular administration of 
5-HT. It has been suggested that the decrease in 5-HT turnover reflects 
reduced actMty of 5-HT-containing neurones and thus decreased release of 
5-HT. However. other studies failed to repl1cate these results. Cook and 
Sepinwall (1975) found a reduction in 5-HT turnover only after chrOniC 
treatment with chlordiazepoxide. and that the maximum anti-conflict effect 
was not accompanied by the maximum reduction in 5-HT turnover. Lister 
and File (1983) found 5 or 10 mg/kg CDP increased the levels of 5-HT. but if 
repeated dosing was administered then no change in 5-HT levels were found 
after 5-10 days of treatment. The results of Llster and FUe (1983) suggest that 
tolerance may have developed to the reduction in 5-HT turnover and Cook 
and Sepinwall (1975) also found tolerance to the decrease in 5-HT turnover. 
occurring between days 2 and 3 of treatment. A more recent study using in 
vivo m1crodialysis showed that both systemic and local administration of 
BDZ agonists (diazepam and flurazepam) inhibited the release of 5-HT from 
the ventral hippocampus. and this effect could be reversed by administration 
of the BDZ antagonist flumazen11 (Ro 15-1788) (Pei et a!.. 1989b). 
It is possible that BDZs reduce 5-HT turnover with very little effect on the 
activity of 5-HT cell bodies, depending on the relative strengths of the 
feedback systems. Potassium-evoked [3HI-5-HT release from hippocampal 
synaptosomes is inhibited by diazepam with spontaneous 5-HT release being 
enhanced (Balfour, 1980), suggesting that BDZs can reduce 5-lIT release via 
an action at the nerve tenn1nals. ColUnge and Pycock (1982) reported 
reductions in both spontaneous and stimulated release of (3HI-5-HT from 
cerebal cortical slices. 
Electrophysiological findings support an Interaction between BDZs and 5-
lIT. In the rat. clonazepam depressed the flr1ng of 5-lIT neurones (Pratt et al .. 
1979). Laurent et a!. (1983), recording multiunit activity In the encephale 
tsole rat found that intravenous chlordiazepoxide and midazolam depressed 
neuronal firing in the dorsal raphe nucleus at doses which are known to be 
anxJolytic. Further, these effects were blocked by the BDZ antagonist 
flumazenll (Ro 15-1788) but the depressent effects of pentobarbitone on 
raphe neurones was not affected. It is now known that the BDZ receptor 
forms part of a receptor complex including a GABAA receptor and a CI- ion 
channel and is found in all areas of the brain (Unnerstall et a1.. 1981). 
Furthermore. BDZs interact at the receptor complex and enhance 
transmission by GABA. In the CNS. the sites which contain 5-lIT and are 
implicated in anxiety also have high denSities of GABA-containing 
neurones. Iontophoretic application of GABA in the dorsal raphe. amygdala 
and hippocampus results in the inhibition of firing of 5-lIT neurones. an 
effect enhanced by BDZs (Gallager. 1978). Local injections ofBDZs or GABA 
into the dorsal raphe release punished responding on a conditioned 
emotional response paradigm (Thiebot et a1.. 1980: Thiebot and Soubrte, 
1983) and GABA injected into the cortical/basolateral amygdala was active 
in a punished drtnking test (Petersen and Scheel-Kruger. 1982). Peterson and 
Scheel-Kruger (1982) also showed muscimol. a GABAA agonist. to release 
punished drinking and that this effect was reversed by the GABAA 
antagonist bicuculline. 
Thus. a body of evidence exists implicating benzodiazepine/GABAA 
interactions with a 5-HT pathway of origin in the raphe. innervating limbic 
structures. in the punishment-releasing effects of BDZs .. 
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The Involvement of Central Noradrenerglc Pathways In Anzlety 
It can be seen from biochemical and electrophysiological studies (Laurent et 
al.. 1983) that the BDZs influence catecholamine as well as indoleamine 
neurones. and hence other pathways may be involved in response 
suppression to aversive stimuli and that these pathways are sensitive to 
arudolytic agents. 
Noradrenergic innervation of the limbic system arises from the locus 
coeruleus. and stimulation of the locus coeruleus induces behavioural 
symptoms of fear in monkeys (Redmond and Huang. 1979). Drugs which 
enhance the function of NA have a similar effect in animals (for review. see 
Redmond and Huang. 1979) and in man subjective experience of fear and 
panic Is reported after administration of yohimbine and piperoxan 
(Charney et al.. 1984). two (l2-adrenoceptor antagonists thought to be 
anxiogenlc by blocking presynaptic (l2-adrenoceptors. In contrast. drugs 
reducing NA function (such as propranolol and c1onidine) are reported to be 
anxlolytic in both animals and man (Hoehn-Saric et a1.. 1981). Clonldine. 
an (l2 -adrenoceptor agonist. alleviates the intense fear and anxiety 
associated with opiate withdrawal (Gold et a1.. 1979) and this has been 
correlated with activity in the locus coeruleus. Clonidine has also been 
shown to inhibit behavioural arousal induced by locus coeruleus neurones 
(De Sarro et al .. 1987). 
Both the elevated X-maze and the fear-potentiated startle behavioural 
paradigms respond not only to manipulations of 5-HT but equally to 
adrenergic agonists and antagonists. which relieve or enhance anxiety 
respectively (Handley and Mlthani. 1984: Davis et a1.. 1979). providing 
further evidence of an involvement of NA in anxiety. 
It is possible that there are interactions between the NA and 5-HT systems. It 
is known that (l2-adrenoceptors also regulate 5-HT release both in vitro 
(Gothert and Huth. 1980) and in vivo (Marsden and Martin. 1986: Routledge 
and Marsden. 1987). with agon1sts decreasing 5-HT release and antagOnists 
increasing it. Furthermore. clonidine attenuates 5-HT2 receptor-mediated 
behaviour in the rat (Heal et al.. 1986). suggesting that there are (l2-
adrenoceptors situated on 5-HT nerve cells and/or terminals regulating 5-HT 
neuronal firing and release. and It has been reported that idazoxan. an (l2-
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adrenoceptor antagonist. increases 5-HT neuronal firing in the dorsal raphe 
nucleus (Garratt et al .. 1991). Thus. any effects ofnoradrenergic compounds 
may be as result of a combined effect upon both the NA and 5-1IT systems. 
SOCIAL ISOLATION 
The environment to which an animal is exposed (social environment) can 
have signJficant effects upon its subsequent behaviour. Thus there has been 
considerable interest in the consequences of different environmental 
conditions. and particularly social isolation (Morgan. 1973; Valzelli. 1977). 
which has been considered to have potential as an animal model of some 
human psychopathologies (Kraemer et al .. 1984; Willner. 1984). Obtaining a 
clear picture of social isolation has been difficult largely due to the variable 
nature of the parameters employed. It is difficult to find two studies that 
have used the same periods of isolation. imposed at the same time point and 
using the same sex and species. 
Many of the effects of social isolation are dependent upon the age at which 
isolated conditions are introduced (Einon and Morgan. 1977). and it has been 
suggested that the effects of stimulus deprivation (isolation) are inversely 
correlated with the age at which isolation was introduced (Bronfenbrenner. 
1968). Differences between isolation at weaning age and isolation when 
mature would be expected given the relative plasticity of the brain at birth. 
which decreases with age. For example. the monoamine inneIVation of the 
CNS. often implicated in the effects of social isolation (Sahakian et al .• 1975; 
Robbins et al .• 1989). largely develops post-natally. Only approximately 20% 
of NA. 25% of DA. and 50% of 5-1IT content of the adult rat brain is present at 
birth and much of the production of these monoamines occurs around 
weaning age. Around weaning. not only do monoamine concentrations 
increase rapidly but so do the aSSOCiated enzymes such as tyrosine 
hydroxylase and dopamine ~ - h y d r o x y l a s e e (for review see Mabry and 
Campbell. 1977). Thus. the prevailing environmental conditions would 
seem most likely to be able to influence neurochemical and behavioural 
processes and development earlier in life. rather than later. 
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Locomotor activity and ezploratory behaviour. 
Increased locomotor activity is one of the most prominent and reproducible 
findings following social isolation in many species including rats (Syme. 
1973; Morley and Worsham. 1978). mice (Essman. 1966; Wilmot et al .• 1986). 
monkeys (Mason et al.. 1968). cats (Seitz. 1959) and dogs (Fox and Stelzner. 
1966). Rats reared in isolation from weaning conSistently produce 
locomotor hyperactivity on exposure to a novel environment, when 
measured in either an open field (Syme. 1973: Morgan. 1973: Gentsch et al.. 
1981a. b. 1982). or in photocell cages (Sahakian et a1.. 1977: 1982) but not on 
an elevated activity platform (Syme. 1973) or runway (Moyer and Kom. 
1965). This effect is relatively independent of the length of isolation period. 
as anything from seven days (Sahakian et a1.. 1982) to twelve months 
(Garzon et al .. 1979) of isolation. can eHcit this increased response. 
Gentsch et a1. (1981 a) describe locomotor activity in a novel environment as 
'reactive activity'. and isolation-reared rats show increases in this reactive 
activity. but not spontaneous activity (when habituated to the test 
environment). and may even show decreases (Gentsch et a1.. 1981a: 1982). 
However. Garzon et a1.. (1979) found that if the isolation period is of a 
suffiCiently long time it may produce hyperactivity even after repeated 
exposures to an open field. 
Thus. the increased locomotor activity in isolates is a change in the response 
to novel stimuli and may therefore reflect Increases in exploratory 
behaviour. This is supported by evidence that isolates show an increased 
incidence of investigative bouts on exposure to novel stimuli (Einon and 
Morgan. 1977). and also show increased preference for novel environments 
(Sahaktan et a1.. 1977). Not all studies have demonstrated this enhanced 
exploratory behaviour in isolation-reared rats (File. 1978; Hughes and 
Ptther. 1987) and even reduced exploratory behaviour has been observed 
(Parker and Morinan. 1986). 
Another interpretation of increased locomotor activity Is that it represents 
"a response to heightened motivational factors" (Essman. 1966). Isolates 
have been found to eat more food and gain weight faster than SOcially-reared 
rats (Morgan and Einon. 1975: Fiala et al .. 1977). Also. if isolated rats are re-
housed in groups one month prior to testing not only are the body weight 
differences abolished but also the increases in exploratory behaviour are not 
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observed (File. 1978). This suggests that the increased weight gain and 
exploratory behaviour in isolates may be under the influence of a common 
mechanism - increased incentive-motivation for food. but other factors such 
as no competition for food in the isolated animals need to be considered. 
Response to psychomotor .tlmuJant drugI 
Isolation-rearing in rats produces an increase in the intensity of the 
stereotyped forms of behaviour elicited by the indirect dopamine agonist 
amphetamine (Sahakian et aI .. 1975: Einon and Sahakian. 1979). Further. 
using intracerebral mircodialysis it has been shown that d-amphetamine 
produces enhanced DA release in isolation-reared rats compared to soctally-
reared controls (Jones et aI.. 1988: 1990). Apomorphine. a direct DA agontst. 
has also been reported to elicit more intense stereotyped behaviours in 
isolation-reared rats (Sahakian et al.. 1975). although this effect does not 
seem as reliable as that induced by amphetamine. Thts suggests that social 
isolation alters pre-synaptic dopamtnergtc mechanIsms more consIstently 
than post-synaptic mechanisms. although both may be implicated 
(Sahakfan et aI.. 1975: Weinstock et aI.. 1978: Wilmot et at. 1986) 
Condltloned Behaviour 
Isolation-reared rats are Impaired in a number of tasks compared with 
SOCially-reared rats. For example. maze learning abilities are consistently 
impaired by rearing rats in a restricted environment (Greenough. 1976). 
Deficits have also been observed in response transfer (Morgan. 1973). 
learning a two-lever alternation schedule (Morgan et a!.. 1975) and In spatial 
memory tasks (Einon. 1980: Juraska et aI.. 1984). Jones et aI. (1989) showed 
isolation-rearing to retard the acquisition of schedule-induced polydipsia in 
rats only when isolation was introduced at weaning. 
Other Alterations 
Chronic exposure to conventional stressors (e.g. tmmob1l1saUon) is widely 
regarded to decrease central NA levels and to increase 5-HT utilisation (for 
review see Anisman. 1978). whereas the opposite effects are seen in socially 
isolated (either immature or mature) rats (Segal et aI .• 1973: Thoa et aI .• 1977: 
Mortnan and Parker. 1985). Isolated rats have higher pain thresholds. 
either following short (Kehoe and Blass. 1986). or long term isolation 
(Gentsch et aI .. 1988). Similar decreases in pain sensitMty are also evident 
following acute exposure to a conventional stressor such as footshock (AkU 
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et a!., 1976) or immobilisation (Am1r and Am1t, 1978). These alterations in 
pain sensItivity following socIal Isolation are thought to reflect changes in 
opioid mechanIsms, with hIgher pain thresholds in Isolates beIng 
attenuated with naloxone (Puglisi-Allegra and Oliverio, 1983). Also, 
reductions in opiOid receptor binding in whole brain homogenates (Schenk 
et a!., 1982) and in the frontal cortex, striatum and hippocampus (Petkov et 
a!., 1985) have been reported. However, Isolation-reared rats show reduced 
sensitivity to the analgesic properties of morphine (Kostowski and 
Czlondowski, 1973), which is the reverse of what the previous data indicate. 
It Is possible that this Is a result of morphine being relatively selective for 
the J..l receptor, and studying the effects of other oplold receptor agontsts 
would help clarify this observation. 
Reversal of Effects of Isolation 
The reversal of the effects of social isolation can be brought about either by 
social factors or by pharmacological treatment. Resocialisation reverses the 
hyperactivity, greater tail-flick latencies (Gentsch et a!., 1988), and maze 
learning deficits (Wood and Greenough, 1974) in isolation-reared rats. 
However. other studies have falled to detect recovery from Isolation-induced 
impairments, particularly if isolatton was introduced at weaning age (Emon 
and Morgan, 1977: File, 1978: Kraemer et al., 1984). This might be expected 
since the brain would be more susceptible to permanent change at an early 
age. Neurochemical changes (Blanc et aI., 1980) and hypertension (Naranjo 
and Fuentes, 1985) induced by isolation of mature rats Is completely reversed 
by resocial1satton. The increased body weight in rats Isolated immediately 
post-weaning can be reduced by rehousing in groups (File, 1978). 
Benzo<iiazeplnes (Garzon et a1.. 1979: Hock and Scheich, 1986), monoamine 
oxidase inhibitors (Crawley, 1985). opiate antagonists (Naranjo and Fuentes, 
1985), NA antagonists (Garzon and Del Rio, 1981), psychomotor stimulants 
(Weinstock et at, 1978) and DA antagonists (Garzon et a!., 1979) have all 
demonstrated an abUity to alleviate some, but not all, of the effects following 
social Isolation in rodents. Because of this reversal. isolation has been 
conSidered an animal model for a range of psychopathological disorders 
including depression (Kraemer et al .. 1984: Willner, 1984: Crawley, 1985) and 
anxiety (Crawley, 1985: Parker and Mortnan, 1986). 
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MEASUREMENT OF NEUROTRANSMITTER RF.L.EASE IN VIVO 
Neurotransmitter release has been measured in vivo for many years now 
using a variety of techniques. The first method developed was the cortical 
cup (MacIntosh and Oborin, 1953) which consisted of a small container fUled 
with artificial CSF held against the surface of the cortex. Either the cup was 
replaced periodically or the fluid changed by a superfusion system and 
subsequently analysed. The main advantage of this system being lack of 
tissue penetration, however, only a 11m1ted brain area could be studied and 
there is direct contact between the perfusion fluid and the brain. In 1961 
Gaddum described a 'push-pull cannulae' system where artiflcial CSF was 
delivered to the brain by one tube ('push') and collected by another ('pull'). 
With this technique all brain regions could be studied. However, as with the 
cortical cup there is direct contact between the tissue and the perfusate. It is 
possible to sample CSF directly by inserting a catheter into the cisternal 
space and collecting and analysing the samples (Sarna et a1., 1983). This 
technique has no pumps pushing or pulling flUid, but only provides 
information about levels of compounds in the CSF which are not necessarily 
the same as those in brain tissue. Also, it is unknown how the removal of 
small quantities of CSF alters the dynamics of the turnover system. 
One of the main collective drawbacks with all of the above techniques is that 
it involves an open system in which the brain comes in direct contact with 
the perfusion medium. Two methods which overcome these problems to 
some extent are intracerebral microdialysis and voltammetry. In 
voltammetric studies carbon fibre electrodes are used to oxidise 
neurotransmitters and the oxidation is measured by the generation of a 
small current (for review see Stamford, 1989). The advantages of this 
method are that the microelectrodes are very small (e.g. 1 2 ~ ) ) and so all 
brain regions. including small nuclei can be accessed, rapid and repeated 
sampling means that changes occurring over seconds can be studied, and 
there is no direct contact of a perfusion medium with the brain. The main 
drawback is that it is difficult to positively identify the electroacUve 
chemical being measured. 
Intracerebral Mlcrodlalyala 
The principle of microdialysis is very simple. The probes consist of semi-
permeable membrane which is filled with an artiflclal CSF solution, as close 
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to endogenous CSF as possible. Once the probe is in place compounds in the 
tissue diffuse down their concentration gradient across the membrane into 
the perfusate and continuous removal of the perfusate maintains this 
concentration gradient. The pore size in the membrane is limited to 
introduce a cut-off weight ensuring that large molecules such as proteins 
cannot cross the membrane. 
The first description of the dialysis technique was by Bito et a1. in 1966 
where they measured amino acids using sacs made of dialysis tubing filled 
with 6% dextran/saline solution, which were implanted into the cortex of 
dogs and left in place for 10 weeks. Histological studies showed the sacs to be 
surrounded by collagen and capillary proliferation and glial cells in the 
surrounding area. The collagen capsule would have limited diffusion of 
compounds into the fluid but BIto et a1. were still able to detect amino acids. 
An improved dialysis system was published in 1972 by Delgado and co-
workers using what they called a 'dialytrode'. This was sim1lar to both a 
push-pull cannula and the dialysis probes in use today, inside a bag made of 
dialysis membrane. Ringer solution was pumped through the dialysis sac 
and this allowed repeated sampling. Delgado and co-workers demonstrated 
that compounds travel in both directions across the membrane so 
substances can be introduced into the local environment of the probe. In 
1982 Ungerstedt and co-workers deSCribed a dialysis probe consisting of a 
loop of dialysiS tubing attached to to two stainless steel cannulae, which was 
implanted vertically into the brain. They also described a horizontal piece 
of dialysis tubing passing horizontally through the brain with glue over 
parts of the tUbing so diffusion was only possible over a limited area (the 
regions of interest in the particular experiment). These two types of probe 
are still used today and have been joined by another design consisting of an 
outer and inner tube with the perfusate being passed down one and up the 
other (Ungerstedt, 1984). This last design is sold commercially and is the 
design on which the dialysis probes in this thesis are based. 
A number of assays are available to measure various neurotransmitters, 
their precursors and their metabolites. One of the advantages of dialysis is 
that it can be used to measure any chemical substance provided that the 
molecule can pass through the membrane and that there is a suitable assay 
for that molecule. The development of high perfonnance liquid 
chromatography with electrochemical detection (HPLC-ECD) has made the 
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study of neurotransmitters easier. with catechols and Indoles being well 
detected (for review see Mefford. 1981). Ungerstedt et a1. (1982) used HPLC-
ECD to detect dopamine and 5-HT was first detected from dlalysates in vivo 
by HPLC-ECD In 1985 by Brazell and co-workers. HPLC-ECD assays have 
now been developed for acetylcholine (Damsma et a1.. 1987) and 
noradrenaline (Routledge and Marsden. 1985). 
Recovery of Compounds by DIalyaIa 
The amount of a particular compound measured by dialysis depends upon its 
'relative' recovery. The 'relative' recovery Is "the relationship between the 
concentration of a particular substance in the perfusate compared to the 
concentration In the medium outside the tube" (Ungerstedt et al.. 1982). The 
'absolute' recovery is the amount of a substance collected in the perfusate per 
unit time (Ungerstedt. 1984). In all future discussion the term recovery Is 
taken to mean relative recovery. 
The recovery of a dialysis probe depends upon a number of factors 
(Ungerstedt. 1984; Benveniste, 1989; Benveniste and Huttemeler, 1990) 
including: (a) the physico-chemical properties of the membrane, (b) the Size 
and design of probe used as the area of the membrane will influence the 
recovery as will variations In Internal pressure. (c) the flow rate which Is 
Inversely related to recovery, (d) the tonicity and composition of the 
perfusion medium. (e) the nature of the compounds being dlalysed as the 
diffusion coeffiCient, which reflects molecular weight, varies, m the 
temperature as recovery in vitro Is often measured at room temperature. 
while the temperature in vivo wUl be 37°C and (g) interactions of the 
substances being dialysed with the dialysis membrane itself. Probes are 
calibrated in vitro by measuring the relative recovery. Calculations to 
correct for the fact that in vivo dialysis is carried out in tissue while recovery 
is measured In solutions are complex (Jacobson et aI., 1985; Benveniste. 
1989; Benveniste and Huttemeier. 1990; Bungay et aI., 1990) and it is not 
clear whether true extracellular concentrations can be accurately 
determined. 
Llmltatlons of the DIalysis Technique 
Although dialysis has advantages over many of the other methods deSCribed 
it has several limitations. The long time required to collect enough sample 
to assay (10 - 20 minutes) means that rapid changes may be missed. The 
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probes are quite large. limiting the size of the brain areas which can be 
dialysed. It Is possible that the continuous removal of neurotransmitters 
will deplete the existing stores and create an artificial situation. Finally. 
cellular reactions to the implantation of the dialysis fibre limit the length of 
time the dialysis probe can be used in Vivo. It has been shown that local 
cerebral glucose metabolism and blood flow returned to near normal after 24 
hours (Benveniste et at. 1987). An experiment done to study the long term 
applications of dialysis for measuring 5-HT concluded that the method was 
most useful between 24 and 72 hours after implantation (Pet et al .. 1989a). 
None of these techniques strictly measure release but rather overflow of 
neurotransmitter from the synaptic cleft into extracellular fluid. 
Alms of the Thesis 
The overall aim of the thesis is to study 5-HT neuronal function. using in 
vivo microdialysis to record 5-HT release. and to correlate this with ongoing 
behaviour thought to reflect anxiety. Initially several different behavioural 
models of anxiety are studied. namely the elevated X-maze. the fear-
potentiated acoustic startle paradigm and social isolation. for their 
suitability to produce 'anxious' behaviour and to be combined with 
microdialysis for monitoring neurochemical changes. From this the 
elevated X-maze was chosen as it is possible to combine this paradigm with 
microdialysis and hereby mOnitor neurochemical and behavioural changes 
in the same animal, and then to study the effects of established (BDZ) and 
putative (5-HT-modulated) arudolytics on these changes. Further. to 
determine whether the 'anxious' behaviour displayed by isolation-reared 
rats correlates with alterations in both pre- and postsynaptic 5-HT function 
using in vivo techniques. 
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CHAPTER 2 
PHARMACOLOGICAL VALIDATION OF THE ELEVATED X-MAZE AND 
FEAR-POTENTIATED ACOUSTIC STARTLE MODELS OF ANXIETY 
INTRODUCTION 
1. ElEVATED X-MAZE 
The test is based on a procedure used by Montgomery (1955) who showed that 
exposure of rats to an elevated (open) maze alley evoked an approach-
avoidance conflict that was considerably stronger than that evoked by 
exposure to an enclosed maze alley. Rats that were allowed access to an 
enclosed alley from their home cage explored considerably more than those 
allowed access to an open alley, and in the latter condition there were more 
retreats to the end of the cage. Montgomery (1955) then showed, using a Y-
maze with a varying ratio of open:enclosed arms, that animals clearly 
preferred (i.e. spent more time on) the enclosed arms. Montgomery 
interpreted this behaviour by proposing that exposure to novel stimuli (in 
this case in the form of maze alleys) can evoke both exploratory drive and 
fear drive, thus generating approach-avoidance conflict behaviour. and that 
elevated (open) maze alleys evoke a greater fear. and hence more avoidance 
behaviour. than enclosed alleys. 
Handley and Mitharu (1984) described a procedure based on that of 
Montgomery (1955), which consisted of a plus-maze with two open and two 
enclosed arms, elevated to a height of 5Ocm. The X-maze and plus-maze are 
essentially the same, and throughout this Introduction the description used 
will be the same as that used by the particular authors. The apparatus used 
in this thesis w1l1 be referred to as an elevated X-maze. Pellow et al. (1985) 
described the validation of such a test by confining rats to either the two 
open arms or the two closed arms of the maze, and taking a series of 
measurements. There was a significant decrease In the number of entries. 
and a significant increase in the time spent motionless or freezing and in the 
number of defaecations in the rats confined to the open arms. Also, although 
rats confined to the open or enclosed anns had significantly elevated plasma 
corticosterone levels compared to home cage controls the elevation in 
corticosterone was Significantly greater in the rats confined to the open 
arms (Pellow et al., 1985). It was suggested that a drug which reduced anxiety 
should increase the overall proportion of entries Into the open arms, 1.e. 
increase the open ann entries as a percentage of the total entries. Also, the 
percentage of the total time spent on the open arms could provide a valid 
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measure of anxiety. The total number of arm entries would provide a 
measure of general acUvIty. 
Pellow et a!. (1985) then went on to phannacologlcally validate the elevated 
plus-maze. Drugs that are active in the clinic as anxlolyUcs. diazepam and 
chlordiazepoxide. were found to increase those measures on the plus-maze 
which are thought to reflect reduced . anxiety' (i.e. time on open arms. and 
percentage open:total entries and time). Other studies have shown that most 
compounds that are agonists at the benzodiazepine-GABA receptor complex 
are active in the plus-maze. e.g. alprazolam. adinazolam. U-43.465 (File and 
Pellow. 1985). CGS 9896 (File and Pellow. 1986) and CL 218.872 (Pellow and 
File, 1986). Having ascertained that the elevated plus-maze can detect 
compounds with anxiolytic activity. further studies by Pellow and File 
(1986) using inverse agonlsts at the benzodiazepine-GABA receptor complex. 
such as the .6-carboline derivative FG 7142. found that these compounds 
significantly enhance the measures thought to reflect 'anxiety'. Yohimbine. 
an cx2-adrenoceptor antagonist has been shown to have anxiogenlc activity 
in man (Charney et al .• 1984) and is found to reduce the percentage open:total 
entries and time on the plus-maze (Handley and Mithanl. 1984: Pellow et al.. 
1985). Caffeine. a psychostimulant compound in man (Uhde et aI.. 1984). 
also had significant anxlogenlc effects in the plus-maze (Pellow et al.. 1985). 
It is important when using the X-maze to attempt to have a measure of 
general locomotor activity in order that changes in open arm exploration 
observed on the X-maze are not a result of changes in general actMty. 
2. FEAR-POTENTIATED STARTLE PARADIGM 
Anecdotal evidence indicates that people startle more when they are afraid: 
Brown et a!. (1951) demonstrated that the amplitude of the acoustic startle 
reflex in the rat can be augmented by presenting the eliciting auditory startle 
stimulus in the presence of a cue (e.g. a Ught) that has previously been paired 
with a shock. This phenomenon has been tenned the 'fear-potentiated 
startle effect' and has been replicated using either an auditory or a visual 
conditioned stimulus and when startle has been elicited by either a loud 
sound or an airpuff (e.g. Anderson et al .. 1969 a. b: Davis. 1979 a. b: Davis and 
Astrachan. 1978: Davis et a!.. 1979: Galvant. 1970). 
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In this paradigm a central state of fear is considered to be the conditioned 
response (McAllister and McAllister. 1971). Conditioned fear is 
operationally defined by increased startle amplitude In the presence of a cue 
previously paired with a shock (see Fig. 1). Thus. the conditioned stimulus in 
this test does not elicit startle and also the startle-eliciting stimulus is never 
paired with a shock. In this model the conditioned stimulus is paired with 
shock and the startle is eUcled by another stimulus either in the presence or 
absence of the conditioned stimulus. If the startle is greater in the presence 
of the conditioned stimulus the fear-potentiated startle is said to have 
occurred. Potentiated startle occurs using either foot-shocks or back-shocks 
(Davis and Astrachan. 1978). indicating that augmented startle probably 
results from increased fear and not because the animal alters its posture (e.g. 
crouching) which results in a greater startle response (Kurtz and Siegel. 
1966). Also. the potentiation of startle measured electromyographically in 
neck muscles occurs without there being any obvious postural adjustment 
(Cassella et a1.. 1986). Additionally. the magnitude of potentiated startle 
correlates well with the degree of freezing. a common measure of fear (Leaton 
and Borszcz. 1985). This information. taken together. indicates that 
potentiated startle is a valid measure of claSSical fear conditioning. 
The acoustic startle pathway 
In the rat. the latency of acoustic startle is 6ms recorded 
electromyographically in the foreleg and 8ms in the hindleg (Ison et a1.. 
1973). This very short latency Indicates that only a few synapses are 
involved in mediating acoustic startle. Davis et a1. (1982) determined the 
acoustic startle pathway in the rat (Fig. 2). The posteroventral cochlear 
nucleus (yCN) is the first synapse in the acoustic startle circuit. The next 
synapse occurs in the ventral nucleus of the laterallemntscus (VLL). and the 
pathway then goes to the nucleus reUcularls pontls caudal1s (RPC). Cell 
bodies in the RPC send their axons to all levels of the spinal cord by way of 
the reticulo-spinal tract. This tract courses near or through the medial 
longitudinal faSCiculus (MLF) on the midline and then bifurcates to form the 
ventral funlcul1in the spinal cord (SC). These fibres synapse in the SC to 
form the final synapse before the neuromuscular Junction. It has not yet 
been determined whether spInalintemeurons are involved. 
In order to determine the area within the startle pathway where fear alters 
neural transmiSSion Berg and Davis (1985) implanted electrodes at various 
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Figure 1 
Cartoon depicting the fear-potentiated startle paradigm. During training a 
neutral stimulus (conditioned stimulus) such as a light is consistently paired 
with a foot-shock. During testing startle is elicited by an auditory stimulus 
(e.g. a l00dB burst of white noise) in the presence (light-tone trial) or absence 
(tone alone trial) of the conditioned stimulus. The pOSitions and postures 
pictured may not mimic the actual behaviour of the animals. Taken from 
Davis, 1988. 
Training: light and shock paired 
'\QI / 
-- ---..-- I> 
,. " 
Testing 
Noise-alone 
trials 
Light-noise 
trials 
Normal startle (in dark) 
\ 1/ 
~ n : :/ \I' 
,/--------... 
Potentiated startle (in light) 
Figure 2 
Schematic diagram of a primary acoustic startle circuit consisting of the 
ventral cochlear nucleus (VCN): ventral nucleus of the lateral lemniscus 
(VLL) and nucleus reUcularis pontis caudalis (RPC). Other abbreviations used 
are: A. aqueduct: CNIC. central nucleus of the inferior colliculus: CU. cuneate 
nucleus: DCN. dorsal cochlear nucleus: DP. decussation of pyramids: DR. 
dorsal raphe nucleus: ENIC. external nucleus of the inferior colliculus: 10. 
inferior olive: LL. lateral lemniscus: LM. medial lemniscus: LV. lateral 
vestibular nucleus: RST. reticulospinal tract. Taken from Davis. 1988. 

pOints along the startle pathway in order that a startle response could be 
electrically elicited. Following recovery. all groups were trained to be fearful 
of a I1ght by pairing it with a foot-shock. The results are shown 
diagrammatically in Fig. 3. There was potentiation of electrically elicited 
startle (equivalent to potentiation of acoustic startle) at all locations up and 
including the VLL. In contrast. startle response el1cied from the RPC was not 
potentiated. These data indicate that the VLL or the RPC is the point in the 
startle pathway where a visual conditioned stimulus modulates 
transmission following conditioning. affecting the startle reflex. 
The role of the central nucleus of the amygdala and various amygdala 
projections in potentiated startle 
Fear-potentiated startle was completely blocked by lesions of the central 
nucleus of the amygdala but not by transection of the cerebellar peduncles or 
lesions of the red nucleus (Hitchcock and Davis. 1986a). Further work 
showed blockade of potentiated startle in animals with amygdala lesions 
was not attributable to visual impairment (Hitchcock and Davis. 1986b). 
suggesting that the amygdala is involved in fear conditioning. given that 
potentiated startle is a measure of conditioned fear. It is possible that the 
cerebellum could also modulate potentiated startle because electrical 
stimulation of the cerebellum has been reported to increase the magnitude of 
potentiated startle (Albert et a1.. 1985). 
The central nucleus of the amygdala has direct projections to a variety of 
bralnstem areas that might be expected to be involved in fear or anxiety. 
These include a region of the central grey (involved with freezing behaviour) 
(Beitz. 1982; Post and Mai. 1980). the dorsal motor nucleus of the vagus 
(concerned with autonomic measures of fear) (Hopkins and Holstege. 1978; 
Schwaber et a1.. 1982; Veenlng et a1.. 1984). parabrachial nucleus (concerned 
with respiratory changes) (Krettek and Price. 1978: Price and Amaral. 1981: 
Takeuchi et al .. 1982), trigeminal and faCial motor nuclei (facial expressions 
of fear), and the RPC (fear-potentiation of the startle reflex) (Berg and Davis. 
1985). 
Electrical stimulation of the central nucleus of the amygdala produces a 
cessation of ongoing behaviour (Applegate et a1.. 1983). Such cessation of 
behaviour is the Critical measure of fear or anxiety in several animal models 
such as the operant conflict test (Geller and Selfter. 1960). the conditioned 
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FIgure 3 
Schematic diagram of modulation of electrically elicited startle by 
presentation of a light previously paired with a shock. The point of 
electrical elicitation of startle Is indIcated by the 'stim' symbol. The model 
predIcts that if the light ultimately modulates neural transmIssion at the 
RPC, then startle elicited electrically in the VCN or VLL w1ll be enhanced by 
the light. since the signal produced by electrical stimulation must travel 
through the area where the light modulates neural transmIssIon. In 
contrast. startle elicited electrIcally in the RPC beyond the area of 
modulation or startle eliCited electrically in spinal motoneurons will not be 
enhanced by light. Refer to Figure 2 for the definition of abbreviations. 
Taken from Davis, 1988. 
SliM 
veN IJ ~ ~ VLL 
VeN ·I·VLL 
Light previously 
paired with shock 
SliM 
I.J _L.. ~ ~ RPC 
Light previously 
paired with shock 
STiM 
_L.. IJ ~ ~ RPC 
~ ~ SC t - - - ~ . . Startle enhanced 
'--_.... by light 
STIM 
I 
~ ~ SC IJ ~ ~ Startle not enhanced by light 
emotional response test (Estes and Skinner, 1941) and social interaction 
(File, 1980). Electrical stimulation of the central nucleus of the amygdala 
also alters heart rate (Applegate et al., 1983), blood pressure (Morgenson and 
Calaresu, 1973), and respiration (Applegate et aI., 1983). Amygdala 
stimulation also produces Jaw movements (Applegate et al., 1983) and gastric 
ulceration (Henke 1980a,b: Innes and Tansy, 1980). It has been reported In 
humans that electrical stimulation of the amygdala elicits feelings of fear or 
anxiety as well as autonomic reactions indicative of fear (Chapman et aI., 
1954: Gloor et al., 1981). Low-level electrical stimulation of the amygdala 
(e.g. 4 0 - 4 ~ , , O.lms square wave cathodal pulses) increases acoustic startle 
amplitude in rats (Rosen and Davis, 1986). 
As outlined earlier, lesioning of the central nucleus of the amygdala blocks 
fear-potentiated startle (Hitchcock and Davis, 1986a), and it has also been 
found to attenuate conditioned changes measured by a cessation of ongoing 
behaviour such as freezing (Iwata et aI., 1986b), reduced bar pressing in the 
operant conflict test (Shibata et aI., 1986) or the conditioned emotional 
response paradigm (Kellicut and Schwartzbaum. 1963: Spevack et al., 1975). 
Lesionlng the central nucleus of the amygdala also blocks changes in heart 
rate (Cohen, 1975; Gentile et aI., 1986), blood pressure (Iwata et at, 1986a), 
and ulceration (Henke 1980a and b) in response to startle. 
METHODS 
1. EIEVATEDX-MAZE 
Animals 
Male, Lister hooded rats (200-270gJ (Nottingham University Medical School 
Animal Unit) were housed in groups of 4-6 in a room with a 12hr light: 12 hr 
dark cycle (0700-1900 lights on), with food and water available ad libitum 
Apparatus 
The X-maze was elevated to a height of 70 em and consisted of two open anns. 
45 x 15 em (length x width), and two enclosed arms, 45 x 15 x 10 em (length x 
width x height), with an open roof, arranged such that the two pairs of 
identical arms were opposite each other and Is shown diagrammatically in 
Fig. 4. The maze was constructed out of matt black perspex (6mm thickriess), 
and lines scored on the maze at the entrance and half way along each of the 
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Figure 4 
Schematic diagram of the elevated X-maze used in all of the studies 
throughout this thesis. 
ELEVATED PLUS MAZE 
MATERIAL BLACK PERSPEX (6mm thick) MATT FI N ISH 
arms. The animal's behaviour was recorded directly into a microcomputer 
by an observer siUing 2 metres away in the same room. 
The X-maze was carefully wiped with a wet towel after each animal. All 
experiments were carried out between 10.30 and 15.30. hrs 
Procedure 
Each rat received an injection of either vehicle control (1% methyl cellulose 
in 0.9% saline), diazepam (1, 2.5 or 5mg/kgl, idazoxan (0.25 or 0.5 mg/kg) or 
FG 7142 (1 or 5 mg/kg) intraperitoneally (i.p.) and was then returned to its 
home cage; 6 or 8 animals per treatment. After 25 min the animal was 
isolated in a cage for 5 min and then placed in the centre of the X-maze facing 
one of the enclosed arms. An entry into an arm or the end of an arm was 
defined as the animal placing all four paws over the line marking that area. 
The cumulative time spent in, and the number of entries made into, the open, 
end of open, closed, or end of closed arms, and the number of rears in the 
open, closed or neutral area in the centre of the maze (a rear being defined as 
the elevation of both forepaws off the ground) were recorded during a 5 min 
test period. The open arm data are expressed as percentage of the total time 
spent in, and the total number of entries made into, both the open and 
enclosed arms and the rearing data as the rears per minute in the open arms, 
closed arms, and central square. 
The percentage open:total time and percentage open:total entries, and the 
actual time in the end of the open arms were used as indices of anxiety, while 
the total number of arm and end of arm entries was used as an index of 
locomotor activity. 
Statistics 
All results are expressed as the mean ± standard error of the mean (S.E.M.). 
The ratio of open:total arm entries and open to total time was calculated for 
each rat individually and the mean ± S.E.M. for each treatment group 
presented in order to show group variation. 
All data were analysed using 2-tailed Mann-Whitney U-test. 
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2. FEAR-POTENTIATED STARTLE PARADIGM 
Animals 
Experimentally naive male Lister hooded rats (Harlan Olac Ltd.) weighing 
340-400g were housed in groups of 6 for two weeks prior to experimentation. 
The rats were maintained on a 12hr light-dark cycle (lights on 0700-1900) 
with food and water were available ad libitum. All experiments were 
performed in the light phase. 
Apparatus 
The acoustic startle box (designed by Instrument Engineering Services, 
Smith Kline Beecham, Harlow) consisted of a clear perspex chamber of 
internal dimensions 18 x 10 x 15 cm (length x width x height) and is 
photographed in Fig. 5. The floor of the chamber was made of stainless steel 
bars (4.5 mm diameter) spaced 10 mm apart. The grid was fixed to a metal 
frame which rested on the base of the startle box by four compression 
springs. An aluminium tray containing a fixed amount of sawdust was hung 
from the metal frame directly under the grid floor: the sawdust was changed 
after each rat was tested. 
An accelerometer (Super-G, G-IA, Hakuto International U.K. Ltd.) of 
sensitivity 200mV / g and frequency response I-300Hz was fixed underneath 
the metal platform in the centre of the test chamber. The accelerometer had 
an internal amplifier and a variable gain setting which was adjusted 
manually. Movement of the chamber produced a displacement of the 
accelerometer and the resultant voltage was amplified with an adjustable 
gain amplifier using a digitally controlled potentiometer. The signal was 
low pass mtered to eliminate high frequency Interference and then passed to 
an analog to digital converter. The digitised signal was then fed to a BBC 
'Master' computer using a IMHz Bus. The signal was sampled continuously 
at 0.5 msec intervals for 300 msec after the start of the tone or shock 
presentation. The samples were stored in the memory of the BBC by a 
machine code algOrithm, and the maximum peak height and associated 
latency determined using a programme written 'in house' by P. Lloyd. 
The noise stimulus (tone) was generated by a sine wave generator integrated 
circuit and the white noise (present throughout the experiment) was 
generated by a digital noise source controlled by an analog Switch connected 
to the computer system. The two signals were added together, amplified. and 
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FIgure 5 
Photograph of the fear-potentiated acoustic startle chamber in which the 
antmals are placed for all studies in this thesis. 

delivered via a 2W speaker mounted in the ceiling of the test chamber. The 
duration. frequency. and intensity of the noise stimulus was controlled via 
the BBC microcomputer. The intensity of the stimulus tone and background 
white noise was measured within the chamber using a precision sound level 
meter (CS 192B. Castle Associates. Scarborough). and the average of five 
readings (one taken from each wall and one from the ceUing) used. 
The conditioned stimulus (CS) consisted of a round MES 4.BW light bulb 
(International Lamps Ud., Hertford) mounted in a protective casing in the 
centre of the startle chamber ceiling. Shocks (unconditioned stimuli. US) 
were delivered through the grid floor from a shock generator designed 'in 
house' and located outside the chamber. Shock delivery was controlled by 
the BBC microcomputer. The startle box was enclosed in a series of sound 
attenuating boxes to minimise exposure of the rats outside of the test 
apparatus and experimenter to the startle noise stimulus. 
Calibration 
This was carried out by dropping bags of sand of known masses (2.5 - IBOg) 
from a fixed height on to the metal grid with a 300g bag of sand pennanently 
on the metal grid to allow for the initial mass of the rat. This was repeated 
10 times for each weight and the average output of the accelerometer 
recorded. 
Matching Procedure 
All rats underwent 1 matching session (3 days prior to the first training 
session) in order to establish their baseline startle responses. Groups of 30-
36 rats were weighed the day prior to matching. and any having values 
outside the range - mean ± 2 standard deviations excluded. Each rat was 
placed individually in the startle chamber and five minutes later presented 
with 20 tones (95dB. 4000Hz. 300msec duration) with a mean inter-stimulus 
interval of 20sec (range 8-32sec). Background white noise (55dB) was present 
throughout the session. The mean startle amplitude was calculated for each 
rat. excluding responses occurring less than 25msec or greater than 200msec 
after the start of the tone presentation. Rats were assigned into 3 groups 
ensuring that the groups were similar with respect to weight. baseline startle. 
and contained a representative number of rats from each of the original 
home cages. Vehicle and drug treatments were randomly assigned to the 
three groups. 
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TraIning Procedure 
All rats underwent 2 training sessions on consecutive days starting on the 
third day after matching. Rats were run in the same order. and at 
approximately the same time of day on both training and testing days. Each 
rat was placed individually in the startle chamber and after 5 minutes was 
exposed to 20 light-shock pairings (trials) in which a 0.5mA shock (US) was 
delivered through the grid floor during the last 0.5sec of the 3sec light 
(conditioning) stimulus. The trials were presented at an average inter-trial 
intelVal of 20sec (range 8-32sec). 
Testing Procedure 
24 hours after the second training session. rats were injected 
intraperItoneally with either vehicle (l %w /v methyl cellulose in 0.9% 
saUne). diazepam (0.625. 1.25. 2.5 or 5mg/kg). idazoxan (0.125. 0.25 or 0.5 
mg/kg) or FG 7142 (2.5 or 5 mg/kg). The pH of all solutions injected was 
checked and adjusted to apprOximate neutrality (pH 6-8). Injections were 
made 25 minutes prior to placing a rat in the startle chamber which resulted 
in a 30 minute pretreatment time including the usual 5 minute latency 
period. 20 tones (see matching procedure) were delivered at a mean inter-
trial intelVal of 20sec (range 8-32sec). 10 of the tones were presented alone as 
in the matching procedure. and 10 were preceded for 2.5sec by the 
conditioning light stimulus (duration 3sec). The presentation of the 'light on' 
and 'light off trials was controlled by the startle programme so that they 
occurred in a random manner across the 20 trials: no more than 2 
consecutive trials of the same type was allowed. No shock is used when the 
light is presented during the test procedure. 
The 'light on' (potentiated startle) responses are used as an index of anxiety 
and the 'light off (basal startle) responses used as an indicator of general 
activity. 
Data Analysis 
The total startle amplitude scores for the 10 'light off' (startle) and 10 'light 
on' (potentiated startle) responses were calculated for each rat. The startle 
score used was the maximum response occurring within 200msec of the onset 
of tone: responses occurring less than 25msec were not included. The mean 
of the total startle amplitudes for each type of trial were calculated for each 
treatment group and are presented graphically. The difference between 'light 
on' and 'light off' responses were analysed using the Wilcoxon matched pairs 
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signed ranks test for each treatment group to ascertain the significance of 
the potentiated startle effect. Comparison across groups for each trial type 
was performed using the Kruskal Wallis one way analysis of variance by 
ranks test with post-hoc 2 tailed Mann-Whitney U-test. 
Drugs 
For both the X-maze and potentiated startle studies drugs were suspended in 
1% methyl cellulose (in 0.9% saline), by sonication. All drugs were prepared 
immed1ately prior to use and injected l.p. in a volume of 1 ml/kg. 
Compounds were obtained from the following sources: Methyl cellulose (BDH 
Chemicals): diazepam (Courtin and Warner Ltd.): idazoxan (ReckUt and 
Coleman): FG 7142 16-carbOline-3-carboxylate methylamide) (synthesized at 
SmithKline Beecham). 
RESULTS 
1. ELEVATED X-MAZE 
The vehicle control animals spent less time on the open arms compared to 
the closed arms indicating the aversive nature of the open arms (these 
animals had less than 30% open:total entries and 20% open:total time). 
Diazepam dose-dependently increased the percentage open:total entries and 
time, and time on the end of the open arms, reaching significance at all doses 
0,2.5 and 5 mg/kg) with the exception of 1 mg/kg on the time on the end of 
the open arms (Fig. 6A and B). None of these doses had any effect on the 
rears/min in each area (Fig. 6C) or the total number of arm and end of open 
arm entries (Table 1). Idazoxan at both doses (0.25 and 0.5 mg/kg) 
significantly decreased the percentage open:total entries and time, and the 
time spent on the end of the open arms (Fig. 7A and B). Neither dose had any 
significant effect on the rears/min in each area (Fig. 7C) or the total number 
of arm and end of open arm entries, although this index of locomotor 
activity was reduced with the 0.5 mg/kg dose (Table 1). FG 7142 at both doses 
(1 and 5 mg/kg) significantly reduced the percentage open:total entries and 
time (Fig. SA) with the higher dose causing the greater reduction. Also both 
doses significantly reduced the time spent on the end of the open arms (Fig. 
8B). Neither dose had any Significant effect on the rears/min in each area 
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Figure 6 
Effects of acute administration of diazepam (1,2.5 or 5 mg/kg 1.p.) on (A) the 
percentage open:total entries and time, (B) the time spent on the end of the 
open anns, and (el the rears/min in the closed anns, open anns and central 
square. Behaviour was monitored in the elevated X-maze for a 5 min period 
30 min after drug administration. Data are expressed as the mean ± S.E.M. 
of 6 observations. 
·p<0.05, "p<O.Ol significantly different from controls. 2-tailed Mann-
Whitney U-test. 
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Effects of acute administration of Idazoxan (0.25 or 0.5 mg/kg l.p.) on (A) the 
percentage open:total entries and time. (B) the time spent on the end of the 
open anns. and (el the rears/min in the closed arms. open arms and central 
square. Behaviour was monitored in the elevated X-maze for a 5 min period 
30 min after drug administration. Data are expressed as the mean ± S.E.M. 
of 6 observations. 
·p<0.05 significantly different from controls. 2-tailed Mann-Whitney U-
test. 
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Table 1 
Number of arm and end of arm entries made by each an1mal during a 5 
minute exposure to the X-maze 30 minutes after drug administration. Data 
are expressed as the mean ± S.E.M. of 6 observations for vehicle and drug 
treated groups. 
No significant difference from vehicle controls. 2-tailed Mann-Whitney U-
test. 
Treatment No. of Ann and 
End of Arm Entries 
Vehicle 32.5 + 1.1 
Diazepam (lmg/kg) 31.2 ± 3.6 
Diazepam (2.5mg/kg) 34.2 ± 2.9 
Diazepam (5ml!/kg) 35.7±3.0 
Idazoxan (0.25mg/kg) 29.3± 3.5 
Idazoxan (0.5mJ:!/k,g) 27.2 + 2.1 
FG 7142 (lmg/kg) 29.8± 2.0 
FG 7142 (5mJ:!/k,(tl 25.2 ± 2.7 
(Fig. 8e) or the total number of arm and end of arm entries. although again. 
the higher dose reduced this parameter rrable 1). 
2. FEAR-POTENTIATED STARTLE PARADIGM 
Callbratlon 
Figure 9 shows that the output of the accelerometer was proportional to the 
vertical force on the grid and that the relationship was cuIVilinear over the 
range of startle responses measured. 
Pharmacological VaUclatlon 
Figure 10 shows a computer printout of a typical startle response in a typical 
control rat during a light and tone trial. The y axis represents the amplitude 
of the deflection (arbitary units) produced when the platform on which the 
animal is standing moves as a result of a startle response. with the x axis 
being the time from the onset of the startle tone. The dotted lines indicate 
the peak amplitude of 76 units occurring 82 msec after the onset of the tone. 
Figure llA shows the mean of the total startle amplitude responses on the 
tone alone and the light and tone trials during testing after injection of the 
vehicle or the various doses of diazepam. Analysis of the data for the vehicle 
treated group using the Wilcoxon matched pairs signed ranks test showed 
that displacement during the light and tone trials were Significantly greater 
than the tone alone trials (p<O.OI). indicating a robust potentiation of the 
startle response. Animals pretreated with diazepam at all doses (0.625. 1.25. 
2.5 and 5 mg/kg) still showed a significant potentiated startle response 
(p<0.05) (FIg. llA). The 0.625 and l.25 mg/kg doses were not SignifIcantly 
different from the vehicle control group in the mean of the total startle 
amplitudes for both the light and tone and the tone alone trials (Fig. llA); 
however. the light and tone response amplitudes tended to be reduced 
resulting in a reduction in the difference between the light and tone and the 
tone alone trials at the 1.25 mg/kg dose (the 'potentiated startle') (Fig. 11B). 
Diazepam at 2.5 and 5 mg/kg significantly reduced the mean of the total 
startle amplitudes for the light and tone trials (p<O.01) (Fig. IIA) and the 2.5 
mg/kg dose significantly reduced the mean of the total startle amplitudes in 
the tone alone trials (Fig. lIA). These doses of diazepam reduced the 
difference between the two types of trial (Fig. lIB). 
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FIgure 9 
Calibration of the fear-potentiated startle platform. Each different weight of 
sandbag was dropped from a set height and the amplitude of the deflection 
(arbitary units) was recorded with a 300g bag of sand permanently on the 
metal grid floor to allow for the weight of a rat under experimental 
conditions. Data points are the mean ± S.E.M. of 10 drops. 
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Figure 10 
A computer printout of a typical acoustic startle response for a rat in the 
acoustic startle chamber. The y axis represents the amplitude of the 
deflection (arbitary units) produced when the platfonn on which the animal 
is standing moves as a result of a startle response. with the x axis being the 
time from the onset of the startle tone. The dotted lines indicate the peak 
amplitude of 76 units occurring 82 msec after the onset of the tone in this 
trial. 
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FIgure 11 
Effect of vehicle (1% methyl cellulose 1.p.) or dIazepam (DZP 0.625. 1.25.2.5 
or 5 mg/kg l.p.) administered 30 minutes prior to testing to rats on (A) mean 
of the total startle ampUtudes of 10 Ught and tone trials and 10 tone alone 
trials. and (B) the mean of the difference in total amplitude of the two types of 
trial (light+tone - tone alone) (I.e. 'potentiated' startle). Each bar represents 
the mean total amplitude of 20 animals for vehicle control and 10 for each 
diazepam treatment group. 
·p<O.05, "p<O.OI significantly different between light and tone and tone 
alone trials using the Wilcoxon matched pairs signed ranks test. 
+p<0.05, ++p<O.OI significantly different from vehicle control using the 
Kruskal Wallis one way analysis of variance by ranks test with post-hoc 2 
tailed Mann-Whitney U-test. 
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Animals pretreated with idazoxan at all doses (0.125. 0.25 and 0.5 mg/kg) 
produced a significant potentiated startle response (p<0.01) (Fig. 12A) and 
showed an increase. but not to significance. in the mean of the total startle 
amplitudes during the light and tone trials (p<0.1 for 0.25 mg/kg). None of 
the doses of idazoxan had any effect on the mean of the total startle 
amplitudes during the tone alone trials (Fig. 12A). Fig. 12B shows the dose-
dependent increase in the difference in mean of the total startle amplitudes 
between the two types of trial with idazoxan pretreatment. 
Animals pretreated with FG 7142 (2.5 and 5 mg/kg) had a significant 
potentiated startle reponse (p<0.05) (Fig. 13A). The mean of the total startle 
amplitudes for both the light and tone and tone alone trials in vehicle 
controls was lower in this experiment compared to the two previous studies. 
FG 7142 at both doses significantly increased both the mean of the total 
startle amplitudes in the light and tone and tone alone trials compared to 
vehicle control (p<0.05) (Fig. 13A). and the net result was a decrease in the 
difference between the light and tone and tone alone trials (Fig. 13B). 
DISCUSSION 
The present study has confirmed that both the elevated X-maze and the 
potentiated startle paradigms can detect the anxiolyUc activity of 
benzodiazepine-like compounds (Pellow et al.. 1985: Davis. 1979a. b: 1984). 
First. considering the elevated X-maze. acute diazepam treatment 
significantly increased the percentage open:total entries and time and time 
on the ends of the open arms in a dose-dependent manner without changing 
the total number of arm and end of arm entries. Several authors (e.g. Pellow 
et al.. 1985: Critchley and Handley. 1987) have previously reported an 
increase in the total arm entries with diazepam and this is thought to be a 
result of enhanced locomotor activity occurring from an increase in 
exploration. However. the marking of a line half-way along each of the arms 
allows activity within a particular arm to be monitored and helps rule out 
the possibility of false positives occurring as a result of increased locomotor 
activity. The control animals did not show a significant reduction in 
locomotor activity compared to the diazepam treated animals. suggesting 
that they explore within an enclosed arm to a greater extent than diazepam 
treated animals and the increase in percentage open:total entries observed 
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FIgure 12 
Effect of vehicle (1 % methyl cellulose l.p.) or idazoxan (Idaz 0.125, 0.25 or 0.5 
mg/kg l.p.) administered 30 minutes prior to testing to rats on (A) mean of 
the total startle amplitudes of 10 light and tone trials and 10 tone alone 
trials, and (B) the mean of the difference in total amplitude of the two types of 
trial (Hght+tone - tone alone) (i.e. 'potentiated' startle). Each bar represents 
the mean total amplitude of 20 animals for vehicle control and 10 for each 
idazoxan treatment group. 
·p<0.05, ··p<O.OI, "·p<0.005 significantly different between light and tone 
and tone alone trials using the Wilcoxon matched pairs signed ranks test. 
(p<O.l) significantly different from vehicle control using the Krusk.al Wa1l1s 
one way analysts of variance by ranks test with post-hoc 2 tailed Mann-
Whitney U-test. 
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FIgure 13 
Effect of vehicle (l % methyl cellulose l.p.) or FG 7142 (2.5 or 5 mg/kg l.p.) 
administered 30 minutes prior to testing to rats on (A) mean of the total 
startle amplitudes of 10 light and tone trials and 10 tone alone trials, and (B) 
the mean of the difference in total amplitude of the two types of trial 
(llght+tone - tone alone) (t.e. 'potentiated' startle). Each bar represents the 
mean total amplitude of 20 animals for vehicle control and 10 for each FG 
7142 treatment group. 
·p<0.05 significantly different between light and tone and tone alone trials 
using the Wilcoxon matched pairs signed ranks test. 
+p<0.05, ++p<O.OI significantly different from vehicle control using the 
Kruskal Wallis one way analysis of variance by ranks test with post-hoc 2 
tailed Mann-Whitney u-test. 
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with the benzodiazepine is most likely a result of increased exploration of 
the open arms (occurring possibly as a result of reduced fear) and does not 
merely reflect an increase in general locomotor activity. Acute diazepam at 
all doses had no effects on the rears/min in the open or enclosed arms of the 
maze suggesting that measurement of rearing alone cannot be used as an 
index of anxiety in the rat. In the potentiated startle. the effects of the 
benzodiazepines are well established with low doses of diazepam (up to 2.5 
mg/kg l.p.) reducing only the potentiated startle and higher doses (e.g. 5-10 
mg/kg l.p.) reducing both potentiated and baseline startle responses (Davis. 
1979a. b). However. in this study diazepam a caused significant reduction in 
potentiated startle at doses which also reduced baseline startle. suggesting 
that the system used in the present study was not as sensitive to the 
benzodiazepines as those deSCribed in the literature. 
As previously reported (e.g. Handley and MUhan1. 1984) the Cl2-adrenoceptor 
antagonist idazoxan reduced the percentage open:total entries and time with 
no significant reduction In the number of arm and end of arm entries. 
indicating that the reduced exploration of the open arms (indicating 
increased fear) was not due to decreased locomotor activity. In the 
potentiated startle paradigm. idazoxan did not produce a significant 
increase in the potentiated startle nor did It effect the baseline startle. 
Similar studies using other Cl2-adrenoceptor antagonists such as plperoxane 
and yohimbine have shown enhancement of the potentiated startle alone 
(Davis et al .• 1979)' and conversely. the Cl2-adrenoceptor agonist clonldine 
has been found to selectively reduce the potentiated startle (Davis et al.. 
1977: Handley and Thomas. 1979). Thus. as seen with diazepam. there is a 
trend to the standard response reported in the literature but due to 
variations between individual animals these changes failed to reach 
significance. In clinical studies yohimbine has been reported to produce 
anxiety and induce panic attacks (Charney et aI.. 1984), and clonidine to 
reduce anxiety (Redmond. 1982). It has been suggested (Marsden. 1989) that 
these drugs may have their effects by indirect actions on 5-HT systems. 
rather than a direct action on noradrenerglc systems. Cl2-Adrenoceptors 
situated on 5-lIT neIVe cells or terminals have been shown to regulate 5-HT 
release in rats (Gothert et al. 1980) and in man (Raiteri et aI.. 1990). 
Application of idazoxan directly into the dorsal raphe nucleus by 
microinjection has been shown to increase 5-HT dorsal raphe neuronal 
firing. suggesting that Idazoxan increases 5-HT activity by either blocking 
51 
with the benzodiazepine is most likely a result of increased exploration of 
the open arms (occurring possibly as a result of reduced fear) and does not 
merely reflect an increase in general locomotor activity. Acute diazepam at 
all doses had no effects on the rears/min in the open or enclosed arms of the 
maze suggesting that measurement of rearing alone cannot be used as an 
index of anxiety in the rat. In the potentiated startle. the effects of the 
benzodlazepines are well established with low doses of diazepam (up to 2.5 
mg/kg l.p.) reducing only the potentiated startle and higher doses (e.g. 5-10 
mg/kg l.p.) reducing both potentiated and baseline startle responses (Davts. 
1979a. b). However. in this study diazepam a caused significant reduction in 
potentiated startle at doses which also reduced baseline startle. suggesting 
that the system used in the present study was not as sensitive to the 
benzodtazepines as those described in the literature. 
As previously reported (e.g. Handley and Mithani. 1984) the <X2-adrenoceptor 
antagOnist idazoxan reduced the percentage open:total entries and time with 
no significant reduction in the number of arm and end of arm entries. 
indicating that the reduced exploration of the open arms (indicating 
increased fear) was not due to decreased locomotor activtty. In the 
potentiated startle paradigm. idazoxan did not produce a significant 
increase in the potentiated startle nor did it effect the baseline startle. 
Similar studies using other <X2-adrenoceptor antagonists such as piperoxane 
and yohimbine have shown enhancement of the potentiated startle alone 
(Davis et al .. 1979). and conversely. the <X2-adrenoceptor agonist clonidine 
has been found to selectively reduce the potentiated startle (Davis et aI.. 
1977: Handley and Thomas. 1979). Thus. as seen with diazepam. there is a 
trend to the standard response reported in the literature but due to 
variations between individual animals these changes failed to reach 
significance. In clinical studies yohimbine has been reported to produce 
anxiety and induce panic attacks (Charney et al.. 1984). and clonidine to 
reduce anxiety (Redmond. 1982). It has been suggested (Marsden. 1989) that 
these drugs may have their effects by indirect actions on 5-HT systems. 
rather than a direct action on noradrenergic systems. <X2 -Adrenoceptors 
situated on 5-HT neIVe cells or terminals have been shown to regulate 5-HT 
release in rats (Gothert et al. 1980) and In man (Ratterl et al.. 1990). 
Application of Idazoxan directly into the dorsal raphe nucleus by 
microinjection has been shown to increase 5-HT dorsal raphe neuronal 
firing. suggesting that idazoxan increases 5-HT activity by either blocking 
51 
CX2-adrenoceptors on 5-HT terminals in the dorsal raphe. or by blocking cx2-
adrenoceptors on noradrenergic terminals in the dorsal raphe resulting in 
enhanced noradrenaline release.and consequently increased 5-HT neuronal 
activity (Garratt et al .• 1991). If 5-HT levels increase in anxiety (Chopin and 
Briley. 1987), cx2-adrenoceptor antagonists. by increasing 5-HT release 
would be predicted to have an arudogenfc profile. and CX2 -adrenoceptor 
agOnists by decreasing 5-HT release. an arudolyUc profile. 
FG 7142 is a well established partial inverse agonist at the GABA-
benzo<iiazepine receptor complex. The present study has confirmed that the 
elevated X-maze. as well as detecting the anxiolytic activity of 
benzodiazepine agonists can also detect the arudogenic activity of partial 
inverse agonfsts at the GABA-benzodiazepine receptor complex (Pellow et a1.. 
1987). In the potentiated startle paradigm. FG7142 significantly increases 
both the potentiated startle and the basal startle. As a result of the increased 
basal startle it cannot be determined whether the raised potentiated startle 
is a result of an anxlogenic effect of FG 7142 or a result of increased arousal 
caused by the drug. Lower doses of FG 7142 may be useful in determining 
whether this compound has an anxlogenic effect. The ~ - c a r b o l i n e e has also 
been found to induce anxiety in man (Dorow et al .• 1983). It has been 
suggested that one of the mechanisms of the anxiolytlc effects of the 
benzodiazepines is via a decrease in central serotonergic transmission 
(Stein et a1.. 1977) and evidence exists which shows that benzodiazepines 
inhibit 5-HT syntheSiS (Saner and Pletscher. 1979) and release (Pei et a1.. 
1989b). Thus. one of the mechanisms by which the part1alinverse agonist 
FG 7142 may be expected to produce anxiety is by increasing 5-HT function. 
Both models have their own advantages. and for the elevated X-maze these 
are: firstly. it is a non-shock procedure. relying not on electrical stimulation 
but on the new (novel) environment producing a conflict between fear and 
exploration. Second. the rats are not deprived of food or water unlike the 
Geller-Seifter and Vogel tests respectively. thus the effects of drugs on 
appetite and thirst need not be conSidered. Third. the animal's behaviour is 
natural. it is not something it has to learn. Fourth. no training of the rats is 
necessary and hence testing the animals is relatively easy. 
For the potentiated startle paradigm. potenUated startle is defined as a 
within-subjects difference in startle amplitude in the presence (light-noise 
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trials) versus the absence (noise-alone trials) of the visual conditioned 
stimulus. Thus. each animal acts as its own control and hence the problem 
of between-subjects variability in startle is reduced. making the test more 
sensitive. Second. it allows evaluation of specific effects (reduction of startle 
on light-noise trials) versus non-specific effects (reduction of startle on 
noise-alone trials). so that qualitative as well as quantitative drug profiles 
can be compared. Third. no shocks are given during testing. thus any drug 
effects observed cannot be explained by changes in sensitivity to shock. 
Fourth. the separation between training and testing sessions allows one to 
determine if a drug alters originallearntng or performance. and testing for 
state-dependent learning can be evaluated (Davis. 1979a). Fifth. potentiated 
startle does not involve any obvious operant. Thus drug effects that might be 
expected to alter operant performance (e.g. rate-dependent. motivational. 
dtsinhibitory motor effects) are avoided. 
Additionally. most animal tests of fear of anxiety involve a suppression of 
ongoing behaviour in the presence of a fear stimulus (e.g. suppression of bar-
pressing in the Geller-Seifter operant conflict test; suppression of licking in 
the licking-suppression test; suppression of normal activity in the social 
interaction test; suppression of exploration of open arms in X-maze). Hence. 
certain treatments (e.g. those causing decreases in 5-HT transmission) may 
appear anxiolytic in these tests if they interact with neural systems common 
to each of these tests (e.g. response inhibition). even if this is not so in the 
clinic. Because fear in the potentiated startle paradigm is reflected by 
enhanced response output. it may provide an important alternative test to 
analyse potential anxiolytic compounds. A further advantage of the 
potentiated startle paradigm is that fear is beIng measured by a change in a 
simple reflex. Hence. with potentiated startle. fear is expressed through 
some neural circuit that is activiated by the condItioned stimulus and 
ultimately impinges on the startle circuit. 
Both tests showed that they could detect both anxiolytic and anxlogenic 
compounds. However. the elevated X-maze produced more reproducible and 
dose-dependent results in comparison to the potentiated startle. in which 
there was a great amount of variation in baseline startle response. For this 
reason. and the SimplicIty of procedure in the elevated X-maze it was chosen 
as the behavioural model of anxiety for use In the studies in this thesIs. 
Furthermore. with the X-maze being open-roofed it is possIble to combine 
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this test with microdialysis. thus allowing simultaneous neurochemical and 
behavioural changes to be measured in the same animal. 
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CHAPTERS 
COMPARISON OF ACUTE AND CHRONIC TREATMENT OF VARIOUS 
.AGENTS THAT ACr DIRECTLY ON 5-HT RECEPTORS WITH THOSE OF 
DIAZEPAM AND IDAZOXAN IN THE ELEVATED X-MAZE 
INTRODUCTION 
In the General Introduction evidence is presented for drugs affecting central 
serotonergic neurones as putative anxiolyUc compounds. The most widely 
used anxiolyUcs. the benzodiazepines. are known to influence 5-HT 
neurotransmission but there is sUlI controversy over whether this action is 
related to their arudolytlc effect (see Soubrie. 1986; Thiebot. 1986; Kahn et 
al.. 1988). Studies of anxiety disorders in humans (Kahn and Westenberg. 
1985; Charney et al.. 1987) point towards the involvement of 5-HT in 
anxiety. 
The 5-HTIA receptor partial agonist buspirone has been found to be effective 
clinically in the treatment of anxiety in benzodiazepine-naive paUents 
(Goldberg and Finnerty. 1979). and the more recently developed 5-HTIA 
receptor partial agonists gepirone and ipsapirone appear to have clinical 
activity regardless of the patient's previous drug treatment (Traber and 
Glaser. 1987). Other clinical studies have reported that buspirone and the 5-
HT2 receptor antagonist rttanserin to be effective in the treatment of 
generalized anxiety disorder (Ceulemans et al.. 1985; Taylor et al.. 1985). The 
5-HT3 antagonists seem to be effective in some behavioural models of 
anxiety (Tyers. 1989) and clinical trials stUdying the anxiolytic potential of 
ondansetron (originally GR38032F) are at present being carned out. 
However, these classes of 5-HT compounds have produced inconsistent 
results in various animal models (see Chopin and Briley. 1987). 
Using the elevated X-maze model of anxiety described in the General 
Introduction and Chapter 2. the 5-HTIA receptor partial agonist ipsapirone 
given acutely has been reported to produce either an anxiolytic (Soderpalm et 
al.. 1989) or an anxiogenic (Moser. 1989a) behavioural profile. or to have no 
effect (File et al.. 1987). Similarly. the 5-HT2 antagonist. rttanserin. has 
shown either an anxiolyUc (Critchley and Handley. 1986) or an anxiogenic 
(File et al.. 1987) profile in the elevated X-maze. Ondansetron has been 
demonstrated to have an anxiolyUc profile on the elevated X-maze (Costall et 
al.. 1989a) and also displays an anxiolyUc profile in other behavioural 
models of anxiety based on exploration such as the black and white box 
(Costall et al .. 1989b) and the social interaction models (Jones et al.. 1988). 
Other 5-HT3 antagonIsts, such as BRL 46470A. have also displayed an 
anxiolyUc profile in the X-maze (Upton and Blackburn. 1991). 
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In the clinic. ipsapirone and ritanserin show greater activity after chronic 
administration (Traber and Glaser. 1987: Ceulemans et al .• 1985) and hence 
the aim of this study was to compare acute and chronic treatments of these 
two compounds and also ondansetron with those of established arudolytic 
(diazepam) and arudogenIc (1dazoxan) compounds using the elevated X-maze. 
In the ondansetron study a group of animals received chronic vehicle 
followed by acute ondansetron to determine the effects of the chronic dosing 
schedule on the acute effects of the compound. One of the problems 
associated with the benzodiazepines are the withdrawal effects sometimes 
obselVed on cessation of chroniC treatment. In the present study animals 
were tested 24 hours after the last dose of the chronic study to determine if 
diazepam withdrawal effects can be obsetved using the X-maze and whether 
Similar effects are produced by ipsaplrone. ritanserln and ondansetron. 
METHODS 
Animals 
Male. Lister hooded rats (200-270g) (Nottingham University Medical School 
Animal Unit) were housed In groups of 4-6 in a room with a 12hr light: 12 hr 
dark cycle (0700-1900 lights on). with food and water available ad libitum. 
Apparatus 
The X-maze used was the same one as described in Chapter 2. 
Procedure 
Each rat received an injection of either vehicle control (1% methyl cellulose 
in 0.9% saline). Ipsaplrone (0.01.0.1 and 1 mg/kg). ritanserin (0.05 and 0.25 
mg/kg). ondansetron (0.01. 0.1 and 1 mg/kg). diazepam (5mg/kg) or idazoxan 
(0.25 mg/kg) intraperltoneally (t.p.) and was then returned to its horne cage: 6 
or 8 animals per treatment group. After 25 minutes the animal was isolated 
In a cage for 5 minutes and then placed in the centre of the X-maze faCing one 
of the enclosed anns and monitored on the X-maze as deSCribed in chapter 2. 
Chronic Treatment 
Groups of 6 or 8 rats were treated twice daily for 14 days with either vehicle. 
ipsaplrone (0.01. 0.1 and 1 mg/kg). ritanserin (0.25 mg/kg). ondansetron 
(0.01 mg/kg). or diazepam (5mg/kg) I.p. between 0730-0900 and between 
1700-1830 hrs. As a result of the rapid metabolism of Idazoxan. two groups 
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of rats had Alzet osmotic mini-pumps placed (under halothane anaesthesia) 
below the skin in the middle of the back contatnlng either Idazoxan (0.8 
mg/kg/hr at a flow rate of 5.5J.LI/hr) or saline (5.5J.Ll/hr). The osmotic 
mlnipumps were still In place during the behavioural testing of these 
animals. On the morning of the 15th day the rats received their final 
injection of either drug or vehicle and were tested 30 min later in the X-maze 
as described above. In the ondansetron study. two groups of animals received 
either vehicle or ondansetron throughout whilst a third group received 
chrOniC vehicle treatment and were then Injected with ondansetron (0.01 
mg/kgl on the test day. 
In the withdrawal study animals were retested on the X-maze 1 (24 hours) 
and 7 days after the last treatment as deSCribed above. No withdrawal study 
was carried out with the Idazoxan treated animals. 
Body weight was monitored throughout the treatment period. Housing 
conditions during the period of chroniC treatment were identical to those 
before chronic dosing (deSCribed above). 
Drugs 
Drugs were suspended in 1% methyl cellulose (in 0.9% saUne). by sonication. 
All drugs were prepared Immediately prior to use and injected l.p. in a 
volume of 1 ml/kg. 
Compounds were obtained from the following sources: Methyl cellulose (BDH 
Chemicals); ipsapirone (Troponwerke Gmbh and Co.); ritanserin (Janssen 
Pharmaceutical: ondansetron (Glaxo); diazepam (Courtin and Warner Ltd.); 
idazoxan (Reckitt and Coleman). 
Statistics 
All results are expressed as the mean ± S.E.M.. The ratio of open:total arm 
entries and open to total time was calculated for each rat individually and 
the mean ± S.E.M. for each treatment group presented. 
All data were analysed using 2-tatled Mann-Whitney U-test. 
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RESULTS 
(8) Acute Studlea 
Diazepam (5 mg/kgl significantly increased the percentage open:total entries 
and time, and the time in the end of the open anns (Fig. 1A and 18), but had 
no effect on the total number of arm and end of arm entries (Table I). 
Idazoxan (0.25 mg/kg) Signtflcantly decreased the percentage open:total 
entries and time (Fig. lA), and reduced, though not Significantly, the time in 
the ends of the open anns (Fig. 18), but had no effect on the total number of 
arm and end of arm entries (Table 1). Ipsapirone at doses of 0.01 and Img/kg 
had no signtflcant effect on the percentage open:total entries and time (Fig. 
2A), or on the time spent in the ends of the open anns (Fig. 28), or on the total 
number of arm and end of arm entries (Table 1). However, ipsapirone (0.1 
mg/kg) signtflcantly decreased the percentage open:total entries and time, 
and the time spent In the ends of the open arms (Fig. 2). This dose of 
ipsapirone had no effect on the number of arm and end of arm entries (Table 
1). Acute ritanserin (0.05 mg/kg) produced no change in the percentage 
open:total entries and time, time in the ends of the open arms (Fig. 3A and 
38), and total number of arm and end of arm entries (Table I). However, 
r1tanserin (0.25 mg/kg) tended to reduce the percentage open:total entries 
and time, and time in the end of the open arms (Fig. 3A and 38) with the 
reduction in open:total time approaching s1gn1f1cance (p<O.06). This dose of 
ritanserin had no effect on the total number of arm and end of arm entries 
(Table I). Acute ondansetron (0.0 I, 0.1 and I mg/kgl had no significant effect 
on any of the parameters scored (Fig. 4). 
(b) Chronic Studies 
Chronic treatment. twice daily for 14 days, with diazepam, ipsapirone, 
r1tanserin and ondansetron had no effect on the body weights of animals 
compared with those receiving vehicle control (data not shown). Chronic 
administration of idazoxan or saline via the mini-pump was also observed 
to have no effect on body weight (data not shown). The number of arm and 
end of arm entries decreases with increase in duration of the experimental 
protocol regardless of the treatment. 
Chronic diazepam treatment increased the percentage open:total entries and 
time, and time spent In the ends of the open arms compared to the control 
group (Fig. 5A and 58). There was no difference in the total number of arm 
and end of arm entries between these two groups (Table 1). Chronic idazoxan 
significantly decreased the percentage open:total entries and time and the 
time spent in the ends of the open arms (Fig. 6A and 68) but had no effect on 
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FIgure 1 
Effects of acute administration of diazepam (5 mg/kg l.p.) and idazoxan (0.25 
mg/kg l.p.) on (A) the percentage open:total entries and time and (B) the time 
spent on the end of the open arms. Behaviour was monitored in the elevated 
X-maze for a 5 min period 30 min after drug administration. Data are 
expressed as the mean ± S.E.M. of 6 obselVations. 
·p<0.05. "p<O.O 1 significantly different from vehicle controls. 2-tailed 
Mann-Whitney U-test. 
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Figure 2 
Effects of acute administration of ipsapirone (0.01, 0.1 and 1 mg/kg Lp.) on 
(A) the percentage open:total entries and time and (8) the time spent on the 
end of the open arms. Behaviour was monitored in the elevated X-maze for a 
5 min period 30 min after drug administration. Data are expressed as the 
mean ± S.E.M. of 6 observations. 
·p<0.05 significantly different from vehicle controls. 2-tailed Mann-
Whitney U-test. 
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Figure 3 
Effects of acute administration of ritanserin (0.05 and 0.25 mg/kg i.p.J on (A) 
the percentage open:total entries and time and (B) the time spent on the end 
of the open arms. Behaviour was monitored In the elevated X-maze for a 5 
mIn period 30 min after drug admInistration. Data are expressed as the 
mean ± S.E.M. of 6 observations. 
There was no sIgnificant difference at the p<0.05 level between either of the 
drug treated groups and the vehicle control. 2-taUed Mann-Whitney U-test. 
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FIgure 4 
Effects of acute administration of ondansetron (0.01, 0.1 and 1 mg/kg Lp.) on 
(Al the percentage open:total entries and time and (B) the time spent on the 
end of the open arms. Behaviour was monitored in the elevated X-maze for a 
5 min period 30 min after drug administration. Data are expressed as the 
mean ± S.E.M. of 8 observations. 
There was no significant difference at the p<0.05 level between any of the 
drug treated groups and the vehicle control. 2-talled Mann-Whitney U-test. 
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Figure 5 
Effects of chronic treatment of diazepam (DIaz. 5 mg/kg l.p.) twice daily for 
14 days, with behaviour monitored 30 min after last Injection on the 15th 
day, and effects after 24 hours withdrawal and 7 days withdrawal of chronic 
treatment on (A) the percentage open:total entries and time and (B) the time 
spent on the end of the open arms. Behaviour was mOnitored in the elevated 
X-maze for a 5 min period. Data are expressed as the mean ± S.E.M. of 6 
observations. 
"p<O.OI significantly different from controls. 2-tailed Mann-Whitney U-
test. 
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FIgure 6 
Effects of chronic treatment of vehicle control (0.9% saline. 5.51J.l/hr) or 
idazoxan (0.8 mg/kg/hr at a flow rate of 5.51J.l/hr) administered using Alzet 
minipumps for a period of 14 days. with behaviour monitored on the 15th 
day with the minipumps still in place. on (A) the percentage open:total 
entries and time and (B) the time spent on the end of the open arms. 
Behaviour was monitored in the elevated X-maze for a 5 min period. Data 
are expressed as the mean ± S.E.M. of 6 obseIVations. 
·p<0.05 significantly different from controls. 2-talled Mann-Whitney U-
test. 
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the total number of ann and end of ann entries (Table 1). Chronic treatment 
with ipsapirone at all of the doses studied had no effect on any of the 
behavioural parameters measured (Fig. 7). Chronic ritanserin (0.25 mg/kg) 
significantly increased the percentage open:total entries and time, and time 
on the ends of the open arms (Fig. SA and 8B) but had no effect on the total 
number of ann and end of arm entries compared to control animals (Table 
1). Chronic ondansetron significantly increased the percentage open:total 
entries and time (Fig. 9A), and also increased the time spent in the ends of the 
open arms (Fig. 9B) but not to significance while having no effect on the 
number of arm and end of arm entries (Table 1). On the whole the increases 
in the Indices used as measures of anxiety seen with chronic ritanserin and 
ondansetron treatments were not as great as those obselVed with chrOniC 
diazepam treatment. 
(c) Withdrawal Studies 
24 hours or 7 days after completion of chronic diazepam treatment there 
were no signiftcant differences in the behaviour of these rats compared to 
vehicle controls (Fig. 5). 24 hours after the last dose of ipsapirone, the rats 
that had received 0.01 and 0.1 mg/kg showed no behaVioural difference from 
their controls (Fig. 7) but ipsapirone (1 mg/kg) reduced scores for all of the 
parameters measured except for the total number of ann and end of arm 
entries (Table 1). This anxtogenic profile observed with ipsapirone (1 mg/kg) 
was lost 7 days after cessation of chroniC treatment when these animals 
displayed behaviour no different from the controls (data not shown). 24 
hours after completion of chroniC ritanserin treatment these animals stm 
had Significantly greater percentage open:total entries and time compared to 
the control group (Fig. BAl, but there was no difference in the total number of 
arm and end of arm entries between these two groups (Table 1). 7 days after 
cessation of chronic ritanserin treatment these rats displayed behaviour 
that was not Significantly different from the control animals, although the 
percentage open:total entries was still somewhat greater than the control 
values (Fig 8A and 8B). 24 hours after cessation of chroniC ondansetron 
treatment there was no difference in the behaviour of these animals 
compared to those of vehicle control (data not shown). 
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FIgure 7 
Effects of chronIc treatment of Ipsaplrone (0.01. 0.1 and 1 mg/kg l.p.) twice 
daily for 14 days. with behaviour monItored 30 mIn after last Injection on 
the 15th day. and effects after 24 hours withdrawal of chronIc treatment on 
(A) the percentage open:total entries and time and (B) the time spent on the 
end of the open arms. Behaviour was monitored in the elevated X-maze for a 
5 min period. Data are expressed as the mean ± S.E.M. of 6 observations. 
·p<O.05 sIgnifIcantly dIfferent from controls. 2-tailed Mann-Whitney U-
test. 
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FIgure 8 
Effects of chronic treatment of ritanserin (Rit. 0.25 mg/kg i.p.) twice daily for 
14 days. with behaviour mOnitored 30 min after last injection on the 15th 
day. and effects after 24 hours withdrawal and 7 days withdrawal of chronic 
treatment on (A) the percentage open:total entries and time and (B) the time 
spent on the end of the open arms. Behaviour was mOnitored in the elevated 
X-maze for a 5 min period. Data are expressed as the mean ± S.E.M. of 6 
observations. 
·p<0.05. "p<O.OI significantly different from controls. 2-tailed Mann-
Whitney U-test. 
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Figure 9 
Effects of chronic treatment of vehicle control (1% methyl cellulose), twice 
daily for 14 days followed by a single injection of either vehicle (Vehicle) or 
ondansetron (0.01 mg/kg 1.p.) (Acute Ondan.) on the test day (day 15), and 
ondansetron (0.01 mg/kg 1.p.) twice daily for 14 days (Chronic Ondan.) with 
behaviour monitored 30 min after last injection on the 15th day on (Al the 
percentage open:total entries and time and (B) the time spent on the end of 
the open arms. Behaviour was monitored in the elevated X-maze for a 5 min 
period. Data are expressed as the mean ± S.E.M. of 8 observatiOns. 
·p<0.05 significantly different from controls. 2-tailed Mann-Whitney U-
test. 
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Table 1 
Effect of diazepam (DZP. 5mg/kg). idazoxan (Idaz. 0.25mg/kgl. ipsapirone 
(Ipsap. 0.01.0.1 and Img/kgl. ritanserin (rut 0.05 and 0.25mg/kg) and 
ondansetron (Ondan 0.01. 0.1 and Img/kg) after acute or chronic (twice dally 
for 14 days) treatment. or 24 hours or 7 days after cessation of chronic 
treatment on the total number of arm and end of arm entries during a 5 
minute exposure to the X-maze. Results are expressed as the mean ± S.E.M. 
for 6-8 observations when animals were exposed on the X-maze for a 5 
minute period 30 minutes after injection i.p .. The number of arm and end of 
arm entries decreases with increase in duration of the experimental protocol 
regardless of the treatment. 
Key: n.t. = not tested. 
There were no significant differences at the p<0.05 level. 2-tailed Mann-
Whitney U-test. each treatment group was compared to its vehicle control. 
Treatment No. of Ann and End of Arm Entries 
Acute Chronic 24 hrs. after 7 days after 
chronic chronic 
Vehicle 32.5±2.1 24.5±3.6 20.3+ 3.1 1B.7+ 1.9 
DZP (5mg/kg) 35.7±3.0 2B.B±5.3 IB.7± 1.6 20.9±3.4 
Idaz (O.25mg/kg) 29.3±3.5 n.t. n.t. n.t. 
Vehicle (0.9% saline) n.t. 1B.0±2.5 n.t. n.t. 
Idaz (O.Bmg/kg/hr) n.t. IB.O±2.2 n.t. n.t. 
Vehicle 30.6±2.9 24.1 ±2.7 17.4± 2.7 15.0± 1.B 
Ipsap (O.Olmg/kg) 27.3±2.6 19.7±4.9 IB.O± 1.9 n.t. 
Ipsap (O.lmg/kg) 25.2± S.9 22.0±3.2 17.7±1.1 n.t. 
Ipsap (lmg/kg) 2B.0±2.6 22.2±2.4 14.2± 2.5 lS.6±2.0 
Vehicle 32.5±2.1 24.5±3.6 20.3± 3.1 IB.7 ± 1.9 
rut (O.OSmg/kg) 26.0±S.7 n.t. n.t. n.t. 
rut (0.2Smg/kg) 26.2±4.9 24.2±4.7 19.B± I.B 17.3±3.7 
Vehicle 2B.B± I.B 23.7±4.0 IB.7± 1.7 n.t. 
Ondan (O.Olrng/kg) 29.B±2.0 2B.7±3.3 n.t. n.t. 
Ondan (O.lrng/kg) 29.4±3.B n.t. n.t. n.t. 
Ondan (lrng/kg) 27.5±2.B n.t. n.t. n.t. 
Chronic Vehicle + 2B.3±5.3 19.0±3.1 n.t. 
Acute Ondan 
(O.Olmg/kg) 
DISCUSSION 
(a) Acute Studies 
It has been demonstrated previously by others (Pellow et al.. 1985) and in 
this thesis (Chapter 2) that the elevated X-maze can detect the arudolyUc 
activity of benzodiazepine-like compounds. This was confinned in the 
experiments described in this chapter showing that acute diazepam 
treatment Signiflcantly increased the percentage open:total entries and time 
and time on the ends of the open arms without changing the total number of 
ann and end of ann entries. Again. as described in Chapter 2 and by other 
authors (e.g. Handley and Mithani. 1984). the (l2-adrenoceptor antagonist 
idazoxan reduced the percentage open:total entries and time with no 
significant reduction in the number of arm and end of ann entries, 
indicating that the reduced exploration of the open anns (indicating 
increased fear) was not a result of decreased locomotor activity. The 
proposed mechanisms of action of these two compounds has been discussed 
in Chapter 2. 
While the lowest and highest doses of ipsaplrone (0.01 and 1 mg/kg) had no 
effect on behaviour in the X-maze the middle dose (0. 1 mg/kg) significantly 
decreased both the percentage open:total entries and time. Using the X-maze 
Soderpalm et al. (1989) have shown an anxiolytic profile for ipsapirone at a 
dose of 0.01 mg/kg s.c. and also for the other 5-HTIA partial agonists over a 
narrow dose range with similar concentrations to Ipsapirone. In contrast. 
Pellow et al. (1987) showed that ipsaplrone had an arudogenic profile at 
doses of 2.5 - 10 rng/kg l.p., producing s1m1lar results to those found in this 
study. Looking at other animal models of arudety. ipsa pirone has been 
shown to antagonise paSSive avoidance behaviour with equipotent activity 
compared to diazepam (Traber et al.. 1984). and in the potentiated startle 
paradigm (DaviS. 1979a and b) ipsaplrone has been found to be arudolytlc 
(Davis et al.. 1988) but at doses which are at least 10 fold greater than those 
found to be anxlolytic by Soderpalm and co-workers (1989). The anx10lytiC 
effects of ipsaplrone and the other pyr1mldlnylplperazlne derivatives (e.g. 
busplrone and geplrone) are thought to be related to a supresslon of 5-HT 
neuronal activity in the dorsal raphe nucleus (Aghajanlan et al.. 1987: 
Glaser and Traber. 1987). However in the CNS. 5-HTIA receptors are found 
not only on the cell bodies/dendrites of 5-HT neurones In the raphe nuclei 
but also at postsynaptic sites such as the limbIc terminal regions (Hoyer et 
al. 1986a). 5-HTIA partial agonists have been shown to reduce 5-HT 
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synthesis, turnover and release in limbic regions, presumably via a 
preferential stimulation of 5-HTIA autoreceptors (Dourtsh et al., 1986: 
Traber and Glaser, 1987; Broadhurst and Brtley, 1988; Sharp et aI., 1989c). 
However, stimulation of postsynaptic 5-HTIA receptors in the limbic regions 
would tend to increase 5-HT neuronal activity and may produce an 
arudogenic-like profile under certain behavioural conditions. It is possible 
that the balance of receptor stimulation of these two sites could vary 
depending on the dose of ipsapirone, with low doses acting predominantly at 
pre-synaptic sites (probably the somatodenritic autoreceptor) and higher 
doses acting at a mixture of pre- and postsynaptic sites. From the results of 
this study two possible explanations for the effects of ipsapirone are that 
either ipsapirone at 0.1 mg/kg i.p. is a high enough dose to cause 
postsynaptic receptor stimulation and produce an anxiogenic proille on the 
X-maze (with the reason for no activity with the 1 mg/kg dose being 
unknown), or stimulation of the presynaptic receptors at the 0.1 mg/kg dose 
produces an anxiogenic profile which is blocked by increasing the dose to 1 
mg/kg and stimulating both pre- and postsynaptic 5-HTIA sites. Overall, the 
effects seen with ipsapirone do not fit well with those in the literature. A 
further complication is that I-pyrimidinylpiperazine (l-PP), the main 
metabolite of ipsapirone, is a potent CX2-adrenoceptor antagonist (Bianchi et 
al., 1988) whIch, from the results of the idazoxan experiment. suggesting that 
this would produce anxiogenic proille. However, It has been reported that 1-
PP does not produce an anxiogenic proille on the X-maze (Moser, 1989b). 
Acute treatment with ritansertn (0.05 mg/kg) had no effect (either anxiolytic 
or arudogenic) on the animals performance on the X-maze. One possible 
explanation for the difference between these results and the anxiolytic 
profile with acute rttanserin obseIVed by Crttchley and Handley (1987) at 
doses Similar to the one used in this study is that they monitored the 
animals on the maze for a 10 min period. The higher dose of ritanserin (0.25 
mg/kg) produced a non-significant anxiogenic profile, supporting the 
observations by File et al. (1987). This observation is somewhat unexpected 
as administration of a 5-HT2 selective agonist such as 1-(2, 5-dimethoxy-4-
iodophenyl) -2-aminopropane (DOl) is also seen to produce an anxiogenic 
profile in the X-maze (unpublished results) and social interaction models 
(Kennett et aI.. 1989). Clinically, the 5-HTIC/2 agonist mCPP has been shown 
to induce panic attacks in both healthy subjects and in patients with panic 
disorder (Charney et aI., 1987). It suggests that rltanserin after acute 
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administration may be acting at a different 5-HTIC/2 site compared with 
that seen with the selective agontsts. 
Ondansetron given acutely (0.01. 0.1 or 1 mg/kg) did not produce behaviour 
different from vehicle controls in the X-maze. The results reported in the 
literature with this 5-HT3 antagonist vary greatly with the particular 
animal model of anxiety. Jones et a1. (1988) found that ondansetron 
produced an anxiolytic-like profile in a social interaction test in rats and 
monkeys but not in the rat water-lick conflict test. However. a more recent 
study (File and Johnston. 1989) found that acute administration of 
ondansetron at 0.1 and 1 mg/kg p.o. and two other 5-HT3 antagonists (BRL 
43694 (0.1 and 1 rug/kg p.o.) and zacopnde (0.01. 0.1 and 1 rug/kg p.o.)) had no 
significant effects on social interaction. Ondansetron and BRL 46470A. 
another 5-HT3 antagonist. have been shown to have an arudolytic profile in 
the X-maze when the animals are monitored for a 10 minute period (Costall 
et a1.. 1989a; Upton and Blackburn. 1991). Thus. increasing the time the 
animal is on the X-maze may produce an anxiolytiC profile. 
(b) Chronic and Withdrawal Studlea 
Chronic treatment with the vehicle control (1 % methyl cellulose) resulted in 
a slight fall in exploratory behaviour. obselVed as reduced percentage 
open:total entries and time. It cannot be determined from this experiment 
whether this was a result of the methyl cellulose or the effects of handling 
and injecting the animals twice daily. It is interesting to note that infusion 
of 0.9% w/v saline via an osmotic mini-pump also appeared to produce a 
reduction in the number of arm and end of arm entries even though these 
animals were not handled on a daily basis. Chronic diazepam treatment (5 
mg/kg twice daily for 14 days) produced an anxiolytic profile. the percentage 
open:total entries and time being Similar to those obselVed in the acute 
study. indicating no tolerance to the anxtolytic effects of diazepam. This 
may be due to the selected dose of diazepam not being large enough to induce 
tolerance using the X-maze. or that the dose of diazepam produced a 
supramaximal effect on the X-maze and hence even if some tolerance 
developed it was stUl possible to obselVe a maximal effect on the X-maze. 24 
hours after the last dose of diazepam no anxiolytic activity was obselVed and 
behaviour did not differ Significantly from controls. However. using a 
different design of elevated X-maze FUe and Baldwin (1989) have been able to 
detect anxiogenic withdrawal effects using chlordiazepoxide at doses of 5 and 
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20 mg/kg l.p .. It may be necessary to use higher (I.e. 10 or 20 mg/kg) doses of 
diazepam to cause significant withdrawal behaviour as indicated by 
previous studies (Costall et a1.. 1990a). From the present results it would 
appear possible in an animal test to produce clear anxiolytic effects with 
diazepam without obvious concomlttant withdrawal effects. however. 
increasing the baseline values of the vehicle controls may produce a greater 
difference between control and diazepam treated animals allowing 
withdrawal to be observed. 
Chronic administration of idazoxan by osmotic mini-pumps still resulted in 
an anxlogenic profile. with the reduction in percentage open:total entries 
and time being more marked than with acute treatment. 
Electrophysiological studies have shown that chronic administration of 
idazoxan elevated the basal 5-HT neuronal firing rate in the dorsal raphe 
nucleus and it remained above the control basal level 24 hours after 
cessation of treatment (Garratt et al .• 1991). The elevated basal firing rate 
could be further increased with an acute dose of idazoxan; the percentage 
increase obtained being equivalent to that observed in animals given the 
same dose acutely. indicating that tolerance to idazoxan does not develop 
after 14 days (Garratt et a1.. 1991). The lack difference between acute and 
chronic idazoxan may be a result of no tolerance or because of the different 
doses used in the two studies. 
Chronic ipsapirone at all doses showed no significant effect in the X-maze. 
Why these results are different from the acute study in which 0.1 mg/kg 
ipsapirone produced anxiogenic effects is not clear; it is possible that 
chronic administration of Ipsaplrone alters somatodendritic and/ or 
postsynaptic 5-HTIA receptor sensitivity or number. Chronic treatment 
with ipsaptrone has been shown to have no effect on the 5-HTIA stimulated 
inhibition of adenylyl cyclase activity in the hippocampus (Varrault et at. 
1991). suggesting that there is no down-regulation of this receptor in this 
region. In an autoradiographic study using another 5-HTIA partial agonist. 
busptrone. it has been found that after chronic treatment there was a down 
regulation of 5-HTIA receptors in the dorsal raphe with no changes observed 
in the hippocampal postsynaptic 5-HTIA receptors (Mennini and Gobbi. 
1990; Gobbi et al .. 1991). Furthermore. chronic administration ofbusptrone 
(1 mg/kg l.p. twice daily for 14 days). produced no significant effects on 
behaviour in the X-maze (Moser. 1989b) although the drug has actMty in the 
clinic (Goldberg and Finnerty. 1979; Goa and Ward. 1984). The present 
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behavioural study supports previous work suggesting that the X-maze cannot 
reliably detect anxiolytic activity with 5-HTIA partial agonlsts after acute or 
chrOniC treatment. The effects of 24 hours withdrawal of ipsa pirone were 
notable as animals withdrawn from 0.01 and 0.1 mg/kg Ipsaplrone were not 
significantly different from controls but those withdrawn from 1 mg/kg 
displayed an absence of activity on the open arms (which reached 
significance). Re-testtng after 7 days showed these animals to be the same as 
controls. This result could be due to possible changes in 5-HTIA receptor 
function after chronic treatment or to some unexplained withdrawal effect 
of that specific dose. 
The arudolytic behavioural profile displayed by the animals receiving 
chronic ritanserin indicate that the elevated X-maze can detect putative 
arudolyUcs from chemical classes other than the benzodiazepines. The 
Increase in the indices used as a measure of anxiety were not as great for 
chronic rttanserin as those seen with either acute or chronic diazepam. 
although it is possible that different doses and regime with rttanserin may 
improve the profile. 24 hours after ritanserin administration the arudolytic 
profile was sUll observed. It cannot be determined from the present 
experiment whether this observation is a result of 5-HT2 receptor down-
regulation (Leysen et al.. 1986) or relates to the pharmacokinetics of 
ritanserin which has a long half-life and receptor occupancy time (Leysen et 
al .. 1985). so the drug may be present in the body 24 hours after completion of 
chronic treatment. All detectable arudolyUc activity was lost 7 days after 
completion of chronic ritanserin treatment. a time when the drug would 
have cleared from the body. Unfortunately. due to the very nature of the 
elevated X-maze measurement of arudety. retesting animals everyday is 
Impossible as the maze is no longer a novel enviroment: this results in 
reduced exploration and sensitivity to benzodiazepines (File. 1990). Hence. 
in this study. it was not possible to determine when. between days 1 and 7 
post-chronic dosing. the anxiolyUc activity was lost. 
Chronic ondansetron treatment produced an anxiolyUc profile with 
significant increases in percentage open:total entries and time and a non-
significant Increase In the time spent on the open arms. This effect is not a 
result of the handling or the chrOniC treatment procedure as chroniC vehicle 
followed by acute ondansetron (0.01 mg/kg) on the day of testing did not 
produce a significant arudolytlc profile (the prof1le produced was very 
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similar to that of acute ondansetron at this dose). The reason for the 
anxtolyUc profile being observed with either rttansertn or ondansetron only 
after chrOniC treatment is not certain. especially as some (Crttchley and 
Handley. 1987; Jones et al. 1988) but not all (File et aI .. 1987) studies show 
both compounds producing anxtolyUc profiles on acute treatment. Though 
there Is still some controversy over the fact that 5-HT3 antagonists are 
capable of producing anxtolyUc profiles on the elevated X-maze (File and 
Johnston. 1989) there is increasing evidence suggesting that stimulaUon of 
central 5-HT3 receptors modifies the functioning of specific 
neurotransmitter systems (Barnes et al.. 1989b; Hagan et al.. 1987). The 
arudolytlc profile of ondansetron. though less pronounced than that of 
diazepam. is lost after 24 hours withdrawal. indicating that ondansetron 
may not cause withdrawal effects (Costall et al .• 1990a). There is evidence to 
suggest that ondansetron reduces the anxtogeniC withdrawal effects observed 
with chronic benzodiazeplne treatment (Costall et al.. 1990a). However. It 
has very ltttle or no effect on other symptoms of withdrawal such as weight 
loss and reduced food intake (Leathley et al.. 1990). 
The results of these expertments demonstrate that the elevated X-maze can 
be used to detect arudolytic activity in non-benzodiazepine drugs. The 5-HT2 
and 5-HT3 antagonists. rttansertn and ondansetron respectively. showed 
arudolytlc profiles but only after chronic treatment. Thus. for rttansertn. 
effects In the X-maze correlate with effects observed In the clinic (Ceulemans 
et al.. 1985). At present prelimtnary c11n1cal trtal data has been published 
but the necessary statistical analysis on this data has not been carried out to 
establish how the current findings with ondansetron In the X-maze relate to 
those obtained In humans (Abuzzahab. 1991). Further studies are required to 
detennlne whether there Is any causal relationship between rttansertn 
induced down-regulation of 5-HT2 receptors (Leysen et al.. 1986) and the 
arudolytic profile observed In the present study. In contrast. the X-maze 
failed to detect anxlolytic activity with the 5-HTIA partial agonist 
ipsapirone after either acute or chronic treatment. and greater range of doses 
may be necessaxy to observe some activity. Ipsapirone displays a different 
cl1n1cal profile compared to rttansertn and ondansetron and It is possible 
that the X-maze Is unable to easily detect compounds with 5-HTIA receptor 
partial agonist activity. 
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CHAPTER 4 
CHARACTERISATION OF 5-HT RELEASE MEASURED IN VIVO BY 
INTRACEREBRAL MICRODIALYSIS 
INTRODUCTION 
The technique of intracerebral microdiaIysis was originally used to study 
the release of dopamine (Ungerstedt et aI .. 1982; Hernandez et at. 1983; 
Imperato and Oi Chiara. 1984; Ungerstedt. 1984). 5-HT has only been 
measured more recently as the levels are lower than those of dopamine and 
therefore more difficult to detect (Sharp et aI .. 1984; Marsden. 1985; Marsden 
et aI .. 1986). 
There is some debate in the literature about the length of time after 
implantation of a dialysis probe at which neuronal 5-HT release can be 
measured. Kalen and co-workers (1988) suggested that neuronal release 
cannot be measured until a period of at least 24 hours has elapsed after 
Implantation. Also Westerink et aI. (1987a) ImpUed that any 5-HT measured 
by dialysis may originate from non-neuronal sources. i.e. platelets. glia or 
mast cells (Sneddon. 1973; Austen. 1978; Kfmelberg. 1986). However. much 
evidence has accumulated which suggests that 5-HT measured after 24 hours 
in freely moving animals or that measured 2 hours after Implantation in 
anaesthetised animals is of neuronal origin. Both types of protocol are used 
in this thesis but in this chapter only experiments in the freely-moving 
animal are studied. Inclusion of tetrodotoxin (TIX) in the perfusate to block 
sodium channels and thus inhibit action potential conduction (Hille. 1968). 
reduced hippocampal 5-HT release in anaesthetised (Oaszuta et at. 1989; 
Sharp et at. 1989c) and cortical and hypothalamic release in conscious 
animaIs (Carboni and Di Chiara. 1989; Auerbach et al.. 1989) measured using 
microdialysis. Perfusion with Ca2+-free CSF helps demonstrate the origin of 
the transmitter as neuronal release is Ca2+-dependent (Augustlne et at. 1987) 
whereas platelet release is not (Pannocchia et a1.. 1987). The Ca2+-
dependency of 5-HT release has been shown in conscious rats in various 
brain regions such as the cortex (Carboni and Oi ChIara. 1989). hippocampus 
(Pei et at. 1989). caUdate-putamen (Kalen et a1.. 1988) and hypothalamus 
(Auerbach et aI .• 1989). In anaesthetised rats electrical stimulation of the 
dorsal raphe nucleus has been shown to increase hippocampal 5-HT release 
(Sharp et aI .. 1989c) indicating that the 5-HT release Is of neuronal origin. 
Drugs such as fenfluramine and p-chloramphetamine. whIch release 5-HT. 
increase extracellular 5-HT in the cortex of anaesthetised (Sharp et aI .. 1986: 
Crespi et a1.. 1990) and conscious rats (Schwartz et a1.. 1989). and the effects 
of fenfluramine were attenuated in anImals lesioned with the selective 
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serotonergic neurotoxin 5.7-DHT (Crespi et al .. 1990). However. these drugs 
also release 5-HT from platelets (Sneddon. 1973; Buckzo et al.. 1975). Using 
compounds such as RU24969. whIch Is thought to act at the 5-HTIB terminal 
autoreceptor (Middlemiss. 1985). inhibition of 5-HT release has been 
observed in anaesthetised rats (Brazell et al .• 1985; Sharp et al .• 1989a). The 
selective 5-HTIA agonist 8-0H-DPAT (Middlemiss and Fozard. 1983) also 
inhibited 5-HT release in anaesthetised animals after either systemic 
admlnistration (Routledge and Marsden. 1985; Sharp et al .• 1989a. b) or local 
infusion into the dorsal raphe nucleus (Hutson et al., 1989; Sharp et al., 
1989c). In conscious rats systemic 8-0H-DPAT has been found to inhIbit 
hypothalamiC (Auerbach et al., 1989) and cortical 5-HT release (Carboni and 
Di Chiara, 1989). 
This study was designed to show that the 5-HT release measured in animals 
implanted with a dialysis probe in the ventral hippocampus, and allowed 24 
hours to recover. is of neuronal origin. This was examined using perfusion 
with artificial CSF containing TIX or perfusion with Ca2+-free CSF. Also. 
basal dialysis samples had exogenous 5-HT and 5-HIAA of a known 
concentration added to them and were then assayed via high-performance 
liqUid chromatography with electrochemical detection (HPLC-ECD) to 
determine whether the endogenous and exogenous 5-HT and 5-HIAA elute off 
the column at the same time and oxidise at the same potential. 
METHODS 
Preparation of Dialysis Probes 
Dialysis tubIng (Hospal. U.K. Ltd. 300J,1m o.d .. 220J,1m i.d .. L made of 
acrylOnitrile-sodIum methallyl sulphonate. with a molecular cut-off point 
of 20.000 Daltons. was obtained from a renal dialysis pack. In the series of 
experiments later in this chapter which look at recovery, methylcellulose 
tubing (Cambro. 250J,Un o.d.). molecular weight cut ofT of 6,000 Daltons was 
obtained from a Similar renal dialysis pack. The dialysis probes were 
manufactured in a Similar manner regardless of the type of dialysIs 
membrane used. A pIece of tungsten wire was threaded into the lumen of a 
length of dialysis tubing (-12Omm) to act as support during the initial 
preparation of the probe. The dIalysis tubing was then inserted (-5mm) into 
a steel cannula (23 gauge) and secured with epoxy resin. The tungsten wire 
was then removed. the dialysis tubing cut (-8mm in length). and the epoxy 
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resin allowed to dry for several hours. A 20mm length of portex-tubing 
(1.02mm o.d .. 0.58nun i.d.) was pushed over the other end (i.e. the end without 
the dialysis tubing) of the steel cannula and this was secured in place with 
cyanoacrylic adhesive. A small hole was then made in the portex-tubing 
using a 25G needle. Fine fused silica-glass capillary tubing (ScienUfic Glass 
Engineering) was then inserted inside the dialysis membrane and pushed 
through the steel cannula and out through the hole (made with the 25G 
needle) in the portex-tubing. The end of the dialysis tubing was sealed with 
epoxy-resin and left to dry for 2 hrs. Finally. the hole in the portex tubIng. 
through which the silica-glass tubing emerges was sealed with epoxy reSin. 
The dialysis probes were then stored until used. The dialysis probe is shown 
diagrammatically in Fig. 1. 
Measurement of Relative Recovery in vitro 
Dialysis probes were perfused at a rate of 1J.l.l/min (Scientific and Research 
Instruments Ltd .• slow infusion pump Ref. 5200) and suspended in a solution 
containing 2.5 x 10-7M 5-HT and 5-HIAA in artificial CSF (Composition: 
5mM glucose. 125mM NaCI. 2.5mM KCI. 0.5mM NaH2P04.2H20. 1.2mM 
Na2HP04. 27mM NaHC03. O.5mM Na2S04 (anhydrous). ImM MgC12.6H20 
and 1mM CaCI2.2H20. pH adjusted to 7.4 with 1M o-phosphonc acid). The 
probes were left to equilibrate for 30 minutes and then three 20 minute 
samples were collected. The samples were assayed directly using HPLC-ECD 
to measure 5-HT and 5-HIAA. Companson with the 5-HT and 5-HIAA 
standards enabled calculation of the concentration of 5-HT and 5-HIAA in 
the perfusate and by dividing this with the concentration in the bulk 
solution enabled the relative recovery to be detennined. The relative 
recoveries of six probes were calculated for each type of probe. 
· Analysis of Dialysis Perfusate. 
HPLC-ECD was used to analyse the levels of 5-HT and 5-HIAA in all 
experiments. Separation of the two tndoles was by ton-pair. reverse phase 
chromatography on a 10cm column (Htchrom. internal diameter 2mm) 
packed with 3J.1IIl Shandon Hypersll (TechnIcol). The mobile phase was made 
up in double-distilled de ionised water further purified in an ELGA purifIer 
and contained O.15M NaH2P04.2H20. O.lmM diamlnoethanetetra-acetic 
acId (EDTA). 0.5mM sodium octyl suphate and 15% methanol with the pH 
adjusted to 3.8 with o-phosphonc acid. Before use it was filtered through a 
0.45J.l.m filter (Millipore) and degassed by sonication for 30 minutes. It was 
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Figure 1 
Diagrammatic representation of the structure of the Intracerebral 
mlcrodlalysls probe used In this thesis. 
2-4mm 
Fused silica glass capillary tubing 
Polythene tUbing 
23G stainless steel tubing 
Polyacrylonitrile membrane 
(300 J.lID) 
pumped through the column at a flow rate of 0.3ml/min using an HPLC 
Technology Pump (RR 1066L). A Rheodyne injection unit (7125) fitted with a 
20J,1linjection loop was used to inject samples onto the column. The glassy 
carbon dual electrode (MF 1000. Bioanalytical Systems) was held at a 
potential of +0.65V versus an Ag/AgCI reference electrode and the currents 
produced by the oxidation of 5-HT and 5-HIAA were detected using a 
Bioanalytical Systems LC-4 electrochemical detector set at 2nA/V and 
recorded on a SP4290 integrator (Spectra-Physics). Standard CUlVes were 
constructed for 5-HT and 5-HIAA in a combined solution over the range of 
0.025 - 1.0 pmoles/20J,J.l and the peak heights were measured. In all 
experiments the dialysis samples were injected using the technique of 
partial loop filling to avoid injecting air into the system. This was done by 
filling the loop with double-distmed deionised water just prior to injection 
of the dialysis sample. The resulting peak heights were compared to 
injections of standards conta1n1ng 0 . 5 p m o l e s / 2 0 ~ ~ of 5-HT and 5-HIAA. For 
the injection of dialysis samples. the sensitivity of the system had to be 
increased four-fold to detect 5-HT after the 5-HIAA peak had been eluted as 
there is a lower level of extracellular 5-HT compared with 5-HIAA. 
Implantation of Dialysis Probes 
Naive male Lister hooded rats (240-300g) (Nottingham University Medical 
School Animal Unit) were housed in groups of four on a 12 hour light/dark 
cycle Oights on 0700-1900). with food and water available ad libitum. Rats 
were anaesthetised with 1.5% halothane in a 50:50 02/N20 gas mixture using 
a Boyle's apparatus. placed in a stereotaxic frame with the mouth piece set at 
-3.3mm. The body temperature of the animals was maintained using a lamp 
and cotton wool. Each animal's head was shaved and an incision made using 
a scalpel blade from behind the eyes to between the ears. The skin was held 
back with artery clips and the surface of the skull scraped to remove the 
connective tissue. Three holes were drilled using a hand-held drill with a 
twist drill bit. two for skull screws to help secure the cement and one for the 
probe which was placed above the ventral hippocampus using co-ordinates 
derived from Paxinos and Watson (1986) (from bregma: anterIor/posterIor-
5.6mm. lateral ±4.6mm. ventral -7.5mm from the surface of the brain). The 
dura was broken using a needle tip. This was necessary as the dialysis probe. 
which is pliable at the tip. would bend upon contact with the tough dura. The 
screws were inserted. followed by stereotaxic implantation of the probe into 
the ventral hippocampus which was then secured in place with dental 
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cement. Care was taken to ensure that the drill hole for the loop was not 
bleeding before implantation as otherwise the samples could be 
contaminated with 5-HT from the blood. Once the dental cement had 
hardened, the artery clips were removed and the incision was sutured. The 
inciSion was then sprayed with an anti-bacterial (Polybactrtn) and a plasUc 
wound dressing (Nobecutane). The animal was then placed in a cage on its 
own with food and water available ad libitum and allowed to recover. 
24 hours after implantation fine Portex tubing (approximately 25cm in 
length) (o.d. 0.75mm, i.d. 0.25mmJ was placed over the capillary outlet and 
secured in place with cyanoacrylic adhesive. The inlet was connected via a 
small steel cannula to a long piece of Port ex tUbing connected to a 5ml 
syringe containIng artificial CSF mounted in a slow infusion pump (set at 
IJJl/mtn). The inlet and outlet were held together by means of small pieces of 
masking tape. After the probe had been flowing for 30 minutes, samples of 
the perfusate were collected every 20 minutes in the cut-off Up of an 
Eppendorf tube containing 5JJl of O. 1M perchloric acid to prevent oxidation 
of the 5-HT and 5-HIAA and analysed by HPLC-ECD. The cut-off tip of the 
Eppendorfwas held In place at the end of the outlet tubing with a small piece 
of masking tape. At the end of the experiment the rats were killed and the 
pOSition of the probe in the ventral hippocampus verified by eye in the 
sectioned brain. 
Local Administration of'MX and zero ca2+ In the Perfusate 
After 30 minutes of flow and 80 minutes of basal release collection, the 
perfusion medium was changed from normal CSF to CSF containing either 
TIX (lJ.1M) or zero Ca2+ (plus O.lmM ethylene glycol-bis U3-aminoethyl 
ether)N,N,N',N'-tetraacetic acid (EGTA) and increasing the Na+ by ImM in the 
Ca2 +-free solution) using a liquid switch (Carnegie MedIcine. CMA/llO). 
After 60 minutes the perfUSion medium was changed back to normal CSF 
and samples collected for a further 2 hours. In these experiments the inlet 
tubing was identical to the fine outlet tubing so that the dead-space between 
the liqUid Switch and the probe was as small as possible. 
Addltlon of Ez0ienoua 5-HT and 5-HIAA. to Dlalyals Samples 
After 80 minutes of basal release collection in a separate group of animals 
0.lpmoles/20J,Jl of both 5-HT and 5-HIAA were added to the samples and they 
were then analysed by HPLC-ECD. 
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Drugs 
5-Hydroxytryptamine creatinine sulphate (5-HT, Sigma) and 5-
hydroxyindole-3-acetic acid (5-HlAA, Sigma) were dissolved in double-
distilled deionised water and dUuted in artificial CSF. Tetrodotoxin (TrX. 
Sigma) was dissolved in glacial acetic acid and dUuted in artificial CSF. All 
necessary precautions were taken when using TrX (laboratory coat. gloves 
and mask) to avoid inhalation or skin exposure as the compound is fatal in 
low doses. Formaldehyde (Vickers Laboratories Ltd.) was dUuted in 0.9% 
saline. 
Data Analysis 
All the results for the experiments were expressed as the mean ± S.E.M .. 
After administration of vehicle or drug the values were expressed as the 
percentage change from the preinjection values. calculated separately for 
each animal. The groups given zero Ca2+ or TrX were analysed separately 
using a one-way ANOVA with repeated measures followed by a Dunnett's t-
test to identify any significant changes from the control group. 
RESULTS 
CaUbratloD of the HPLC 
Fig. 2 shows the standard curves obtained after injection of increasing 
concentrations of 5-HT and 5-HIAA in a combined solution onto the HPLC. 
A linear relationship can be seen between the concentration of the standard 
and the peak height. The minimum detectable amount of 5-HT and 5-HIAA 
In a standard. taken as 3 times the basal noise was found to be 
20fmoles/20ll1. From the standard curve a concentration of O . 5 p m o l e s / 2 0 ~ ~
was chosen to be used as the standard concentration In all future 
experiments. 
Measurement of Relative Recovery in vitro 
In Table 1 the relative recoveries for 5-HT and 5-HIAA are shown for dialysis 
probes made of either Hospal tubing or methylcellulose. It can be seen that 
the recovery for both indoles Is higher in probes made from the Hospal 
membrane: 5-HT:- 15.1% compared to 4.9% and 5-HIAA:- 12.9% compared 
to 3.7%. 
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Figure 2 
Graph showing the linear relationship between peak heights for 5-HT (r = 
0.983) and 5-HIAA (r = 0.996) and their concentrations measured by HPLC-
ECD. Each point Is the mean of three injections. and the line of best fit 
(plotted) calculated using linear regression. A standard concentration of 
0.5pmoles/20Il1 was chosen from these curves for use in all future 
experiments. 
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Table 1 
Comparison of percentage relative recoveries for 5-lIT and 5-HlAA measured 
in vitro using dialysis probes made of Hospal or methylcellulose tUbing. The 
recoveries were detennfned by immersion of the probes in a solution 
containing 2.5 x 10-7M 5-HT and 5-HlAA. After a 30 minute equilibration 
period three 20 minute samples were collected and assayed via HPLC-ECD. 
Comparison with the 5-HT and 5-HIM standards enabled calculation of the 
concentration of 5-lIT and 5-HIM in the perfusate and by dJvlding this with 
the concentration in the bulk solution enabled the relative recovery to be 
determined. The relative recoveries of six probes were calculated for each 
type of probe. 
Membrane Mean % Recovery ± S.E.M. 
5-HT 5-HIAA 
Hospal T u b i n ~ ~ 15.1 ± 1.9 12.9 ± 2.5 
Methylcellulose T u b l n ~ ~ 4.9±O.7 3.7 ± 1.4 
Basal Release of 5-BT and 5-11IAA 
A diagram of a dialysis probe in place in the ventral hippocampus of a rat 
brain is shown in Fig. 3. The HPLC traces in Fig. 4 show typical results 
following injection of a standard solution containing 0.5pmoles/201l1 5-HT 
and 5-HIAA and the injection of a sample taken from the basal release of a 
control rat. The traces show clear separation of 5-HT and 5-HIAA in both 
cases and the dtfference between the levels of the two indoles in the rat brain. 
Local Administration of 'ITX III the Perfusate 
Perfusion with TIX (lJJM) produced a dramatic decrease in the levels of 5-1IT 
(43%) in the first sample after the TTX infusion started (Fig. 5). After this 
1n1tial large drop the maximal fall in the 5-1IT level was 83% occurring 80 
minutes after commencing TIX perfusion. Once the perfusion medium was 
changed back to normal CSF the release of 5-1IT did not recover during the 
following 2 hours (Fig. 5). During the TTX perfusion there was a small, 
significant decrease in the levels of 5-HIAA (15%), returning towards basal 
levels upon reperfusion with CSF (Fig. 5). There was a slight fall in the level 
of 5-HTwhen the liqUid switch Is turned and normal CSF perfused, this was 
probably a result of a fall in pressure on turning the switch leading to a 
smaller sample volume. 
Local Administration of ea2+-free Solution 
Perfusion with zero Ca2+ produced a maximal fall in the 5-HT levels of 67% 
occurring 80 minutes after commencement (Fig. 6). Once the perfusion 
medium was changed back to normal CSF the release of 5-HT began to 
recover In the following 2 hours (Fig. 6). During the zero Ca2+ perfusion there 
was a small non-significant decrease in the levels of 5-HlAA of 11% before 
returning towards basal levels upon reperfuslon with CSF (Fig. 6). The 
inhibition observed with the Ca2+-free solution was more delayed and not as 
great as that seen with TTX. Again, there was a slight fall In the level of 5-1IT 
when the liqUid switch was turned and normal CSF perfused. 
Addltlon of Exogenous 5-BT and 5-11IAA 
Figure 7 shows typical HPLC traces before and after the addition of 
exogenous 5-1IT and 5-HIAA to the dialysis sample. Table 2 shows that 
addition of exogenous 5-1IT and 5-HlAA increased the peak height of the 5-
HT and 5-HIAA respectively by the amount equivalent to the concentration 
of the exogenous solution. 
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FIgure 3 
A diagram of a coronal section of a rat brain showing a dialysis probe in the 
ventral hippocampus (co-ordinates from bregma: AlP -S.6mm. L ±4.6mm. V -
7.Smm from the skull surface (Paxinos and Watson. 1986). The diagram was 
adapted from the stereotaxic atlas of the rat brain by Paxinos and Watson 
(1986). Length of steel cannula of dialysis probe is not to scale. 
Out 
Figure 4 
Typical HPLC traces obtained after the injection of a standard (5-HT and 5-
HIAA O.5pmoles/20JlI) or a 20Jll dialysis sample of extracellular levels of 5-
HT and 5-HIAA. The arrows on both traces indicate the point of injection. 
The asterisk on the sample trace after the 5-HIAA peak indicates the time 
when the sensitivity of the system was increased four-fold for easier 
detection of 5-lIT. Basal levels of 5-lIT = 59 ± 8 fmol/20lll and 5-HIAA = 1.26 
pmol/20Jll. 
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Figure 5 
Changes in the extracellular levels of (A) 5-HT and (B) 5-HIAA in the 
hIppocampus of naive rats before and after local application of tetrodotoxin 
(TIX, 111M) in the perfusate. The perfusate was changed by means of a liquid 
switch from normal artifIcial CSF to CSF containing TIX for 60 minutes 
(marked with VZZZJ) and then the probe was reperfused with the TIX-free 
solution. The results are expressed as the mean extracellular level of 5-lIT 
compared to the basal samples ± S.E.M., n=5. Changes in the levels of 5-lIT 
and 5-HIAA were analysed separately using a one-way ANOVA with repeated 
measures (5-HT: F = 9.91, p<O.OI; 5-HIAA: F = 2.82, p<0.13) followed by a 
Dunnett's t-test to identify any Significant differences between control and 
TIX groups; ·p<0.05, ··p<O.Ol. 
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Figure 6 
Changes in the extracellular levels of (A) 5-HT and (B) 5-HIAA in the 
hippocampus of naive rats before and after local application of a Ca2+-free 
perfusate. The perfusate was changed by means of a liquid switch from 
normal artificial CSF to Ca2+-free CSF for 60 minutes (marked with f2'ZZ.Zl) 
and then the probe was reperfused with CSF containing Ca2+. The results are 
expressed as the mean extracellular level of 5-HT compared to the basal 
samples ± S.E.M., n=5. Changes in the levels of 5-HT and 5-HIAA were 
analysed separately using a one-way ANOVA with repeated measures (5-HT: 
F = 7.39, p<O.Ol: 5-HIAA: F = 1.84. p<O.24) followed by a Dunnett's t-test to 
identify any significant differences between control and Ca2+-free groups: 
"'p<O.05 ..... p<O.O 1. 
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Figure 7 
Typical HPLC traces obtained after the injection of: (A) 20J,.Ll of 5-1IT and 5-
HlAA (O.lpmoles/20J,.Ll1. (Bl a 2 0 ~ 1 1 dialysis sample of extracellular levels of 5-
HT and 5-HIAA. and (e) a 20J.Ll dialysis sample with 10J.Ll of O.2pmoles/20J,.Ll 
of 5-HT and 5-HIAA solution added to it. The arrows on the traces indicate 
the point of injection. The asterisk on the traces after the 5-HIAA peak 
indicates the time when the sensitivity of the system was increased four-fold 
for easier detection of 5-1IT. 
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Table 2 
Peak heIghts of basal 5-HT and 5-HIAA dIalysIs samples (20Jll) before and 
after the addition of IOJll exogenous 5-JIT and 5-HIAA (O.lpmoles/20Jll). n=6 
per group. 
Injection Peak H e i ~ h t t (mm) 
5-HT 5-HIAA 
2 0 ~ ~ O . l p m o l e s / 2 0 ~ ~ mixed 67±7 14±4 
standard 
2 0 ~ ~ Basal Sample 45±7 126± 13 
2 0 ~ ~ Basal Sample + 1 ~ ~ lOO± 11 138± 15 
O . 2 p m o l e s / 2 0 ~ ~ mixed standard 
DISCUSSION 
HPLC MeaamemeDt8 and lfeuurement of In VItro Recovery 
The minimum detection level of 2 0 f m o l e s / 2 0 ~ ~ for both indoles was lower 
than the basal levels in the brain thus the assay of HPLC-ECD could be used 
for these experiments. 
The mean relative recovery in vitro using dialysis probes made with Hospal 
membrane was better than that for probes made with the methylcellulose 
tUbing. These results show the importance of determining the relative 
recovery in vitro and of trying to obtain the best possible recovery. The 
results from the dialysis experiments were not corrected for recovery as in 
vitro recovery Is not comparable to in vivo recovery (Alexander et al., 1988; 
Benveniste, 1989: Benveniste et at, 1989: Benveniste and Huttemeier, 1990). 
Therefore dialysis is not a useful way of accurately determining 
extracellular concentrations but is excellent for monitoring quantitative 
neurotransmitter changes. 
Neuronal Release of 5-HT 
The evidence in the ltterature reviewed In the Introduction to this chapter 
supports the idea that 5-HT measured by dialysis is of neuronal origin, in 
both anaesthetised and conscious rats. The validation of the neuronal 
origin of 5-HT in this chapter is only for conscious animals and later work 
concerning anaesthetised animals Is based on the validation by Ktdd (1990) 
who worked in the same laboratory. The experiments deSCribed here show 
that the release of 5-HT in the ventral hippocampus in conscious rats Is of 
neuronal origin. This conclusion is based on the results of (a) the ability of 
TrX to decrease markedly the levels of 5-HT. (b) the decrease in 5-HT levels 
seen after removal of Ca2+ from the CSF. and (c) the oxidation peak 
corresponding to the oxidation of endogenous 5-HT coinciding with that of 
exogenous 5-HT. 
The release of 5-HT was inhibited by local perfusion with 1 ~ ~ Tn( while 5-
HIAA levels were only slightly affected. As TrX blocks conduction in 
neurones (Hille. 1968) resulting in reduced neurotransmitter release. this 
provides good evidence that the 5-HT release Is of neuronal origin. There was 
no sign of a return to basal levels after the perfusion medium had been 
switched back to normal CSF. This was probably a result of a long-lasting 
action of TrX blnd1ng to the nerves and continuing to prevent action 
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potential conduction. Other studies have found a return to basal levels after 
cessation of TIX perfusion (Auerbach et al.. 1989: Carboni and Oi Chiara. 
1989). but Sharp et al. (l989c) only demonstrated a partial return to basal 
levels two hours after cessation ofTIX. TIX did not totally abolish the 5-lIT 
release. indicating that either the 5-HT came from an area beyond that 
perfused with TI'X or that this residual component. approximately 20%. was 
derived from non-neuronal sources such as glial cells. mast cells or platelets 
(Sneddon. 1973: Austen. 1978; Ktmelberg. 1986). 5-HIAA was hardly affected 
by TTX and thus very little appears to be released by action potentials and is 
likely to be the product of Intraneuronal metabolism of 5-HT which spUls 
over Into the synapse. This agrees with earlier findings that the 5-HIAA 
measured is not a product of the released 5-HT but Is from the Intraneuronal 
metabolism of unreleased 5-HT (Grahame-Smith. 1971. 1974; Kuhn et al.. 
1986; Kalen et al .• 1988: Auerbach et at. 1989; Sharp et al .• 1989c: Crespi et 
aI.. 1990). Thus changes In 5-HIAA levels are not a good Indication of 
corresponding changes In 5-HT levels. Similar work on the dopaminerglc 
system has found that dopamine release Is inhibited by the addition of TIX 
to the perfusion medium In conscious animals (Westerink et aI.. 1987b). 
PerfUSion with Ca2+-free CSF (and O.lmM EGTA to chelate extracellular 
Ca2+) decreased 5-lIT levels by 67%. Ca2+ is required for exocytotic release of 
neurotransmitters (Augustine et aI.. 1987) and thus this result further 
confirms the neuronal origin of 5-HT In this study. Two hours after 
returning to normal CSF the basal levels had started to return to normal but 
had not yet reached the origtnallevel. As with TIX. the effect of Ca2 +-free 
CSF on the 5-HIAA levels was only small. supporting other evidence 
suggesting that the 5-HIAA is a result of intraneuronal metabolism of 5-HT 
spilling over into the synapse. PerfUSion with Ca2+-free CSF did not reduce 
the 5-HT peak down to zero. and doubt has been expressed concerning the 
validity of the use of Ca2+-free solutions as an indicator for neuronal release 
of any neuronal transmitter (Oi Chiara. 1990). It is possible that there Is 
suffiCient endogenous Ca2+ present. even with a Ca2+ chelator such as EGTA 
included in the perfusion medium. to maintain some release of 
neurotransmitters. Ca2+-free CSF has also been used to demonstrate 
neuronal release of dopamine in both anaesthetised (Imperato and 01 
Chiara. 1984) and conscious rats (Westerink and Oe Vries. 1988). 
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A third method of demonstrating neuronal transmitter release is by local 
stimulation with a high K+ concentration in the perfusate which depolarises 
the neIVe terminals directly. High K+ has been shown to increase dopamine 
release in anaesthetised (Imperato and Oi Chiara, 1984) and conscious rats 
(Westertnk and Tuinte. 1986). Kalen et al. (1988) showed that a high K+ 
solution could still release 5-HT even in the absence of Ca2+ and the presence 
of EGTA. thus it 15 not surpriSing that the release of 5-HT was only partially 
affected by perfusion with a Ca2+-free solution. 
Addition of exogenous 5-HT and 5-HIAA to basal dialysate samples 
increased the peak heights correlating to 5-HT and 5-HIAA respectively. 
This indicates that the retention time on the column and oxidation at the 
working electrode is the same for exogenous 5-HT and the endogenous 
compound (presumed to be 5-HT) and exogenous 5-HIAA and Its respective 
endogenous peak. 
Conclusions 
These experiments have shown that the 5-HT measured in the ventral 
hippocampus by intracerebral microdlalysls is released from neurones as it 
is TIX-sensitive and affected by the removal of Ca2+. The 5-HIAA measured 
is predomlnently as a result of intraneuronal metabolism of 5-HT which 
subsequently spills over into the synapse and Is not a good correlate of 5-HT 
levels. 
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CHAPTERS 
EFFECT OF DIAZEPAM, IPSAPIRONE AND F2692 ON EXTRACELLULAR 
5-HT AND 5-HIAA RELEASE IN THE VENTRAL mPPOCAMPUS OBSERVED 
IN RATS ON THE ELEVATED X-MAZE MODEL OF ANXIETY USING IN VIVO 
M1CRODIALYSIS 
INTRODUCTION 
In the Introduction to this thesis evidence was presented for the involvement 
of the central serotonergic systems as one of the mechanisms of arudolytic 
action of the benzodiazepines (Kahn et al .. 1988: Iversen. 1984: Soubrie. 
1986; Stein et a1.. 1975: Thiebot. 1986). Thus. an important question is 
whether changes in serotonergtc function can be related to the anxiolytlc 
action of the benzodiazepines. Benzodiazepines have been reported to reduce 
5-JIT turnover after acute and chroniC treatment (Chase et al .. 1970: Udbrink 
et a1.. 1973: Wise et al .• 1972). suggesting that the decrease in 5-JIT turnover 
reflects reduced activity of 5-I-IT-containing neurones and thus decreased 
release of 5-1-IT. A more recent study using in vivo microdialysis showed that 
both systemic and local administration of benzodiazepine agonists 
(diazepam and flurazepam) inhibited the release of 5-HT from the ventral 
hippocampus. and this effect could be reversed by adminIstration of 
flumazenil (Ro 15-1788) (Pel et al .. 1989b). In vitro studIes have shown that 
benzodiazepines inhIbit potassium-evoked (3HJ-5-HT release from 
hippocampal synaptosomes (Balfour. 1980; Colline and Pycock. 1982). 
suggesting that 5-HT release can be inhibited via an action at the neIVe 
terminals. Electrophysiological findings support an interaction between 
benzodiazepines and 5-1-IT. Laurent et a!. (1983). recording multiunit activity 
in the encephale tsole rat found that intravenous chlordiazepoxide and 
midazolam depressed neuronal firing in the dorsal raphe nucleus at doses 
which are known to be anxiolytlc. Further. these effects were blocked by the 
benzodiazepine antagonist flumazenil but the depressent effects of 
pentobarbitone on raphe neurones was not affected. It is now known that the 
benzodiazepine receptor is part of a receptor complex Including a GABAA 
receptor and a Cl- Ion channel In all areas of the brain (Unnerstall et a1.. 
1981). Furthermore. benzodiazeplnes interact at the receptor complex and 
enhance GABAergic transmission. In the CNS. sites such as the amygdala 
and hippocampus, which contain 5-HT and are implicated in anxiety. also 
have high densities of GABA-contalning neurones. Iontophoretic 
application of GABA in the dorsal raphe. amygdala and hippocampus results 
in the inhibition of firing of 5-HT neurones. an effect enhanced by 
benzod1azeplnes (Gallager. 1978). 
The 5-I-ITIA partial agonlsts busprrone. gepirone and Ipsapirone have been 
shown to produce Similar results to the benzodiazepines on 5-JIT release. 
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turnover, and cell firing but differ in theIr behavtoural profile (see Chapter 
3). Busplrone. geplrone and Ipsaplrone all Inhibit dorsal raphe neurone 
firing, mimIcking the effect of 5-HT (Dourish et aI., 1986; Rowan and Anwyl. 
1987; Van der Maelen et at. 1986; Wilkinson et aI., 1987). In the 
hippocampus all three compounds produced only the inhibitory component 
of the action of 5-JIT (Rowan and Anwyl. 1987; Van der Maelen et aI., 1986; 
Martin and Mason, 1987). Measurement of 5-HT in vivo with either 
microdlalysls or differential pulse voltanunetry. the 5-HTIA agonists have 
been found to decrease 5-HT release (Crespi et aI.. 1990; HJorth and 
Magnusson; 1988: Hutson et al.. 1989; Sharp et aI.. 1989a). This effect is 
thought to be predominantly as a result of action at the somatodendrlUc 
autoreceptor in the dorsal raphe nucleus (HJorth and Magnusson. 1988; 
Hutson et aI.. 1989: Sharp et al .• 1989c). In behavtoural studies the picture is 
somewhat confusing with the 5-HTIA partial agonlsts having either 
arudolyUc. anxiogenic or no effect depending on the behavtoural model used 
(for review see Introduction to this thesis and Traber and Glaser. 1987). 
A new potential arudolyUc compound. known as F 2692 (chemical name: 1-
(3'-trifluoro-methylphenyl) 1.4-dihydro 3-amino 4-oxo 6-methyl 
pyridazine). has been shown to have an anxiolyUc profile In the elevated X-
maze (Assie et aI.. 1991) but only has weak affinity for the benzodiazepine 
binding site (Assie et al.. 1991). Also no tolerance has been seen after chrOniC 
treatment (Chopin et al .• 1991). At present the mechanism of acUon of this 
compound is unlmown but the effects of F 2692 in the elevated X-maze can be 
reversed with flumazenil. a benzod1azepine antagonist. but only at very high 
doses (2Omg/kg 1. p.) (Assle et al.. 1991) suggesting that it may be havtng part 
of Its effect via the benzodiazepine-GABAA receptor complex. 
The aim of this study was to first determine the effects of placing a rat on the 
elevated X-maze upon the levels of extracellular 5-HT and 5-HIAA in the 
ventral hippocampus. and to determine whether there Is any difference 
between restricting the animal to either the closed or open arms on the 
changes in levels of extracellular 5-HT and 5-HIAA. Second. to determine 
the effects of an establlshed anxiolytic. diazepam. a 5-HTIA partial agonist. 
ipsapirone, and an anxlolytic which as yet does not have a known 
mechanism of action. F 2692. on the changes In extracellular 5-HT 
concurrent with the animals' behavtour when they are placed on the elevated 
X-maze. 
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METHOD 
Animals 
Naive male Uster hooded rats (240-300g) (Nottingham University Medical 
School Animal Unit) were housed in groups of four on a 12 hour light/dark 
cycle (lights on 0700-1900). with food and water available ad libitum. 
Procedure 
Dialysis probes were prepared and implanted under halothane anaesthesia 
as described in Chapter 4. After implantation rats were housed singly in a 
high-sided open top cage for 24 hours to recover. After this period of time the 
animal's inlet and outlet were connected and the probe perfused with 
artificial CSF at a flow rate of IJ.1.l/mtn as described in Chapter 4. Dialysis 
samples were collected every 20 minutes and analysed for 5-HT and 5-HIAA 
via HPLC-ECD as described in Chapter 4. 
Restriction to either Cloled or Open Arms 
30 Minutes after perfusion started four 20 minute dialysis samples were 
taken. After this time the animal was placed on the X-maze with either the 
closed or open arms sectioned off with pieces of matt black perspex (15cm x 
IOcm) (during the time the animal was on the X-maze the liqUid swivel was 
moved from a fixed position above the cage to one above the centre of the X-
maze where it could freely rotate). The animal was on the X-maze for a 
period of 20 minutes (four groups of 5 minutes) during which time its 
behaviour was monitored as described in Chapter 2 and one dialysis sample 
collected. The animal was then returned to its home cage and dialysis 
samples taken for a further two hours. 
Effect of Established and Putative Anzlolytlcs 
30 minutes after perfusion started four 20 minutes dialysis samples were 
taken. After this time the animal received an intraperitoneal injection of 
either vehicle (1% methyl cellulose). diazepam (2.5mg/kg). ipsapirone 
(lIng/kg) or F 2692 (lOmg/kg) and dialysis samples were taken for a further 
40 minutes. The animal was then placed on the X-maze and its behaviour 
monitored for a period of 20 minutes (four groups of 5 minutes) (one dialysis 
sample) as described in Chapter 2. After this time the animal was returned to 
its home cage and dialysis samples taken for a further two hours. 
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Drugs 
All drugs were suspended or dissolved in 1% v/v methyl cellulose (in 0.9% 
w Iv saline), by sonication. All drugs were prepared tmmediately prior to use 
and injected l.p. in a volume of 1 ml/kg. 
Compounds were obtained from the following sources: Methyl cellulose (BDH 
Chemicals Ltd.); diazepam (CourUn and Warner Ltd.); ipsapirone 
(Troponwerk); F 2692 (Pierre Fabre). 
Data Analysis 
All the results for the experiments were expressed as the mean ± S.E.M .. All 
behavioural data were analysed using a 2-tailed Mann-Whitney U-test and 
all neurochemical data were analysed using a one-way ANOVA with repeated 
measures followed by a Dunnett's t-test to identify any significant 
differences between vehicle control and drug treated groups. Vehicle controls 
were assigned to each of the series of experiments and grouped together for 
statistical analySis compared to the drug treated groups. 
RESULTS 
Restriction to either Closed or Open Arms 
Restriction to either closed or open arms resulted in a significant increase in 
extracellular levels of 5-1-IT whether the animal was restricted to either the 
closed or open arms (Fig. lA); there was no significant change in the 
extracellular levels of 5-HIAA (Fig. IB). Exposure to the X-maze resulted in 
an increase in the levels of 5-HT which peaked 20 minutes after being 
returned to the home cage (a result of a deadspace of approximately 15 
minutes and picking up the rat to return it to the home cage) and returned 
back to basal levels 40 minutes after being exposed to the X-maze (Fig. lA). 
The increase in extracellular 5-1-IT appeared to be greater when the animal 
was restricted to the open arms compared to the closed arms but this did not 
reach Significance (Fig. 1). When restricted to the open anns the rats' spent a 
decreaSing amount of time on the open ~ n d d end of open arms with each 
successive 5 minute time period (Fig. 2A and 2B), and hence an increasing 
amount of time was spent in the central square of the X-maze (data not 
shown). 
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Figure 1 
Effect of restricting the rat to either the open or closed anns of the elevated X-
maze for a 20 minute period (marked by ..KJ on the extracellular levels of (A) 
5-HT and (B) 5-HIAA measured using intracerebral microdialysis with 
HPLC-ECD. The results are expressed as the mean extracellular levels of 5-
HT and 5-HIAA compared to the basal samples ± S.E.M .. n=6. Basal levels of 
5-HT and 5-HIAA before being restricted to either the open or closed arms 
were: 5-HT: open = 71 ± 10 fmol/20J.1l. closed = 64 ± 11 fmol/20J.1l: 5-HIAA: 
open = 1.17 ± 0.22 pmol/20J,Jl. closed = 1.24 ± 0.31 pmol/20J.1l. Changes in the 
levels of 5-HT and 5-HIAA were analysed separately using a one-way ANOVA 
with repeated measures followed by a Dunnett's t-test to identify any 
significant differences between open and closed arm values. There were no 
significant differences at the p<0.05 level. 
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FIgure 2 
(A) The time spent on the open and (B) ends of open arms of rats restricted to 
the open arms on the elevated X-maze for a period of 20 minutes expressed In 
successive 5 minute inteIVals. The results are expressed as the mean ± S.E.M. 
of 6 obseIVattons. 
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Effects of Pharmacoloelca1 Aaents on Extracellular Levels of 5-HT and 5-
IIIAA and Behaviour 
a) Neurochemlatry 
Giving the animal free access to both the open and closed anns of the X-maze 
not surprisingly resulted in an increase in the extracellular levels of 5-HT 
but there was no change in the extracellular levels of 5-HIAA (FIg. 3). 
SystemIc dIazepam (2.5mg/kg l.p.) had no effect on 5-HT levels in the home 
cage but significantly reduced the increase in extracellular 5-HT levels when 
the rat was on the X-maze (Fig. 3A). Furthermore. diazepam produced a 
significant decrease in extracellular 5-HT from 60 min after removal from 
the X-maze until the end of the experiment (Fig. 3A) but had no effect on the 
extracellular levels of 5-HIAA (Fig. 3B). Similarly. systemIc ipsapirone 
(lmg/kg i.p.) had no effect in the home cage but Significantly reduced both the 
increase in extracellular 5-HT when the animal was placed on the X-maze 
and the basal levels of extracellular 5-HT reaching a maximum 80-100 
minutes after being placed on the X-maze (Fig. 4A). F 2692 (lOmg/kg l.p.) 
Significantly reduced basal levels of 5-HT in the home cage before exposure to 
the X-maze (Fig. 5A) and then SIgnificantly reduced both the increase in 
extracellular 5-HT when the animal was exposed to the X-maze and the basal 
levels of extracellular 5-HT having a maximum effect 100 minutes after 
being placed on the X-maze (Fig. 5A). Ipsapirone and F 2692 had no 
significant effect on the extracellular levels of 5-HIAA throughout this group 
of experiments (Fig. 4B and 5B). 
b) Behaviour 
During the first 5 minutes on the X-maze (standard exposure time during a 
behavioural experiment) diazepam (2.5mg/kg i.p.) sIgnificantly increased 
both the time spent on the open and ends of open arms (Fig. 6A) and the 
percentage open:total entries and time (Fig. 6B). Over the full period of 
exposure to the X-maze (20 minutes: one dialysis sample) dIazepam 
significantly Increased the time spent on the open arms (Fig. 7 A) and the 
percentage open:total entries and time (Fig. 7B). There were no significant 
differences in the number of arm and end of arm entries (an Index of 
locomotor activity) between the vehicle control and the diazepam treated 
group for both the 5 minute and 20 minute data rrable 1). Ipsapirone (lmg/kg 
l.p.) had no effect on any of the behavioural parameters measured both 
during the first 5 minutes (Fig. 8) and the whole 20 minute exposure on the X-
maze (Fig. 9). F 2692 significantly increased both the time spent on the open 
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FIgure 3 
Effect of diazepam (DZP, 2.5mg/kg l.p.) (arrow) on the extracellular levels of 
(A) 5-HT and (B) 5-HIAA when placed on the elevated X-maze for a 20 minute 
period (marked by 20 and then returned to the home cage. Extracellular 
levels of 5-HT and 5-HIAA were measured using intracerebral microdialyslS 
with HPLC-ECD. The results are expressed as the mean extracellular levels 
of 5-HT and 5-HIAA compared to the basal samples ± S.E.M., n=lO for vehicle 
controls and n=6 for diazepam treated rats. Basal levels of 5-HT and 5-HIAA 
before being placed on the X-maze were: 5-HT: vehicle = 64 ± 10 f m o l / 2 ~ , ,
DZP = 69 ± 11 f m o l / 2 0 ~ : : 5-HIAA: vehicle = 1.30 ± 0.32 p m o l / 2 ~ , , DZP = 1.25 
± 0.36 p m o I / 2 ~ . . Changes in the levels of 5-HT and 5-HIAA were analysed 
separately using a one-way ANOVA with repeated measures (5-HT: F = 17.85, 
p<O.OOI; 5-HIAA: F = 0.813, p<0.39) followed by a Dunnett's t-test to identify 
any significant differences between vehicle and drug treated groups. 
·p<0.05. ··p<O.OI Significantly different from vehicle treated animals. One-
way ANOVA with repeated measures with post-hoc Dunnett's t-test. 
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Figure 4 
Effect of ipsapirone (lmg/kg l.p.) (arrow) on the extracellular levels of (A) 5-
HT and (B) 5-HIAA when placed on the elevated X-maze for a 20 minute 
period (marked by ..xJ and then returned to the home cage. Extracellular 
levels of 5-HT and 5-HIAA were measured using intracerebral microdialysls 
with HPLC-ECD. The results are expressed as the mean extracellular levels 
of 5-HT and 5-HIAA compared to the basal samples ± S.E.M .. n= 10 for vehicle 
controls and n=6 for ipsapirone treated rats. Basal levels of 5-lIT and 5-
HIAA before being placed on the X-maze were: 5-HT: vehicle = 64 ± 10 
fmol/20jJ.l. ipsapirone = 71 ± 12 fmol/2o,.ll; 5-HIAA: vehicle = 1.30 ± 0.32 
pmol/20jJ.l. ipsapirone = 1.14 ± 0.20 pmol/2o,.ll. Changes in the levels of 5-HT 
and 5-HIAA were analysed separately using a one-way ANOVA with repeated 
measures (5-lIT: F = 10.15. p<O.OOI: 5-HIAA: F = 0.486. p<O.57) followed by a 
Dunnett's t-test to identify any Significant differences between vehicle and 
drug treated groups. 
·p<0.05. ··p<O.OI significantly different from vehicle treated animals. One-
way ANOVA with repeated measures with post-hoc Dunnett's t-test. 
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Figure IS 
Effect of F 2692 (IOmg/kg Lp.) (arrow) on the extracellular levels of (A) 5-HT 
and (B) 5-HIAA when placed on the elevated X-maze for a 20 minute period 
(marked by .xJ and then returned to the home cage. Extracellular levels of 5-
HT and 5-HIAA were measured using intracerebral microdialysis with 
HPLC-ECD. The results are expressed as the mean extracellular levels of 5-
HT and 5-HIAA compared to the basal samples ± S.E.M., n=10 for vehicle 
controls and n=6 for F 2692 treated rats. Basal levels of 5-HT and 5-HIAA 
before being placed on the X-maze were: 5-HT: vehicle = 64 ± 10 f m o l / 2 ~ , ,
F2692 = 68 ± 9 fmol/20J1l: 5-HIAA: vehicle = 1.30 ± 0.32 p m o l / 2 ~ , , F2692 = 
1.41 ± 0.36 p m o l / 2 ~ 1 . . Changes in the levels of 5-HT and 5-HIAA were 
analysed separately using a one-way ANOVA With repeated measures (5-HT: 
F = 9.21, p<O.OOI: 5-HIAA: F = 0.462. p<0.51) followed by a Dunnett's t-test to 
identify any significant differences between vehicle and drug treated groups. 
·p<0.05, ··p<O.Ol significantly different from vehicle treated animals. One-
way ANOVA With repeated measures With post-hoc Dunnett's t-test. 
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Figure 6 
Effects of acute administration of diazepam (DZP, 2.5mg/kg 1.p.) on (A) the 
time spent on the closed, open and end of the open arms, and (B) the 
percentage open:total entries and time. Behaviour was monitored in the 
elevated X-maze for a 5 minute period (during which time microdialysts was 
continued) 40 minutes after drug administration. Data are the expressed as 
the mean ± S.E.M., n= 1 0 for vehicle and n=6 for diazepam. 
*p<O.05, "p<O.Ol significantly different from controls. 2-taUed Mann-
Whitney U-test. 
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F1gure 7 
Effects of acute administration of diazepam (DZP, 2.5mg/kg 1.p.) on (A) the 
time spent on the closed, open and end of the open anns, and (B) the 
percentage open:total entries and time. Behaviour was monitored in the 
elevated X-maze for a 20 minute period (during which time microdialysis 
was continued) 40 minutes after drug administration. Data are the expressed 
as the mean ± S.E.M., n= 10 for vehicle and n=6 for diazepam. 
·p<0.05 significantly different from controls. 2-talled Mann-Whitney U-
test. 
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FIgure 8 
Effects of acute administration of ipsaptrone (lmg/kg l.p.) on (A) the time 
spent on the closed. open and end of the open arms. and (B) the percentage 
open:total entries and time. Behaviour was monitored in the elevated X-
maze for a 5 minute period (during which time microdialysis was continued) 
40 minutes after drug administration. Data are the expressed as the mean ± 
S.E.M .. n=lO for vehicle and n=6 for ipsapirone. 
There was no significant difference from controls. 2-tatled Mann-Whitney 
U-test. 
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Flgwe9 
Effects of acute administration of ipsapirone (lmg/kg l.p.) on (A) the time 
spent on the closed, open and end of the open arms, and (B) the percentage 
open:total entries and time. Behaviour was monitored in the elevated X-
maze for a 20 minute period (during which time mlcrodialysls was 
continued) 40 minutes after drug administration. Data are the expressed as 
the mean ± S.E.M., n=1O for vehicle and n=6 for Ipsaplrone. 
There was no significant difference from controls. 2-talled Mann-Whitney 
U-test. 
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and ends of open anns (Fig. lOA) and the percentage open:total entries and 
time (Fig. lOB) during the first 5 minutes on the X-maze. F 2692 also 
significantly Increased the number of ann and end of ann entries compared 
to vehicle control (Table 1) during the first 5 minutes. After the full 20 
minutes on the X-maze F 2692 had no Significant effect upon any of the 
parameters scored (Fig. 11) although the percentage open:total entries 
approached Significance (p<O.l) (Fig. lIB). 
Correlations 
For the vehicle control data correlations were carried out between the 'peak 
increase' in extracellular 5-HT (percentage increase above basal level when 
placed on the X-maze) and either:- (a) the percentage open:total entries (F test. 
p=0.1037. correlation coefficient = 0.554) (Fig. 12 A); (b) the percentage 
open:total time (F test. p=0.3874. correlation coefficient = 0.308) (Fig. 12B); (c) 
time spent on open anns (F test. p=0.2647. correlation coefficient = 0.390) 
(Fig. 13A); (d) time spent on the ends of the open anns (F test. p= 0.241. 
correlation coeffiCient = 0.409) (Fig. 13B) over the 20 minute exposure period. 
None of these showed any significant correlation. 
DISCUSSION 
The present study. using in vivo microdialysls. demonstrated that 20 minute 
exposure on the X-maze results In increased levels of extracellular 5-HT 
which return back to basal levels 40 minutes after returning the animal to 
its home cage. Exposure to the X-maze had no effect on the extracellular 5-
HIAA levels. supporting data from Chapter 4 where it was suggested that the 
extracellular 5-HIAA measured is not the product of the released 5-HT but is 
from the intraneuronal metabolism of unreleased 5-HT which then 'spills 
over' into the synaptic cleft (Grahame-Smith. 1971. 1974; Kuhn et al .• 1986; 
Kalen et aI.. 1988; Auerbach et aI.. 1989; Sharp et al .. 1989c; Crespi et al .• 
1990). Thus changes in 5-HIAA levels are not a good indication of 
corresponding changes in 5-HT levels. Generally. exposure to 'stress' 
occurring in a variety of different fonns results in an increase in 
neurotransmitter release. Using microdtalysis. increases in hippocampal 5-
HT have been obselVed after handling and applying a tail-pinch (Kalen et al.. 
1989). and increases in dopamine in the nucleus accumbens and 
acetylcholine in the hippocampus observed after restrainIng the animals 
(Imperato et aI .• 1991). Thus the increase in 5-1IT observed when the animal 
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FIgure 10 
Effects of acute administration of F 2692 UOmg/kg 1.p.) on (A) the time spent 
on the closed. open and end of the open arms. and (B) the percentage 
open:total entries and time. Behaviour was monitored in the elevated X-
maze for a 5 minute period (during which time microdialysis was continued) 
40 minutes after drug administration. Data are the expressed as the mean ± 
S.E.M .. n=lO for vehicle and n=6 for F 2692. 
*p<0.05. "p<O.OI significantly different from controls. 2-tatled Mann-
Whitney U-test. 
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FIgure 11 
Effects of acute administration of F 2692 (lOmg/kg t.p.) on (A) the time spent 
on the closed, open and end of the open anns, and (B) the percentage 
open:total entries and time. Behaviour was monitored in the elevated X-
maze for a 20 minute period (during whIch time microdialysis was 
continued) 40 minutes after drug administration. Data are the expressed as 
the mean ± S.E.M., n=lO for vehicle and n=6 for F 2692. 
There were no Significant differences at the p<0.05 level. 2-tailed Mann-
Whitney U-test. 
A 
1000 o Vehicle 
.. F 2692 (lOrng/kg) 
C) 800 
v 
rn 
- 600 
v 
e 400 .... f-1 
200 
0 
Closed Open End of Open 
Area of X-maze 
v B. 0 Vehicle e 
~ ~ II F 2692 (lOrng/kg) 
"d 40 a (p<O.l) 
rn 
Q) 30 E 
c:: 
~ ~
-a 
20 
~ ~
0 
E:; 10 
c:: 
v 
0. 
0 0 
?? % Entries % Time 
Table 1 
Effect of diazepam (2.5mg/kg l.p.). ipsapirone (lmg/kg l.p.) and F 2692 
(lOmg/kg Lp.) on the total number of arm and end of arm entries during 5 
and 20 minutes exposure to the X-maze 40 minutes after injection. Results 
are expressed as the mean ± S.E.M .. n=10 for vehicle and n=6 for drug. 
·p<0.05 significantly different from controls. 2-tailed Mann-Whitney U-
test. 
Treatment No. of Arm and End of Arm Entries 
5 min 20 min 
Vehicle 26.5 ± 1.3 92.7±4.8 
Diazepam 30.5±3.3 93.5±8.4 
Ipsapirone 24.3 ± 1.9 83.5±6.2 
F2692 35.0±4.4 • 82.5± 9.9 
FIgure 12 
Graph of increase in 5-HT peak (expressed as a percentage ofthe basal level) 
(x axis) verses (A) percentage open:total entries (y axis) and (B) percentage 
open:total time (yaxis) over a 20 minute period on the X-maze. The line on 
each graph represents a simple regression analysis of 10 data pOints from 
the vehicle treated group only; (A) slope = -.106, correlation coefficient = .554, 
F test: p = .1037: (B) slope = -.05, correlation coefficient = .308, F test: p = 
.3874. 
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Figure 13 
Graph of increase in 5-HT peak (expressed as a percentage of the basallevell 
(x axis) verses (A) time on the open arms (y axis) and (B) time spent on the 
ends of the open arms (y axis) over a 20 minute period on the X-maze. The 
line on each graph represents a simple regressIon analysis of 10 data pOints 
from the vehIcle treated group only: CAl slope = -.565. correlation coefficIent 
= .39. F test: p = .2647; (B) slope = -.441. correlation coeffiCient = .409. F test: p 
= .241. 
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is placed on the X-maze may occur as a result of 'stress' in a novel 
environment. It is also possible that the increased 5-HT levels may be a 
result of increased locomotor activity since it has been demonstrated that 
during the night (or dark phase) rats have greater locomotor activity and 
also greater 5-HT and noradrenaline release (Kalen et al .. 1989). Thus. 
placing the rat on the X-maze results in exploration and increased activity 
compared to the home cage. and could contribute to the increased 5-HT 
levels. Using two different designs of X-maze Copland and Balfour (1987) 
were able to show a correlation between locomotor activity and 5-HT 
turnover in several brain regions. gMng support for the hypothesis that 5-
HT turnover in the hippocampus may be directly related to the level of 
spontaneous activity. However, in this study the number of arm and end of 
arm entries were recorded as an index of general locomotor activity and no 
significant differences were found between the vehicle controls and any of 
the drug treated groups after the 20 minute exposure period. suggesting that 
the drug-induced alterations in extracellular 5-HT seen in this study are not 
the result of changes in locomotor activity. 
The increase in 5-HT observed when animals were restricted to the open 
arms appeared to be greater than that observed by isolation in the closed 
arms but this did not reach significance. It is thought that the open arms of 
the elevated X-maze cause greater 'fear' in the rat and hence it spends less 
time exploring this area. and this effect is reversed by the benzodtazepines. 
Thus it would be expected that restricting the animals to the open arms 
would result in a greater increase in 5-HT release compared to the closed 
arms. if 5-HT is involved in 'fear/anxiety'. A possible explanation as to why 
no Significant difference was observed between the two different types of arm 
is that when the rat is restricted to the open arms it spends approximately 60 
seconds exploring the open arms in the first two 5 minute periods and for the 
last 5 minute observation period (15 -20 minutes on the X-maze) it only 
ventures out onto the open arms for an average period of 3 seconds. i.e. the 
animal spends most of its time sat in the central square of the X-maze and 
not on the open arms. Thls demonstrates the aversion to the open arms upon 
which the model is based. and a greater increase in extracellular 5-HT may 
be observed if the animal was placed on an elevated runway which had no 
central square to act as a 'closed environment'. This is a Critical experiment 
to determine whether changes in 5-HT levels are graded with anxiety. 
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In the vehicle control rats the increase in extracellular 5-HT was analysed 
for correlations with a range of behavioural measures of anxiety on the X-
maze. For all of the behaviours scored except the percentage open:total 
entries there is no stgn1ficant correlation between that behaviour and the 
increase in 5-HT when the animal is placed on the X-maze. For the 
percentage open:total entries the correlation reaches 10.37%, indicating that 
there may be some relationship between this parameter and 5-HT levels in 
the ventral hippocampus. It is possible that the greater the increase in 5-HT 
when the an1mal is placed on the X-maze the more 'anxious' it is and less 
likely to enter the open arms. thus reducing the percentage open:total 
entries. However. it is very difficult to say if this theory is correct, as it 
should be pointed out that the other parameters were not changed. Also a 
larger group of animals is required for a more accurate correlation. 
Diazepam markedly inhibited the increase in extracellular 5-HT in the 
ventral hippocampus and had an anxiolyUc profile over the 20 minute 
period when the rat was placed on the X-maze. The ab1l1ty of diazepam to 
inhibit the increase in 5-HT when the animal was placed on the X-maze may 
be associated with the anxiolytlc profile it produces in the same animal. 
Diazepam treated animals have significantly reduced increases in 
extracellular 5-HT when placed on the X-maze and significantly greater 
percentage open:total entries and time and spent more time on the open arms 
compared to vehicle controls. Diazepam also inhibited 5-HT release from 
the ventral hippocampus when the rat was returned to its home cage. It 
cannot be determined from this study whether the decrease in basal 5-HT 
levels when the animal is returned to the home cage is a direct result of 
diazepam, agreeing with a Similar m1crodialysis study earned out by Pei et 
al. (l989b), or a result of exposure to the X-maze as diazepam produced a very 
marked reduction in Increased 5-HT when on the X-maze and did not inhibit 
5-HT levels in the home cage before exposure. The major innervation of the 
ventral hippocampus originates from the dorsal raphe (Azmit1a and Segal, 
1978) and using autoradiography and light-microscopic immuno-
cytochemistry it has been demonstrated that there is a high density of the 
GABAA/benzodiazepine receptor complex in both the dorsal raphe and 
ventral hippocampus (Squires and Braestrup. 1977; De BIas et al .. 1988). In 
agreement with this finding and the one by Pei et al. (1989b) that systemic 
diazepam decreased extracellular 5-HT in the ventral hippocampus. 
iontophoretic or systemic administration of benzodiazepines inhibit 5-HT 
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cell firing in the dorsal raphe and potentiate the inhibitory action of GABA 
agonists (Gallager. 1978: Trulson et al .• 1982). It has been shown using 
synaptosomal preparation of hippocampus that GABA and diazepam 
decrease K+-evoked release of [3H]-5-HT (Balfour. 1980). and with 
microdlalysts that local perfUSion of flurazepam decreases extracellular 5-
HT levels (Pei et al .• 1989b). Thus in this study diazepam may be having its 
inhibitory effect by acting at the dorsal raphe and also the 5-HT terminal 
region in the hippocampus. The data from this part of the study suggest that 
reducing 5-HT release may be one of the mechanisms of action of the 
benzodiazepines which is important for their anxiolytic activity. 
Ipsapirone treated animals did not differ in their behaViour from vehicle 
controls over the 20 minute period on the X-maze. Similar results were 
observed with this dose of ipsaptrone (1 mg/kg) when placed on the maze for 
a 5 minute period. and the possible reasons for this behavioural profile are 
discussed in Chapter 3. However. ipsaptrone was seen to Significantly reduce 
the increase in extracellular 5-HT when the animals were placed on the X-
maze and to reduce basal levels when the animal was returned to its home 
cage. Ipsaptrone and two structural analogues. busplrone and geptrone. all 
inhibit dorsal raphe neurone firing. m1m1cking the effect of 5-HT (Dourish et 
a1.. 1986; Rowan and Anwyl. 1987: Van der Maelen et at. 1986: Wilkinson et 
a1.. 1987). In the hippocampus all three compounds produced only the 
inhibitory component of the action of 5-HT (Rowan and Anwyl. 1987: Van 
der Maelen et a1.. 1986: Martin and Mason. 1987). This group of 5-HTIA 
partial agonlsts have been found to decrease 5-lIT release using either in vivo 
microdialysis or differential pulse voltammetry (Crespi et at. 1990: Hjorth 
and Magnusson: 1988: Hutson et al .• 1989: Sharp et a1.. 1989a). This effect Is 
thought to be predominantly as a result of action at the somatodendritic 
autoreceptor in the dorsal raphe nucleus (Hjorth and Magnusson. 1988: 
Hutson et al .• 1989: Sharp et at. 1989c). The abUtty of Ipsaptrone to mimic 
the effects of diazepam on 5-HT release would suggest that the inhibition of 
the increase in extracellular 5-HT observed with diazepam is not important 
for its anxiolytic activity. However. 5-HTIA receptors are found not only on 
the cell bodies/dendrites of 5-HT neurones In the raphe nuclei but also at 
postsynaptic sites in the limbic terminal regions (Hoyer et al. 1986a). Thus. 
even though ipsaptrone is inhibiting 5-HT release in the hippocampus via an 
action at the raphe nuclei it may also be stimulating postsynaptic 5-lITIA 
receptors in the hippocampus to have an overall effect of not altering 5-HT 
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neuronal activity, resulting In a behavioural profile that it not different 
from the vehicle treated animals. 
F 2692 had an anx10lytlc profile In the X-maze when placed on it for a 5 
minute period, agreeing with the results of Assle et al. (1991). However, the 
anx10lytlc profile was lost when the antma1s were placed on the X-maze for a 
20 minute pertod. F 2692 was synthesized as a non-benzodiazeplne which 
acts at the benzod1azepine-GABAA receptor complex (In the hope that the 
benzodlazepine side effects would be absent), and a possible reason for the 
absence of an anxtolyUc profile after 20 minutes is that F 2692 has been 
reported to have sedative effects at 30 mg/kg i.p. (Marsden, unpublished 
observations) using the same X-maze and protocol as this study for a 5 
minute time period. and hence sedative effects may become apparent on the 
X-maze at 10 mg/kg when the animal Is exposed for a 20 minute period. 
Looking at the number of arm and end of ann entries, it can be seen that F 
2692 Significantly increased the number of entries after 5 minu.tes but not 20 
minutes, indicating the onset of sedation In the remaining 15 minutes. F 
2692 reduces both the increase in extracellular 5-HT when the animal is 
placed on the X-maze and the basal levels when the animal is returned to its 
home cage. The mechanism by which it does this is at present unknown as it 
has low affinity for the benzod1azepine site (Agsle et a!., 1991) and the effect 
of F 2692 on the X-maze can be reversed with flumazenil but only at high 
doses (20 mg/kg I.p.) (Assie et al., 1991) suggesting that It is only having a 
weak effect at the benzodlazepine site. The side effects of this compound are 
very s1m1lar to those of the benzodlazepines, suggesting that F 2692 may be 
acting through the benzodiazeplne-GABAA receptor complex but not 
necessarily at the benzodlazeplne site. Thus, the decrease in extracellular 5-
HT. both on the X-maze and when returned to the home cage, seen with F 
2692 may be a result of its action somewhere on the benzodiazepine-GABAA 
receptor complex. The ability of F 2692 to reduce the increase In 
extracellular 5-HT observed when the rat is placed on the X-maze may be 
associated with its anxiolytic activity provided that sedative effects were 
predOminant after 20 minutes. 
In summary, plaCing a rat on the X-maze increased the extracellular levels of 
5-HT in the ventral hippocampus but the correlation between 'increased 5-
HT' and 'anxious behaviour' was not good. Thus it is important to determine 
whether there Is a significant difference in the increased 5-HT levels when 
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animals are restricted to either the open or the closed anns. It is possible 
that the lack of correlation may be a result of the 20 minute time period. and 
small discrete effects occurring within the first 5 minutes may be missed. so 
it is necessary to try to increase the sensitMty of the assay so that 5 minutes 
samples can be analysed. Diazepam. ipsa pirone and F 2692 all reduced this 
increase In extracellular 5-HT and decreased basal 5-HT levels when the 
animal was retwned to its home cage. Diazepam and F 2692 produced an 
arudolyUc profile when on the X-maze for 5 minutes but only diazepam 
produced an anx10lyUc profile after 20 minutes exposure. It is possible that 
the reduced increase in extracellular 5-HT after diazepam pretreatment may 
be one of the mechanisms by which diazepam has its arudolyUc action. The 
decrease in 5-HT release being important for anxiolytic activity is supported 
by F 2692. an anxiolytic with weak activity at the benzodiazepine-GABAA 
Site. also reducing extracellular 5-HT and having an arudolytic profile. It 
would be useful to try lower doses of F 2692 where the sedative effects may 
not be as prenounced. However. against this theory is the ability of 
ipsapirone to reduce extracellular 5-HT and not to have any arudolyUc 
activity in this study. but it is possible that post-synaptic 5-HTIA receptor 
stimulation by ipsapirone In the hippocampus and other limbic regions may 
have the net effect of not changing 5-HT function in these animals. It may be 
useful to try lower doses ipsa pirone which are more selecUve for the 
somatodendritic autoreceptor In an attempt ot eliminate any postsynaptic 5-
HTIA receptor stimulation. 
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CHAPTER 6 
THE EFFECTS OF ISOLATION-REARING AND SUBSEQUENT 
RESOCIALISATION ON THE BEHAVIOUR OF RATS ON THE ELEVATED 
X-MAZE MODEL OF ANXIETY 
INTRODUCTION 
The rearing conditions (social environment) to which an animal is exposed 
in the early stages of life have been shown to influence its subsequent 
behaviour. One of the most prominent and reproducible findingS following 
social isolation is increased locomotor activity, and this is found in many 
species including rats (Syme, 1973; Morley and Worsham. 1978). mice 
(Essman, 1966; Wilmot et al., 1986), monkeys (Mason et al., 1968), cats (Seitz. 
1959) and dogs (Fox and Stelzner, 1966). Isolation-reared rats show 
increases in locomotor actMty when placed in a novel environment with no 
change in the spontaneous activity (when habituated to the test 
environment) (Sahakian et al., 1975, 1977). In the rat, socialisolaUon has 
been reported to produce other behavioural disturbances such as reduced 
(Parker and Morinan, 1986) or enhanced (Sahakian et al., 1977; Einon and 
Morgan, 1977) exploratory behaViour, and a possible anxtogenlc profile in 
the elevated X-maze model of anxiety (Morinan and Parker, 1985). 
Few studies have examined the relative permanence of isolation-induced 
changes. Resocialisation can be effective in reversing many, but not all, of 
the effects of social isolation. Gentsch et al. (1988) demonstrated that the 
hyperactivity and greater tail-flick latencies in isolation-reared rats could 
be reversed by resocialisation. as can maze learning deficits (Wood and 
Greenough, 1974). Other experiments have failed to detect recovery from 
isolation-induced impairments, particularly if isolation was introduced at 
weaning age (Einon and Morgan, 1977: File, 1978: Kraemer et al., 1984). This 
might be expected as brain maturation processes would be more susceptible 
to permanent change at an early age. HypertenSion (Naranjo and Fuentes, 
1985) and neurochemical changes (Blanc et al.. 1980) induced by isolation of 
mature rats are completely reversed by resocialisation. supporting this 
theory. 
The initial aim of this study was to investigate the effects of social isolation 
of rats at weaning on their behaviour in the elevated X-maze model of 
anxiety (Handley and Mithani. 1984). Furthermore. to then determine 
whether resocial1sation of the rats reared in isolation from weaning 
reversed any behavioural changes observed in the X-maze and if isolation of 
the SOCially-reared group when adult produced behaViour Similar to that 
seen when isolation was induced at weaning. 
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METHODS 
48 male Lister hooded rats (Nottingham University MedIcal School Animal 
Unit) obtained at weaning (21 days of age) were divided into the two rearing 
condition groups counterbalanced by weight. Rats were housed either 
individually or In social groups of four per cage for the duration of the first 
part of the experiment. All cages were constructed of plastic and were lined 
with sawdust. so subjects had to be removed from their cages for cleaning. 
The isolation-reared rats were housed singly in a cage 41cm x 26cm x 20cm 
high. The social group cages were 52cm x 32cm x 20cm high. Both groups had 
food and water available ad libitum. All animals were housed in the same 
holding room with a 12 hr. light: 12 hr. dark cycle (0700-1900 Ughts on). It is 
important to note that the isolated animals still had auditory. visual. and 
olfactory contact with the other animals and hence the study is concerned 
only with the effects of socIal isolation. 
30 days post-weaning the animals were monitored in locomotor activity 
cages (described below) and 3 days later monitored on the elevated X-maze 
(described below). After testing. half of the isolation-reared anImals 
remained isolated (n= 12) (isolation-reared) and the other half were socially 
housed in groups of four (n=12) (isolation-reared and then socially-housed). 
and half of the SOCially-reared animals remaIned in groups of four (n= 12) 
(socially-reared) and the others isolated (n=12) (SOCially-reared and then 
isolated): the regrouping being counterbalanced by the rats behaviour on the 
elevated X-maze. 30 days post-rehousing the animals were retested on the 
elevated X-maze. 
Spontaneous Locomotor Activity 
Procedure 
Animals were placed in Perspex cages (25cm x 18cm x 18cm)with wire mesh 
tops. and each cage was located between two photocells. An infrared beam 
ran between the photocells and movement of the animal from one half of the 
cage to the other resulted in this beam beIng broken and an incremental 
count beIng recorded. Counts were recorded every 5 min for a period of 1 hr 
immediately after the animal was placed in the cage. Activity was 
mOnitored between 1030 and 1430 hrs. 
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Elevated X·maze 
Apparatus and Procedure 
The elevated X·maze apparatus and protocol was identical to that described 
in Chapter 2 with the exception that the X-maze was only elevated to a height 
of 50cm and the animals were not isolated for a 5 minute period before being 
exposed to the X-maze because the effects of isolation are being studied and 
thus socially-housed animals should not be isolated. 
Statistics 
All results are expressed as the mean ± standard error of the mean (S.E.M.). 
The ratio of open:total arm entries and open to total time was calculated for 
each rat individually and the mean ± S.E.M. for each treatment group 
presented. 
All data after 1 month (2 groups) were analysed using 2-talled Mann-Whitney 
U-test. 
All data after 1 month rehousing (2 months from Original housing) (4 groups) 
were analysed using Kruskal Wallis one way analysIs of variance by ranks 
test with post-hoc Dunn's test. 
RESULTS 
Spontaneous Locomotor Activity 
Rats reared in isolation were spontaneously hyperactive when placed in the 
novel environment compared to the socIally reared controls but the 
hyperactivity only occurred between 5 and 35 min in the activity cages (Fig. 
1). After this time there was no significant difference in the number of 
counts between the isolation- and socially-reared animals. 
X-maze 
Isolation-reared rats spent significantly less time on the open and the end of 
the open arms (Fig. 2A) and had Significantly reduced percentage open/total 
entries and time (Fig. 28) but no difference was observed in the time spent on 
the enclosed arms (Fig. 2A) or the total number of arm and end of arm entries 
(Fig.2B). 
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FIgure 1 
Locomotor activity measured in 5 minute intervals for a period of 60 
minutes in isolation- and social-reared rats. expressed as photobeam 
interruptions. Results are expressed as the mean number of interruptions ± 
S.E.M.: n=24 in each group. 
·p<0.05 significantly different from socially-reared animals. 2-tailed 
Mann-Whitney U-test. 
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Figure 2 
(A) Time spent in the closed anus. open anus and end of open anus. and (B) 
percentage open:total entries and time and total number of anu and end of 
arm entries in isolation- and socially-reared rats during 5 minute exposure 
on the elevated X-maze. Results are expressed as the mean ± S.E.M.: n=24 in 
each group. 
·p<O.05 significantly different from SOCially-reared animals. 2-tailed 
Mann-Whitney U-test. 
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There were no significant differences between any of the 4 groups of animals 
in the time spent on the enclosed arms of the X-maze (Fig. 3A) or in the total 
number of ann and end of ann entries (Fig. 3B). However. animals reared in 
isolation throughout the experiment and those isolated at weaning and then 
socially housed spent significantly less time on the open and ends of open 
arms compared to the socially-reared throughout group (Fig. 3A). The 
behaviour in the X-maze of rats kept in isolation throughout the experiment 
was not significantly different from those kept in isolation then rehoused in 
groups. This was also true for rats housed in social groups throughout and 
those housed in groups then isolated (Fig. 3A and 3B). 
DISCUSSION 
In agreement with previous results (Morley and Worsham. 1978: Sahakian et 
al.. 1975) isolation-reared animals were hyperactive compared to socially 
reared controls when placed in a novel environment. After a period of about 
35 min the animals had habituated to the environment and no difference in 
locomotor activity was observed between the two groups. again agreeing with 
work by Sahakian at al. (1975: 1977). This part of the study confirms that 
the initial rearing conditions used in our laboratory produced effects 
comparable with those reported in the literature. 
In the elevated X-maze. isolation-reared rats showed a Significant reduction 
in the time on the open and ends of open arms and in the percentage 
open:total entries and time compared to SOCially-reared controls. There was 
no significant difference in the total number of arm and end of arm entties. 
indicating that reduced exploration of the open arms Is not a result of 
alterations in locomotor activity. The anxiolytic activity of 
benzodiazepine-like compounds can be detected on the X-maze as an increase 
in time spent exploting the open arms (Chapter 2: Pellow et aI.. 1985). and 
conversely. compounds with anxiogenic activity. such as a2-adrenoceptor 
antagonists. decrease the time spent in the open arms (Chapter 2: Handley 
and Mithanl. 1984). This suggests that isolation-reared rats display an 
anxiogenic profile compared to socially-housed controls when placed on the 
X-maze. and that this is not as a result of the increased locomotor activity 
observed in these animals. These results are in agreement with a previous 
90 
Figure 3 
(A) Time spent in the closed anns, open aIDlS and end of open anns, and (B) 
percentage open:total entries and time and total number of ann and end of 
ann entries in isolation-reared (lsol-Isol). isolation-reared and then 
socially-housed (lsol-Soc), SOCially-reared and then isolation-housed (Soc-
Iso1) , and SOCially-reared (Soc-Soc) rats during 5 minute exposure on the 
elevated X-maze. Results are expressed as the mean ± S.E.M.: n=12 in each 
group. 
·p<O.05 Significantly different from SOCially-reared animals. 
+p<O.05 significantly different from socially-reared and then isolated 
animals. Kruskal Wallis one way analysis of variance by ranks test with 
post-hoc Dunn's test. 
No significant differences were observed between either the Isol-Isol and 
Isol-Soc groups or the Soc-Soc and Soc-lsol groups. 
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study (Parker and Morinan. 1986). and indicate that the changes seen in 
locomotor activity and behaviour on the X-maze are vIa two different 
mechanisms. 
Resocialisation of isolation-reared rats did not alter the behaviour of these 
animals on the X-maze. There was no significant difference between the rats 
reared and kept in Isolation throughout and the rats reared in Isolation then 
socially-housed. Both groups explored the open arms SignifIcantly less than 
the SOCially-reared throughout group. Thus. after 30 days resocial1sation the 
animals that were isolation-reared and then socially-housed dIsplayed a 
statistically significant anxiogenic profile compared to socIally-reared 
throughout controls. SocIally-reared rats that were isolated when adult 
displayed no sIgnificantly different behaviour on the X-maze compared to 
the SOCially-reared throughout group. ThIs indIcates that Isolation of adult 
rats does not produce the arudogentc profile observed on the X-maze in rats 
isolated at weaning. Further. resocialisation of the isolation-reared 
animals does not reverse this anxiogentc profile. thus the changes observed 
may indicate a permanent developmental change. The behaviour of rats 
after 30 (initial isolation) and 60 days (isolation-reared throughout animals) 
isolation from weaning was very similar. suggesting that the effects observed 
are a result of developmental changes from weaning which do not appear to 
markedly increase after a period of 30 days isolation. It has yet to be 
determined the time after weaning at which isolation can be introduced and 
these behavioural differences are no longer observed. Also. handling during 
the development of the Isolation-reared animals. which has been shown to 
reverse some changes such as hyperactivity and tail-flick latency (Gentsch et 
a1.. 1988). may reverse the behavioural changes obseIVed in this study. 
In summary. rats reared in isolation from weaning display an anxtogentc 
profile on the elevated X-maze compared to SOCially-reared controls. and 
this arudogenic profile is not observed when adult rats are isolated. Further. 
resocialisation of the isolation-reared rats does not reverse the arudogenIc 
profile. Thus the changes observed in the isolation-reared rats appear to be 
developmental and long lasting as they are not reversed by resocialisation. 
Usually in the elevated X-maze compounds such as FG7142 or idazoxan are 
normally used to induce an anxiogenic profile; however. with isolation-
reared rats the same profile is obseIVed and it would be of interest to 
determine whether there are any neurochemical changes in pre- and 
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postsynaptic 5-HT function and if these are related to the behavioural 
changes reported here. 
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CBAPTER7 
CHANGES IN PRE- AND POSTSYNAPTIC RECEPTOR FUNCTION IN 
ISOLATION-REARED RATS. 
INTRODUCTION 
As discussed In the Introduction to the thesis isolated rats demonstrate 
many behavioural disturbances such as increased locomotor actMty (Syme. 
1973: Morley and Worsham. 1978). reduced (Parker and Mortnan. 1985) or 
enhanced (Elnon and Morgan. 1977: Sahakian et al .. 1977) exploratory 
behaviour and deficits In both learning and spatial memory tasks (Juraska 
et al.. 1984). It has been demonstrated In Chapter 6 that Isolation-reared 
animals have an anxiogenic profile on the elevated X-maze compared to 
socially housed controls and that this effect is not reversed by 
resocial1satlon. These and other disturbances define the "isolation 
syndrome" (Morgan et al.. 1975: Morinan and Parker. 1985: Sahakian et al.. 
1977). The central dopamlnergic system has been a focus of research on the 
biochemical effects of isolation rearing for some years now. For example. 
isolates show greater increases In frontal cortex dopamine (DA) metabolism 
In response to footshock (Blanc et al.. 1980) and DA release stimulated by 
amphetamine is Increased (Jones et al .. 1988. 1990) as well as other Indices 
of dopamlnergic function (Weinstock et al 1978: Guisado et al.. 1980). 
However limited data are available on the "isolation syndrome" and central 
5-lIT systems and contrasting reports have suggested either an increase (File 
and VellUCCi. 1978) or a decrease (Morinan and Parker. 1985) in the turnover 
of central 5-HT. 
Isolation-reared animals have an anxiogenic profile compared to socially-
housed controls and with the implications of the involvement of 5-lIT In 
anxiety the aim of this study was to determine whether there are changes In 
pre- and post-synaptic 5-HT function in isolation-reared animals. 
Presynaptic changes were Investigated by studying the effects of 
pharmacological stimulation on 5-HT release measured in the frontal 
cortex of isolated rats in comparison with socially reared controls using 
intracerebral microdialysis. The functional state of the post-synaptic 5-
HTIA and 5-lIT2 receptors was investigated using the '5-lIT behavioural 
syndrome'. This was obsetved following administration of 5-HT precursors 
such as L-tryptophan or 5-hydroxytryptophan (5-JITP) In the presence of a 
peripheral decarboxylase inhibitor (Grahame-Smith. 1971: Jacobs. 1976; 
Green et al.. 1983b). Components of the 5-HT syndrome are also observed 
after administration of the 5-HTIA full agonist 8-hydroxy-2-(di-n-
propylamino) tetralin (8-0H-DPAT; Hjorth et al.. 1982; Tricklebank et al.. 
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1985a: Goodwin and Green, 1985) and consists of hyperlocomotton, 
hindlimb abduction, head weaving, flat body posture and reciprocal forepaw 
treading (Hjorth et al., 1982: Tricklebank et al., 1985a). It is thought that the 
flat body posture and reciprocal forepaw treading are mediated by post-
synaptic 5-HTIA receptors (Tricklebank et al., 1985a). The main 
behavioural response seen after 5-HT2 receptor agontsts is the head-twitch 
response In mice (Come et al., 1963; Come and Pickering, 1967: Goodwin and 
Green, 1985: Heaton et al., 1988) and the 'wet-dog shake' (WDS) response in 
rats (Bedard and Pycock, 1977; Mathews and Smith, 1980: Goodwin and 
Green, 1985). Intrathecal administration of the selective 5-HT2 agorusts 2.5-
dimethoxy-a,4-dimethyl-2-aminopropane (DOM) and 1-(2,5-dlmethoxy-4-
iodomethyl)-2-amino-propane (001) produces WDS and also back muscle 
contractions: both behaviours can be antagOnised by ketansertn, a 5-HT2 
antagonist (Fone et aI., 1989, 1990). Thus the functional states of the post-
synaptic 5-HTIA and 5-HT2 receptors were studied by observing the '5-HT 
behavioural syndrome' induced by the non-selective 5-HT receptor agonist, 
5-methoxy-N,N-dlmethyltryptamine (5-MeODMT), the relatively selective 5-
HTIA full agonist 8-0H-DPAT and the 5-HT2/IC agonist DOl. 
METHODS 
a) In Vivo MlerocUalyala 
Animals 
15 male Lister hooded rats (Nottingham University Medical School Animal 
Unit) obtained at weaning (21 days of age) were divided into the two reartng 
condition groups counterbalanced by weight. Rats were housed either 
individually (n=7) or in social groups of four per cage (two groups of n=4) for 
the duration of the experiment. All cages were constructed of plastic and 
were lined with sawdust, so subjects had to be removed from their cages for 
cleaning. The isolation-reared rats were housed singly in a cage 41cm x 
26cm x 20cm high. The social group cages were 52cm x 32cm x 20cm high. 
Both groups had food and water available ad libitum. All animals were 
housed in the same holding room with a 12 hr. light: 12 hr. dark cycle (0700-
1900 lights on). It is important to note that the isolated animals still had 
auditory, vtsual, and olfactory contact with the other animals and hence the 
study Is concerned only with the effects of social isolation. 
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Procedure 
I) Spontaneous Locomotor AcUvity 
30 days post-weaning animals were placed in Perspex cages (25cm x 18cm x 
18cm) with wire mesh tops. and each cage was located between two 
photocells. An infrared beam ran between the photocells and movement of 
the animal from one half of the cage to the other resulted in this beam being 
broken and an incremental count being recorded. Counts were recorded 
every 5 min for a period of 1 hour immediately after the animal was placed 
in the cage. ActMty was monitored between 1000 and 1430 hrs. 
11) Neurochemical Stud.Is 
2 days after the locomotor activity had been determined the neurochemical 
study commenced. Animals were anaesthetised with chloral hydrate (500 
mg/kg l.p.) and positioned in a stereotaxic frame (anaesthesia was 
maintained throughout the study). A micro dialysis probe (CMA/ll. 
Carnegie Medicin) was stereotaxically implanted into one frontal cortex 
(anterior-posterior 3.6mm. lateral. 1.5mm. ventral 2mm: Paxinos and 
Watson. 1986) and perfused with artificial CSF (described in Chapter 4) at a 
flow rate of IJ,1l/min. Two hours after implantation into the frontal cortex 
baseline measurements were made for 80 minutes with dialysis samples 
collected every 20 minutes. The dialysis samples were analysed for 5-HT and 
5-HIAA as deSCribed in Chapter 4. During the first minute of each of the 
subsequent 3 dialysate samples KCI (lJ,ll. ImM) was administered locally via 
a cannula (looJ.1ffi diameter) implanted alongsIde the dIalysIs probe. It has 
been shown using in vivo voltammetry that the extracellular levels of 5-HT 
have returned to baseline 10 minutes after each KCI injection (Crespi. 
personal communication). After a further 40 mins fenfluramine (25 mg/kg 
l.p.) was administered and samples collected for the next 80 minutes. 
b) 5-HT Induced Behaviours 
Animals 
40 male Lister hooded rats (Nottingham University Medical School Animal 
Unit) obtained at weaning (21 days of age) were divided into the two rearing 
condition groups counterbalanced by weight. Housing and isolation 
conditions were exactly the same as the micro dialysis study. 
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Procedure 
1) Spontaneous Locomotor Activity 
30 days post-weaning the animals locomotor activity was studied as 
described in the microdialysis study. 
U) 5-HT Behavioural Syndrome 
Approximately 7 days after studying the spontaneous locomotor activity the 
animals were selected to receive one of the following drugs (counterbalanced 
according to their locomotor activity): 
a) 5-MeODMT (2 mg/kg I.p.). The forepaw treading, flat body posture and 
headweaving components of the '5-HT behavioural syndrome' were scored 
during 30 seconds every 2 minutes for 14 minutes immediately after 
injection, using a rank scale similar to that employed by Tricklebank et al. 
(1985a) where O=absent, l=equivocal, 2=present and 3=intense. 
b) 8-0H-DPAT (0.32 mg/kg s.c.). Observations commenced immediately after 
injection and forepaw treading and flat body posture scored using the above 
rank scale for 30 seconds every 2 minutes for a total of 30 minutes. 
c) DOl (2.5 mg/kg 1.p.). Observations commenced immediately after injection 
and wet-dog shakes (defined as multiple rotatory movements of head and 
shoulders and/or body about the long axis typical of a dog emerging from 
water) and back muscle contractions counted in 2 minute periods for a total 
of 14 minutes. 
Behavioural observations on these rats occurred in Perspex cages (25cm x 
18cm x 18cm) with wire mesh tops. The animals had no prior experience of 
this test environment and drugs were not administered using a blind 
protocol. 
Preliminary dose response studies were carried out using group reared 
animals to determine a dose of each agonist which did not produce a 
maximal behavioural response (data not shown). This was to ensure that 
differences in responsiveness (either an increase or decrease) between the 
two groups of animals could be observed. 
Drugs 
All drugs, dissolved in 0.9% saline, were prepared immediately before 
administration and injected either subcutaneously (s.c.) or intraperitoneally 
(1.p.) in a volume of 1 ml/kg. KCI was dissolved in artificIal CSF 
(composition deSCribed in Chapter 4). The compounds were obtained from 
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the following sources: KCI (BDH Chemicals Ltd.): fenfluramine 
hydrochloride and 5-MeODMT (Sigma); 8-0H-DPAT and 001 (RBI 
Chemicals). 
Analysis of Data 
The behavioural data were analysed using a 2-taUed Mann-Whitney U-test 
but are displayed as mean ± standard error of the mean (S.E.M.) in order to 
illustrate the group variaUon. All microdialysis data were analysed using a 
one-way ANOVA with repeated measures followed by a Dunnett's t-test to 
identify any significant dttrerences between the two groups. 
RESULTS 
a) Locomotor activity 
Both groups of rats reared in isolation were spontaneously hyperactive 
compared to their respective socially reared controls but the hyperactivity 
only occurred between 10 and 35 minutes in the activity cages in the first 
group of isolated rats (micro dialysis study) (Fig. lA) and between 10 and 40 
minutes in the second group of isolated rats (5-HT behavioural syndrome 
study) (Fig. IB). After this time there was no Significant difference in the 
number of counts between the isolation- and socially-reared animals. The 
activity counts per 5 minute pertod were higher in the second part of this 
study compared to the first part. 
b) MicrocUalysls 
Basal 5-HT levels detennined by microdialysis were lower in the isolation-
reared animals compared to the socially-reared ones but not to a significant 
extent (Table 1). There was no difference in the levels of 5-HIAA between the 
two groups (Table 1). The 5-HIAA : 5-HT ratio (used as a measure of 5-HT 
turnover) was greater in isolation-reared rats but this did not reach 
Significance (Table 1). 
Local injections of KCI stimulated 5-HT release as shown in Fig. 2. 
Measurement by microdialysis shows that stimulated 5-HT release Is 
reduced in isolation-reared rats but this only reached Significance on the 
first depolartsation (Fig. 2A). All of the three KCI injections slightly 
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Figure 1 
Locomotor activity measured in 5 minute intervals for a period of 60 
minutes in isolation- and social-reared rats used in either (A) the 
microdialysis study, or (B) the 5-lIT behavioural syndrome study, expressed 
as photobeam interruptions. Results are expressed as the mean number of 
interruptions ± S.E.M.; n=7 in each group for the microdialysis study and 
n= 18 in each group for the 5-HT behavioural syndrome study. 
·p<0.05 significantly different from socially-reared animals. 2-tailed 
Mann-Whitney U-test. 
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Table 1 
Extracellular levels of 5-HT and 5-HIAA in the frontal cortex of isolation-
and socially-reared rats measured using microdialysis. 5-HT and 5-HIAA 
were analysed using HPLC-ECD. The ratio of 5-HIAA:5-HT was calculated 
and is shown. Results are expressed as the mean ± S.E.M .. n=7 in each group. 
Rearing conditions 
Social Isolation 
5-HT levels (fmol/20J,1.l) 177±23 132± 18 
5-HIAA levels (pmol/2OJ.U) 1.33 ± 0.06 1.48 ± 0.08 
5-HIAA/5-HT 7.90±0.97 11.52 ± 1.21 
Figure 2 
Effect of three local injections of KCI (lJ..Ll. lrnM) (named depolarisations 1 -
3) on the extracellular levels of (A) 5-HT and (B) 5-HIAA as measured by 
microdialysis in the frontal cortex of either isolation- or socially-reared 
rats. 5-HT and 5-HIAA were analysed using HPLC-ECD. Results are 
expressed as the mean ± S.E.M. percentage effects compared to basal levels 
for each group; n=7 in each group. 
·p<O.05 significantly different from socially-reared animals. One-way 
ANOVA with repeated measures with post-hoc Dunnett's t-test. 
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increased the levels of 5-HIAA In the dialysate but no Significant difference 
was obselVed between the two groups (Fig. 2B). 
Fenfluramine increased the extracellular levels of 5-HT as detected by 
mtcrodialysis (Fig. 3Al. Measurement by mlcrodlalysls found no Significant 
difference between the two groups but it was obselVed that the 5-HT release 
appeared to occur earlier In the socially-reared anImals (Fig. 3A). 
Fenfluramlne had no effect on the levels of 5-HIAA in either Isolation or 
socially reared animals as measured by mtcrodialysis (Fig. 3B). 
c) 5-HT Behavioural Syndrome 
a) 5-MeOOMT 
5-MeOOMT (2 mg/kg l.p.) Induced body tremor. circling behaviour. hindlimb 
abduction. head weaving. forepaw treadIng and flat body posture. These were 
obselVed in both groups of animals but the body tremor. Circling behaviour 
and hindlimb abduction were to Infrequent to be scored. Of the behaviOUrs 
scored. 5-MeOOMT produced a Significantly greater degree of forepaw 
treading and flat body posture in the isolation-reared animals compared to 
the socially-reared controls (Fig. 4A and 4B respectively). There was no 
significant difference in the amount of head weaving between the two groups 
of rats (Fig. 4C). 
b) 8-0H-DPAT 
8-0H-DPAT (0.32 mg/kg s.c.) produced mastication. some head weaving. 
forepaw treading and flat body posture. All these behaviours were obselVed 
in both groups of animals but the mastication and head weaving were too 
Infrequent to be Included In the scoring list. 8-0H-OPAT produced a 
significantly greater cumulative score In isolation-reared animals 
compared with the socially housed controls for forepaw treading (FIg. 5A) 
and flat body posture (Fig. 5B) with the enhanced degree of forepaw treading 
being most marked. 
c) 001 
DOl (2.5 mg/kg I.p.) produced wet-dog shakes. back muscle contractions. 
hyperactivity. slight forepaw treading. some flat body posture. mastication 
and circling. Wet-dog shakes and back muscle contractions were the most 
marked of these responses while hyperactivity. forepaw treading. flat body 
posture. mastication and Circling were Infrequent. The number of 001-
98 
Figure 3 
Effect of fenfluramine (25mg/kg i.p.) (arrow) on the extracellular levels of (A) 
5-HT and (B) 5-HIAA as measured by microdialysis in the frontal cortex of 
either isolaUon- or socially-reared rats. 5-HT and 5-HIAA were analysed 
using HPLC-ECD. Results are expressed as the mean ± S.E.M. percentage 
effects compared to basal levels for each group; n=7 in each group. 
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FIgure 4 
Effect of 5-MeODMT (2mg/kg l.p.) on forepaw treading (A), flat body posture 
(B) and head weaving (C) behaviour in tsolation- and socially-reared rats 
over a 14 min time period. Separate components of the '5-HT behavioural 
syndrome' were scored by a rank scale (see Materials and Methods) for 30 sec 
every 2 min for 14 min immediately after injection. Each column represents 
the mean cumulative behavioural score ± SEM obtaIned: n=6 rats in each 
group. 
·p<O.05, "p<O.Ol significantly different from socially-reared animals. 2-
tailed Mann-Whitney U-test. 
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Figure IS 
Effect of 8-0H-DPAT (0.32 mg/kg s.c.) on forepaw treading (A) and flat body 
posture (B) behaviour in isolation- and socially-reared rats over a 30 min 
time period. Separate components of the '5-HT behavioural syndrome' were 
scored by a rank scale (see Materials and Methods) for 30 sec every 2 min for 
30 min immediately after injection. Each column represents the mean 
cumulative behavioural score ± SEM obtained: n=6 rats in each group. 
·p<0.05, "p<O.O 1 significantly different from SOCially-reared animals. 2-
tailed Mann-Whitney U-test. 
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Figure 6 
Effect of DOl (lmg/kg Lp.) on back muscle contractions (A) and wet-dog 
shakes (B) in tsolation- and socially-reared rats over a 14 min time period. 
Back muscle contractions and wet-dog shakes were counted during 2 min 
periods for a total of 14 min immediately after injection. Each column 
represents the mean cumulative behavioural score ± SEM obtained: n=6 rats 
in each group. 
·p<O.05 significantly different from socially-reared animals. 2-tailed 
Mann-Whitney U-test. 
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induced back muscle contractions at the end of the 14 min period was 
significantly greater in the isolation-reared rats compared with the socially-
housed controls (FJg. GAl. However. over the 14 min obseIVation period there 
was no significant difference in the number of wet-dog shakes between the 
isolation- and SOCially-reared animals (Fig. 6B). 
DISCUSSION 
In agreement with previous results (Chapter 6: Sahakian at aI.. 1975) 
isolation-reared animals were hyperactive compared to socially reared 
controls when placed in a novel environment. After a period of about 40 min 
the animals had habituated to the environment and no difference in 
spontaneous locomotor activity was obseIVed between the two groups. again 
agreeing with work by Sahakian at al. (1975). The reason for the difference 
in the activity counts per 5 minute period obseIVed between the two different 
parts of the study is not clear. This part of the study was carned out to 
confirm that the rearing conditions used in our laboratory produced effects 
comparable with those reported in the literature and that the same 
behavioural effects as those studied in Chapter 6 were present in these 
animals in the hope that neurochemical changes would be Similar. 
The microdialysis data obtained suggest that there was a small. but non-
Significant. increase in 5-HT turnover in isolation-reared rats as the 5-
HIAA:5-HT ratio was greater. In contrast. the increase in extracellular 5-HT 
when stimulated with KCI was significantly less in isolation-reared animals 
suggesting that KCI stimulated release of 5-HT was reduced in these animals. 
There was no significant change in extracellular 5-HIAA indicating that it is 
a poor correlate of 5-HT neuronal function. possibly because it is not the 
product of the released 5-HT but arises from the intraneuronal metabolism 
of un-released 5-HT (Grahame-Smith. 1971. 1974: Kuhn et al.. 1986: Kalen et 
al.. 1988: Auerbach et al .• 1989; Sharp et al .• 1989c; Crespi et al .. 1990). 
Fenfluramine increased the levels of extracellular 5-HT in both the 
isolation- and SOCially-reared groups. There was no Significant difference in 
the effect of fenfluramtne between these two groups. A very similar effect on 
both extracellular 5-HT and 5-HIAA levels monitored by in vivo 
microdialysis in the frontal cortex of naive rats treated with fenfluramine 
has been reported (Crespi et aI.. 1990). thus supporting the feasibility of 
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performing experiments with fenfluramtne even after several injections of 
KCl. The reduced stimulated release of 5-HT, together with the possible 
increase in 5-HI' turnover and delayed effects of fenfluramine in the frontal 
cortex suggest that the "functional pool" (Glowinski et al., 1979) may be 
reduced and the higher turnover of 5-HT preferentially stored in the "reserve 
pool" (Green and Grahame-Smith, 1975), with prolonged stimulation 
possibly leading to 5-HT 'sp1ll1ng over' into the "functional pool". However, 
further experiments are required to determine whether this is true, possibly 
using a technique such as voltammetry with which more frequent sampling 
of 5-HT levels can occur. 
The agonists used in the second part of this study produced various '5-HT 
mediated responses' via either 5-HTIA and/or 5-HT2/lC postsynaptic 
receptor stimulation. The ability of 8-0H-DPAT and 5-MeODMT to produce 
the full 5-HT behavioural syndrome has been well established (Tricklebank 
et al., 1985a & b). After reserpine and p-chlorophenylalanine pretreatment 
the forepaw treading and flat body posture components of the behavioural 
syndrome are still induced by 8-0H-DPAT (Tricklebank et al., 1985a) 
suggesting that indirect catecholamine mechanisms are not involved in the 
production of these two components and that the response to 8-0H-DPAT is 
mediated by a post-synaptic receptor. Since 8-0H-DPAT is a potent and 
selective 5-HTIA agontst (Hjorth et al., 1982) it was concluded that forepaw 
treading and flat body posture occurred as a result of 5-HTIA receptor 
activation (Tricklebank et al., 1985a). Stimulation of the 5-HI'lA receptor by 
either the non-selective receptor agonist 5-MeODMT (Tricklebank et al.. 
1985b) or the 5-HTIA selective agonist 8-0H-DPAT (Hjorth et al., 1982) 
produced a significantly greater response in the isolation-reared animals, 
indicating postsynaptic 5-HTIA supersensitivity. We have shown earlier in 
this chapter that stimulated release of 5-HT is reduced in isolation-reared 
animals, suggesting reduced presynaptic function. It is possible that the 
reduced presynaptic function may result in compensatory postsynaptic 
receptor up-regulation. In work investigating isolation-induced behaVioural 
deficits in mice Frances et al. (1990) also found enhanced effects of 8-0H-
DPAT in isolated animals compared to the controls suggesting 
hyperreactivity to 5-HTIA agonists. However, an electrophysiological study 
looking at the sensitivity of the soma to dendritic 5-HTIA autoreceptor in the 
dorsal raphe nucleus found greater inhibition in response to 8-0H-DPAT in 
isolation-reared rats but this did not reach Significance (Mundey et al., 
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1991). The use of a different strain of rat and absence of reserpine 
pretreatment may explain the reduced forepaw treading behaviour obselVed 
in this study in the socially-reared group after 8-0H-DPAT treatment 
compared with published data (e.g. Tricklebank et al.. 1985a). The head 
weaving component of the 5-HT behavioural syndrome induced by both 5-
MeODMT and 8-0H-DPAT is abolished by reserpine pretreatment 
(Tricklebank, 1984). suggesting that this component is not a direct result of 
post-synaptic receptor activation. This may explain why no difference was 
observed in 5-MeODMT-tnduced head weaving between social- and Isolation-
reared anJrnals in the present study. 
In alcohol-preferring rats it has been shown that there is a reduction in the 
tissue levels of 5-HT in the cortex, hippocampus and striatum (Murphy et al .. 
1982). In this same strain of rats it has been shown that there is a higher 
density of 5-HTIA receptors in the hippocampus and cerebral cortex (Wong et 
al .• 1990) and they suggest that this results from reduced levels of 5-HT. This 
is indirect supportive evidence for the effects obselVed in this study. 1.e. 
reduced presynaptic 5-HT function may lead to the enhanced post-synaptic 
responslvity obselVed in the present study following agonist induced post-
synaptic receptor stimulation. 
Back muscle contractions have been shown to be mediated by 5-HT2 
receptors (Fone et al.. 1989; Fone et al.. 1990) whilst wet-dog shakes are 
thought to involve 5-HT2 and other (non-5-HT) receptors (Bedard and 
Pycock. 1977; Fone et al.. 1987; Yap and Taylor. 1983; Yocca et al.. 1990). 
DOl. a 5-HT2 agonist (Glennon. 1987). produced some forepaw treading and 
slight flat body posture. indicating some 5-HTIA activity. and using a lower 
dose may have removed all activity at this site. DOl produced a greater 
number of back muscle contractions in isolation-reared rats Indicating that 
the 5-HT2 receptor responsiveness is also enhanced in the SOCially-isolated 
rats. In contrast. DOl induced wet-dog shakes were not increased in the 
isolation-reared animals. However. other neurotransmitters apart from 5-
HT have been implicated in this wet-dog shake behaviour. For example. 
dopamine has an inhibitory effect on 5-HT-mediated wet-dog shake 
behaviour (Bedard and Pycock. 1977). and a previous study has demonstrated 
increased dopamlnergic function in isolation-reared animals (Jones et al.. 
1988). This may explain the lack of effect of isolation-rearing on DOl 
induced wet-dog shakes. The enhanced DOl-induced back muscle 
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contractions in isolation-reared animals is of interest as few other studies 
investigating 5-HT2 receptors have shown up-regulation. Fone et al. (1989) 
showed a significantly greater number of back muscle contractions induced 
by the 5-HT2 selective agonist 2.5-dimethoxy-cx.4-dimethyl-benzene 
ethamine hydrochlOride (DOM) (Glennon. 1987) 10 days after intrathecal 
administration of 5.7 -dthydroxytryptamtne but with no change observed in 
wet-dog shake behaviour. Enhanced 5-HT2 receptor-mediated responses and 
5-HT2 binding sites have been observed after electroconvulsive shock 
treatment in rats (Green et al .. 1983a). However. chronic treatment with 5-
HT2 antagonists. for example ritansertn. leads to down-regulation and 
reduced 5-HT2 receptor number in the frontal cortex (Leysen et al.. 1986) 
indicating the difficulty of phannacologically up-regulating these receptors. 
The 5-HT2 receptors mediating back muscle contractions are thought to be 
located post-synaptic to the bulbospinal serotonergic nerve terminals and 
hence it is possible that these spinal 5-HT2 receptors may have different 
characteristics to those located supraspinally. 
An alternative explanation for the differences in responsiveness of the two 
groups of animals to 5-HT agonists is a change in metabolism of the drugs, 
with it being slower in the isolation-reared animals. thus leading to a greater 
behavioural response. Against this hypotheSiS is that only certain 
responses were enhanced (forepaw treading and flat body posture) while 
others (head weaving and wet-dog shakes) were unchanged. whereas a change 
in metabolism would be expected to alter all of the responses. 
In summary. the results indicate that isolation-rearing produces changes in 
the releasable pool of 5-HT in the frontal cortex compared to group-reared 
rats and there is an enhanced postsynaptic responsiveness of the 5-HTIA and 
5-HT2 receptors in these animals. However, the present study has not 
detennined whether the changes in responsiveness of the 5-HTIA and 5-HT2 
receptors are as a result of increased receptor number or an enhanced 
response by the receptor-coupling mechanism system. questions which are 
currently under investigation. Further studies are also needed to determine 
whether the effects observed with the 5-HT agonists in the isolation-reared 
animals occur as a result of a long-tenn developmental change caused by 
social isolation. 
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CHAP1ER8 
GENERAL DISCUSSION 
GENERAL DISCUSSION 
The overall aim of this thesis was to study 5-HT neuronal function, using in 
vivo mlcrodlalysls to monitor 5-HT release, and to correlate this with 
ongoing behaviour thought to reflect anxiety. After studying two different 
models of anxiety, the elevated X-maze and the fear-potentiated acoustic 
startle paradigm, the elevated X-maze was used to study the effects of various 
serotonerglc agents thought to be putative arudolyUcs after both acute and 
chronic treatment. Using the X-maze it was possible to combine behaviour 
with mlcrodialysis and monttor neurochemical and behavioural changes in 
the same animal, and then to study the effects of established (BDZ) and 
putaUve (5-HT) anxiolyUcs on these changes. Using in vivo techniques 
allowed the study of both pre- and postsynaptic 5-HT function in the 
SOCially-isolated rats which displayed 'anxious' behaviour on the X-maze. 
Pharmacological VaUclation of the Elevated X-Maze and Fear-Potentiated 
Acoustic Startle Behavioural Paradlgml 
Both the elevated X-maze and the fear-potentiated acousUc startle paradigms 
are well established behavioural models of anxiety. In order to look at the 
effects of putative anxiolyUcs, such as the 5-HTIA receptor partial agonist 
Ipsa pirone, it Is first necessary to demonstrate that the paradigms used in 
this thesis could detect the activity of established anxlolytlc and anxlogentc 
compounds, and also the Suitability of these models for combined studies 
with microdlalysls. In the elevated X-maze, diazepam, a benzodiazeplne 
agonist, was found to dose-dependently reduce the Indices of anxiety but had 
no effect on the general locomotor acUvity. In the fear-potenUated acoustic 
startle paradigm diazepam was found to have an anxiolyUc effect but at 
doses which also caused some sedation. Conversely, the partial Inverse 
agonist at the benzodlazepine/GABAA receptor complex, FG 7142. which has 
been found to induce anxiety in man (Dorow et aI., 1983), dose-dependently 
increased the indices of anxiety In the X-maze. In the potentiated startle 
paradigm, FG 7142 slgntflcantly increased both the potentiated startle and 
the basal startle. As a result of the increased basal startle it cannot be 
determined whether the raised potentiated startle Is a result of an anxiogentc 
effect of FG 7142 or a result of increased arousal caused by the drug. 
Idazoxan, an «2 -adrenoceptor antagonist, significantly Increased the 
Indices of anxiety In the X-maze, but as a result of variations between 
Individual animals this only approached significance in the potentiated 
103 
startle paradigm. The arudogenic effects of idazoxan in the X-maze are in 
agreement with clinical studies in which yohimbine, another a2-
adrenoceptor antagonist. has been reported to produce anxiety and Induce 
panic attacks (Charney et aI., 1984), and clonldine, an a2-adrenoceptor 
agonist. to reduce anxiety (Redmond, 1982). 
Although both behaVioural paradigms have been pharmacologically 
validated. the elevated X-maze produced more reproducible and dose-
dependent results In comparison to the potentiated startle. For this reason, 
and that the model has been well validated phySiologically (Pellow et aI., 
1985). together with the simplicity of procedure, the elevated X-maze was 
chosen as the behavioural model of arudety for use In the studies In this 
thesis. Having established the behavioural responses to standard anxiolytic 
and anxiogenic compounds it was possible to look at the effects of acute and 
chrOniC treatments of various agents that directly interact with 5-HT 
receptors on behaviour in the X-maze. Further. with the X-maze being open-
roofed it was possible to combine this test with microdlalysis, thus allowing 
simultaneous neurochemical and behavioural changes to be measured in the 
same animal. 
Effects of Acute and Chronic Treatment of Various Serotonergic Agents In 
the Elevated X-Maze 
Acute diazepam produced a significant anxiolytic profile on the elevated X-
maze. Chronic treatment with diazepam produced an anxtolyttc profile, 
indicating no tolerance to its anxtolytic effects. This may be due to the 
selected dose of diazepam not being large enough to induce tolerance using 
the X-maze, or that the dose produced a supramaximal effect on the X-maze 
and hence even if some tolerance developed it was still possible to observe a 
maximal effect on the X-maze. 24 hours after the last dose of diazepam no 
anxtolyttc activity was observed and behaviour did not differ significantly 
from controls. However, using a different design of elevated X-maze File and 
Baldwin (1989) have been able to detect arudogenic withdrawal effects using 
chlordiazepoxide at doses of 5 and 20 mg/kg l.p .. It may be necessary to use 
higher (t.e. 10 or 20 mg/kg) doses of diazepam to cause Significant 
withdrawal behaviour as Indicated by previous studies (Costall et aI., 1990a). 
Idazoxan given both acutely and chronically resulted in an arudogenic 
profile, indicating a lack of tolerance to the drug. This is supported by 
electrophysiological data where acute idazoxan after 14 days chroniC 
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treatment with idazoxan Increased dorsal raphe nucleus 5-HT neuronal 
firing to the same level as that of acute idazoxan (Garratt et al .. 1991). Acute 
administration of the 5-HT1A partial agonist ipsapirone had no effect on 
behaviour on the X-maze at doses of 0.01 and 1mg/kg l.p .. but O.lmg/kg l.p. 
produced a sign1ficant anxtogenic proflle. 5-HTIA receptors are located both 
presynaptically on the cell bodies/dendrites of 5-HT neurones In the raphe 
nuclei and also postsynaptically In the limbic terminal regions (Hoyer et a1. 
1986a). It Is possible that the balance of receptor stimulation of these two 
sites varies depending on the dose of ipsaplrone. with low doses acting 
predOminantly at pre-synaptic sites and higher doses acting at a mixture of 
pre- and postsynaptic sUes. From the results of this study two possible 
explanations for the effects of Ipsaplrone are that 0.1 mg/kg l.p. is a high 
enough dose to cause postsynaptic receptor stimulation and produce an 
anxlogenic proflle on the X-maze (with the reason for no activity with the 1 
mg/kg dose being unknown). or stimulation of the presynaptic receptors at 
the 0.1 mg/kg dose produces an anxlogenlc profile which Is blocked by 
Increasing the dose to 1 mg/kg and stimulaUng both pre- and postsynaptic 5-
HTIA sites. Overall. the effects seen with ipsapirone do not fit well with 
those In the literature. Chronic treatment with Ipsapirone at these three 
doses had no significant effect on rat behaviour on the X-maze. A s1m1lar 
study has shown chrOniC administration of another 5-HTIA partial agonist. 
busplrone (1 mg/kg i.p. twice daily for 14 days). to have no effect In the X-
maze (Moser. 1989) although the drug has activity in the clinic (Goldberg and 
Finnerty. 1979; Goa and Ward. 1984). However. 24 hours after withdrawing 
chronic treatment. Ipsaplrone at 1mg/kg produced a Significant anxlogenlc 
profile. indicating a withdrawal effect which may be the result of changes in 
5-HTIA receptor function after chroniC treatment or to some unexplained 
withdrawal effect of that specific dose. Ritanserin. a 5-HT2 receptor 
antagonist. given acutely had no effect on any of the behavioural 
parameters. but chrOniC treatment produced a significant anxlolyUc effect 
which was still present 24 hours after cessation of treatment. correlating 
with effects obseIVed in the clinic (Ceulemans et al.. 1985). Further studies 
are required to determine whether there is any causal relationship between 
rltanserin Induced down-regulation of 5-HT2 receptors (Leysen et al.. 1986) 
and the anxiolytic profile observed in the present study. Acute ondansetron. 
a 5-HT3 receptor antagOnist. at all of the doses studied had no effect on 
behaViour on the X-maze. However. chroniC ondansetron treatment 
produced a significant anxiolytic profile. At present preUmiary clinical 
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trial data has been published but the necessary statistical analysis on this 
data has not been carried out (Abuzzahab. 1991). Thus, the results 
demonstrate that the X-maze can detect anx:1olytic activity in non-
benzodiazepine drugs. with the 5-HT2 and 5-HT3 receptor antagonists, 
ritansertn and ondansetron respectively. showing anx10lytic profiles but 
only after chronic treatment. In contrast. the X-maze falled to detect 
anx:1olytlc activity with the 5-HTIA partial agonist ipsaplrone after either 
acute or chrOniC treatment. In this study we were not able to detect any 
possible anx:1olyUc activity of ipsaptrone. and a greater range of doses may 
be necessary to observe some activity. Ipsapirone displays a different 
clinical profile compared to ritanserin and ondansetron and it is possible 
that the X-maze is unable to easily detect compounds with 5-HTIA receptor 
partial agonist activity. 
Intracerebral MlcrocUalyals and NeUlOw Release 
Intracerebral m1crodialysis was chosen as the technique to examine in vivo 
serotonergic function. Before microdialysis can be used in conjunction with 
behaviour on the X-maze or to study stimulated release in isolation-reared 
rats it was necessary to demonstrate that the 5-HT being measured was of 
neuronal origin and not from platelets, mast cells or gl1a (Sneddon. 1973: 
Austen, 1986: Kimelberg. 1986). Chapter 4 deSCribes the validation procedure 
used for the technique and these experiments led to the conclusion that the 
release of 5-HT measured in the hippocampus was indeed neuronal. In 
Chapter 7 dialysis is carried out in the frontal cortex of anaesthetised 
animals. and validation of the origin of 5-HT in this procedure comes from 
data of Kidd (1990) who used this technique extensively and validated the 
neuronal origin of 5-HT. The neuronal nature of 5-HT release in the freely 
moving and anaesthetised animals was first examined using tetrodotoxin 
(TIX), which blocks action potential conduction in neurones (H1l1e, 1968), 
which was included in the perfusate and inhibited 5-HT release, showing 
that it was dependent upon action potentials. Second. perfusion with Ca2+-
free CSF also decreased the release of 5-HT in both the conscious and 
anaesthetised experiments suggesting that a Ca2+-dependent mechanism was 
involved. In both conscious and anaesthetised animals there was a small 
residual component of 5-HT release which was not sensitive to TrX or 
dependent upon Ca2+ and was probably, therefore, not neuronal. In the 
anaesthetised animals electrical stimulation of the dorsal raphe nucleus 
which sends projections to the cortex (Azm1t1a and Segal. 1978; Parent et al.. 
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1981) resulted in an increase in 5-HT release. None of these three 
manipulations altered 5-HIAA levels greatly. confirming previous reports 
that extracellular 5-HIAA is a product of intraneuronal metabolism of 
unreleased 5-HT and not of the released 5-HT (Grahame-Smith. 1971. 1974; 
Kuhn et al .. 1986; Kalen et al" 1988; Auerbach et al .. 1989: Sharp et al .. 1989c: 
Crespi et a1.. 1990). Therefore. 5-HIAA levels are not a good indicator of 5-HT 
release. In anaesthetised animals the 5-HTIA receptor agonist. 8-0H-DPAT. 
inhibited cortical 5-HT release probably as a consequence of stimulation of 
the somatodendrltic 5-HTIA autoreceptors in the dorsal raphe nucleus which 
inhibit 5-HT neuronal firing (Sprouse and AghaJanian. 1986: Crespi et a1.. 
1990: VanderMaelen et al .. 1986) and thus decrease 5-HT release. Having 
validated the dialysis technique for measuring neuronal release of 5-HT. it 
could then be used to determine changes in 5-HT levels upon exposure to the 
X-maze and the effects of established and putative arudolytlc compounds on 
these changes. Second. to examine pre-synaptic function in isolation-reared 
rats. 
Mlcrodlalysls and Behaviour OD. the Elevated X-Maze 
Placing the rats on the X-maze for a 20 minute period resulted in Increased 
extracellular 5-HT which returned to basal levels 40 minutes after the 
animals were returned to the home cage. The increase in 5-HT is not likely to 
be as a result of increased locomotor activity as drug-induced changes in 
extracellular 5-HT levels had no effect on general locomotor activity. It is 
thought that the open arms produce a greater 'fear' drive In rats. and thus 
more avoidance. compared to the closed arms and restricting the rats to 
either the open or closed arms of the X-maze resulted in increased 
extracellular 5-HT, with the increase being greater when restricted to the 
open arms. but not to a significant extent. This is pOSSibly due to the rats 
spending a large proportion of the time in the central square when they were 
placed on the open arms. and an open elevated runway may have proved a 
better as this would not have a central square to act as a 'closed 
environment'. Having established possible reasons for the lack of a 
significant graded response in increased 5-HT on the X-maze it should also 
be noted that when stUdying behaviour on all of the X-maze there was a lack 
of correlation between the peak increase in 5-HT levels and behaviour. 
except for the percentage open:totalentries which only approached 
significance. but this may be a result of relatively small numbers for the 
correlations. 
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Diazepam inhibited the increase in extracellular 5-HT in the ventral 
hippocampus and had an anx10lytic profile over the 20 minute period when 
the rat was placed on the X-maze. The ability of diazepam to inhibit the 
increase in 5-HT when the animal was placed on the X-maze may be 
associated with the anxiolytic profile it produces in the same animal. 
Diazepam also inhibited 5-HT release from the ventral hippocampus when 
the rat was returned to its home cage. Because no reduction in 5-1ff release 
was observed with diazepam before exposure to the X-maze it cannot be 
determined from this study whether the decrease in basal 5-HT levels when 
the animal is returned to the home cage after exposure to the maze is a result 
of diazepam on basal release, agreeing with a similar microdialysis study 
carried out by Pei et al. (1989b). or a 'hangover' effect occurring due to 
exposure to the X-maze where diazepam produced a very marked reduction in 
increased 5-lIT. The data from this part of the study suggest that redUCing 5-
HT release may be one of the mechanisms of action of the benzodiazepines 
which is important for their arudolyt1c activity. 
Ipsapirone treated animals did not differ in their behaViour from vehicle 
controls over the 20 minute period on the X-maze, but like diazepam, 
ipsapirone Significantly reduced the Increase In extracellular 5-HT when the 
animals were placed on the X-maze and also the basal levels when the 
animal was returned to its home cage. It is thought that ipsapirone inhibits 
the extracellular levels of 5-HT in the hippocampus via an action at the 5-
HTIA somatodendritic autoreceptor In the dorsal raphe nucleus (Hjorth and 
Magnusson. 1988: Hutson et aI., 1989; Sharp et aI., 1989c). This would 
suggest that inhibtion of hippocampal 5-HT release is not important in the 
mechanism of action of diazepam. However, ipsapirone may also be 
stimulating postsynaptic 5-HTIA sites in the limbiC regions such as the 
hippocampus to have an overall effect of not altering 5-HT neuronal activity, 
resulting in a behavioural profile that is not different from the vehicle 
treated animals. 
Further evidence towards the Inhibition of hippocampal 5-HT release being 
important in the arudolyUc activity of arudolytics comes from the data of 
F2692. This compound has very little activity at the benzodJazepIne/GA8AA 
complex but reduces the increase in 5-HT when the an1malis on the X-maze 
and has an anx10lytic profile but only during the first 5 minutes of exposure. 
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The lack of activity after 20 minutes may be a result of sedatory effects of 
this compound at the dose used. 
Overall. all three compounds inhibited the increase in 5-HT when the 
animals were exposed to the X-maze. Diazepam and F 2692 produced an 
anxlolytic profile and it is possible that the reduced increase In extracellular 
5-HT after diazepam or F2692 treatment may be one of the mechanisms by 
which they have their anxiolytic actions. However. against this theory is the 
ability of ipsapirone to reduce extracellular 5-HT and not to have any 
anxiolytic activity in this study. but it is possible that post-synaptic 5-HTIA 
receptor stimulation by ipsapirone in the hippocampus and other limbic 
regions may have the net effect of not changing 5-HT function in these 
animals. 
RedUCing the dialysis sample time by increasing the sensitivty of the HPLC-
ECD assay would allow changes in 5-HT levels to be studied over shorter 
periods of time. such as 5 minutes. the standard exposure time to the X-maze 
when studying behaviour alone. It is possible that over the period of 20 
minutes there is some habituation to the X-maze and this may reduce the 
changes in 5-HT levels and behaviour between drug treated and control 
animals. Also. providing the practical difficulties could be overcome. 
carrying out this type of study using in vivo voltammetry would prove very 
informative as monitoring could then occur over periods of seconds rather 
than minutes and differences in neurotransmitter release between the open 
and closed arms could be studied during normal behaviour on the X-maze. 
eliminating the need to restrict the animal to either of the arms. 
Behavioural Effects of Soclallsolatlon In Rats 
Rats reared in isolation from weaning show many behavioural and 
neurochemical differences from socially-reared controls. In this study rats 
were reared from weaning. either in isolation or social groups for 30 days 
and then for the duration of the experiment. were shown to have increased 
locomotor activity. Isolation-reared rats displayed an anxiogenic profile on 
the X-maze compared to SOCially-reared controls. which was not a result of 
the Increased locomotor activity. These results indicate that the changes 
seen in spontaneous locomotor activity and behaviour on the X-maze are via 
two different mechanisms. Resocialisation of isolation-reared rats for a 
further 30 days did not reverse this anxiogenic profile. and isolation of the 
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socially-reared rats for 30 days did not produce an arudogenic behavioural 
profile. indicating that the differences observed may be a result of a 
permanent developmental change. It remains to be determined what 
neurochemical events are involved in the sustained effects of rearing in 
isolation and whether the anxiogenic profile observed in the isolation-
reared rats is related to alterations in 5-HT function. 
Alterations In pre- and PMtaynaptic receptor function In laolation-reared 
rata 
Identical rearing conditions to those used in Chapter 6 were used and 
isolation-reared rats again showed increased locomotor activity. Using in 
vivo microdialysis it was demonstrated that 5-HT turnover in isolation-
reared rats was slightly increased but the stimulated increase in 
extracellular 5-HT by local KCI application was significantly less. suggesting 
that KCI stimulated release of 5-HT is reduced in isolation-reared animals. 
Also. after systemic administration of fenfluramine the rise in extracellular 
5-HT was slightly 'later' in the isolation-reared animals. The reduced 
stimulated release of 5-HT. together with the possible increase in 5-HT 
turnover and delayed effects of fenfluramine in the frontal cortex suggest 
that the "functional pool" (Glowinski et at. 1979) may be reduced and the 
higher turnover of 5-lfI' preferentially stored in the "reserve pool" (Green and 
Grahame-Smith. 1975). with prolonged stimulation possibly leading to 5-lfI' 
'sp1lling over' into the "functional pool". 
The functional state of the post-synaptic 5-HTIA and 5-HT2 receptors was 
investigated using the "5-lfI' behavioural syndrome" induced by the non-
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selective 5-HT receptor agonist. 5-methoxy-N,N-dimethyltryptamine (5-
MeODMl1. the relatively selective 5-HTIA receptor agonist 8-hydroxy-2-(di-
n-propylamino) tetralin (8-0H-DPAl1 and the 5-HT2/1C receptor agontst 1-
(2. 5-dimethoxy-4-iodophenyl)-2-amtnopropane (DOl). It is thought that the 
flat body posture and forepaw treading components of the syndrome are the 
result of postsynaptic 5-lfI'IA receptor activation (Tricklebank et at. 1985a). 
and 'wet-dog shakes' and back muscle contractions are a result of 5-HT2 
receptor stimulation (Fone et at. 1989). 5-MeODMT and 8-0H-DPAT elicited 
various components of the "5-HT behavioural syndrome" in both groups of 
animals. with forepaw treading and flat body posture being Significantly 
more pronounced in isolation-reared animals. DOl produced a Significantly 
greater number of back muscle contractions in isolation-reared animals but 
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there was no difference between the two groups in the number of wet-dog 
shakes produced. Forepaw treading and flat body posture are thought to be 
mediated by 5-lITIA receptor activation, and stimulation of this receptor by 
either 5-MeODMT or 8-0H-DPAT produced greater responding in isolation-
reared rats suggesting supersensitMty of the post-synaptic 5-l-fI'lA receptor. 
Wet-dog shakes are thought to be mediated by 5-1-fI'2 and other (non-5-HT) 
receptors while back muscle contractions have been shown to be mediated by 
5-HT2 receptors, indicating that there is also an increase in 5-lIT2 receptor 
responsiveness in the SOCially-isolated animals. In general. the results 
indicate post-synapUc 5-1-fI' receptor supersensiUvity in isolation-reared 
rats (which may be a consequence of reduced presynaptic function) and these 
receptor changes may be involved in the behavioural profile observed in 
such rats. 
Future Ezperlments 
5-HT3 receptor antagonists have been shown to have an arudolyUc profUe in 
the elevated X-maze and to date these compounds have not been reported to 
have any effects on serotonergic transmission. Thus it would be worthwhile 
to study the effects of these compounds on behaviour and 5-lIT release in the 
ventral hippocampus while on the X-maze: if an arudolyUc profile was 
produced and also inhibition of increased 5-HT release occurred it would 
provide strong evidence for the involvement of 5-HT in arudety. Now that 
microdialysls on the elevated X-maze is possible it would be useful to study a 
variety of brain regions to determine whether the same neurochemical 
changes occur throughout the brain, and also to go on and study other 
neurotransmitters. such as noradrenaline, to determine their involvement 
in 'arudous' behaviour on the X-maze. 
It would be interesting to combine in vivo microdialysis with other models 
of anxiety to determine whether any changes in 5-HT release observed. 
together with the effects of established and potential arudolyUcs on these 
changes. are the same as those seen in the X-maze, or whether changes in 5-
lIT function vary depending on the test used. 
In isolation-reared rats the postsynaptic supersensiUvity may be the result 
of increased receptor number or increased sensitivity in the receptor-coupled 
transduction system. Using both binding and second messenger studies it 
would be possible to determine what changes are occurring at the 
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postsynaptic membrane. It Is interesting to speculate whether the changes 
observed in the serotonergic system are a direct effect of isolation or 
secondary to alterations In another system. such as that of dopamine. It is 
known that some aspects of dopamine-induced behaviour are blocked by 5-
HT3 receptor antagOnists. and that the dopamlnergic system is enhanced In 
isolation-reared rats. and hence studying the dopamine - 5-HT3 receptor 
antagonist interaction in these animals may provide information on 
possible alterations In the interactions of these two systems in socially 
isolated rats. 
The 5-HTIA and 5-HT2 receptor postsynaptic supersensitivity observed In 
isolation-reared rats could alter their behavioural responses to potential 
anxiolytics that have a direct action on 5-HT receptors. Thus. it would be 
interesting to determine the effects of these compounds on behaviour of 
isolation-reared rats In several models of anxiety. 
The changes observed in both the serotonerg!c and dopaminergic systems in 
isolation-reared rats are robust and it may be possible using 
immunohistochemical studies to determine whether these changes are the 
result of alterations in the sprouting of these neurones during development 
leading to changes in the density of 5-HT and DA fibres. or alterations In the 
amount of transmitter stored in the vesicles or the number of vesicles 
releasing the transmitter when the neurone is depolartsed. 
Conclusions 
Overall. 5-HT appears to be involved In anxiety. with 'anxious' behaviour 
either on the X-maze or by isolation-rearing causing changes in 5-HT 
function. Thus one of the mechanisms of action of established and putative 
anxtolytlc and anxiogenic compounds may be via modulation of the 
serotonergic system. 
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